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ABSTRACT 
Functional and Biochemical Characterization of KCNQ1/KCNE1 Subunit Interactions in 
the Cardiac IKs Potassium Channel  
Priscilla Jay Chan 
The IKs potassium channel, critical to control of heart electrical activity, requires 
assembly of pore-forming alpha subunits (KCNQ1) and accessory beta (KCNE1) 
subunits.  IKs is the slowly activating component of delayed rectifier K+ current in the 
heart and is a major contributor to the timing of repolarization of the cardiomyocyte 
membrane potential.  Inherited mutations in either IKs channel subunit are associated with 
cardiac arrhythmia syndromes, including long QT syndrome (LQTS), short QT syndrome 
(SQTS) and familial atrial fibrillation (FAF). 
The biophysical properties of IKs channel current are dramatically altered when 
KCNE1 associates with the KCNQ1 channel. Functional tetrameric channels can be 
formed by KCNQ1 alone, but co-assembly with KCNE1 is required for the unique 
kinetics necessary to regulate human cardiac electrical activity as well as for the 
channel’s functional response to the sympathetic nervous system. Specifically, KCNE1 
co-assembly results in a depolarizing shift in the voltage dependence of activation, an 
increase in the single channel conductance, and an increase in current density. IKs channel 
current is also characterized by slow activation and deactivation kinetics, with little or no 
inactivation, in contrast to the KCNQ1 homomeric channel, which is characterized by 
fast activation and deactivation kinetics and clear inactivation.   
We wanted to understand how KCNE1 modulates the KCNQ1 channel 
functionally and investigate the structural determinants of this modulation. In Chapter II, 
we explore the role(s) of KCNE1 in the context of two KCNQ1 atrial fibrillation 
associated mutations, S140G and V141M.  In contrast to published results, we find 
distinct dependence on the KCNE1 subunit for V141M, but not for S140G.  Having 
determined the importance of KCNE1 for V141M functionally, we continued to explore 
the role of KCNE1 structurally for this mutation.  Using cysteine substitution in both 
KCNQ1 and KCNE1 subunits, we monitored spontaneous disulfide bond formation and 
find that V141C crosslinks to KCNE1, while S140C does not.  Having established the 
functional and structural importance of KCNE1 for V141M, we proposed that there could 
be mutations in KCNE1 that could reverse the consequences of slow deactivation in the 
V141M mutation.  In Chapter III, we engineer amino terminal KCNE1 mutations and 
demonstrate that this domain is important for controlling deactivation, but not activation, 
kinetics of the KCNQ1 channel.  We find two KCNE1 mutations, L45F and Y46W, 
which when co-expressed with either V141M or S140G mutations in KCNQ1, help 
restore the mutant channel back towards a wild-type IKs channel.  From these results, we 
propose that the amino-terminal domain could play an important role in mediating the 
rate of deactivation in KCNQ1/KCNE1 channels.  After testing mutations on KCNE1 
that could affect normal channel function, we continued with a project to study mutations 
on KCNQ1 that would have similar dramatic effects on the channel.   In Chapter IV, we 
mutated KCNQ1 residue S140 to Threonine and found that S140T co-assembled with 
KCNE1 produced a channel having functional characteristics opposite to that of 
S140G/KCNE1 channels.  In contrast to S140G/KCNE1 channels, where channels tend 
to stay open due to very slow deactivation kinetics, S140T/KCNE1 channels tend to be 
stabilized in the closed state and require more depolarized pulses to open channels.  In 
addition, we find that a mutation at position Y46 in KCNE1, when co-expressed with the 
S140T mutation in KCNQ1, helps restore the mutant channel back towards a wild-type 
channel.   Again, here we provide evidence that the amino terminal end of KCNE1 could 
play a role in controlling deactivation.  In Chapter V, we investigated the importance of 
where KCNE1 is located in the channel and also how KCNQ1/KCNE1 subunits assemble 
using a tandem construct, with 1 KCNE1 subunit tethered to 2 KCNQ1 subunits (EQQ). 
To investigate the significance of KCNE1 location, we explored the functional 
consequences of having the S140G or V141M mutations in the proximal (closest to 
KCNE1) or distal (farthest from KCNE1) KCNQ1 subunit.  We find that having a 
mutation in the proximal subunit is subject to modulation by KCNE1, but not the distal 
subunit.  Using crosslinking, we want to confirm proper assembly of the heterotetrameric 
channel to verify that KCNE1 assembles between S1 from one KCNQ1 subunit and the 
S6 domain of an opposing KCNQ1 subunit.   
Taken together, we demonstrate that the proximity between the N-terminus of 
KCNE1 and the S1 domain of KCNQ1 could play a role in modulating deactivation 
kinetics of KCNQ1.  These findings will be of great importance in understanding normal 
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In order for the mammalian heart to function properly, a coordinated sequence of 
electrical impulses, that initiates in the atria and propagates to the ventricles, is required.  This 
electrical activity comes from the generation of action potentials, which are a net result of the 
sequential activation and inactivation of ion channels that conduct depolarizing inward (Na+ and 
Ca2+) and repolarizing outward (K+) currents.  Potassium currents are particularly important in 
the repolarization phase of the action potential and help to stabilize the resting potential in cell 
membranes.  Repolarization is attributed to the efflux of K+ ions due to activation of several 
voltage-gated potassium channels.    
 
The Cardiac IKs channel is comprised of KCNQ1 and KCNE1  
Potassium (K+) channels in the heart are important for the regulation of action potential 
duration and control of the cellular resting membrane potential.  Noble and Tsien first identified 
in sheep Purkinje fibers that there are two potassium-sensitive components, that contribute to the 
delayed rectifier K+ current in order to control action potential duration (Noble and Tsien, 1969).   
These two components were later defined pharmacologically as IKr and IKs.  IKr was described as 
the rapidly activating component, which could be blocked by class III anti–arrhythmic drugs, 
while IKs was classified as the slowly activating outward component of the delayed rectifier K+ 
current and was drug insensitive (Sanguinetti and Jurkiewicz, 1990).   The molecular identity of 
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IKs, consisting of a tetramer of pore-forming alpha subunits, KCNQ1, and the accessory beta 
subunit, KCNE1, remained unknown for several more years.  
KCNE1 was discovered before KCNQ1 and was thought to form the basis of the IKs 
current because it produced a slowly activating outward potassium current when expressed in 
Xenopus oocytes (Takumi et al., 1988).  However, the idea that KCNE1 formed functional 
channels on its own caused a fair amount of debate because it is a single membrane spanning 
protein containing only 129 amino acids and it did not share the same characteristics as other 
voltage gated K+ channels (Murai et al., 1989; Folander et al., 1990; Takumi et al., 1991).  In 
later studies, it was shown that KCNE1 did not conduct currents when expressed in mammalian 
cell lines: ClC-2, CHO, and Jurkat cell lines (Lesage et al., 1993).  The controversy was 
eventually settled when KCNQ1 was discovered in a positional cloning study that was 
investigating the gene responsible for Long QT Syndrome (LQTS) (Wang et al., 1996b).  In this 
study, the authors establish KCNQ1 as the chromosome 11-linked LQT1 gene responsible for the 
most common inherited cardiac arrhythmia.   
Further studies clarified that KCNE1 is not a K+ channel itself, but is an essential subunit 
that assembles with KCNQ1 to form the IKs channel complex (Barhanin et al., 1996; Sanguinetti 
et al., 1996).  Both groups observed that when KCNE1 was expressed in mammalian cells, COS-
7 and CHO, they saw no detectable current, but when co-expressed with KCNQ1, they saw a 
slowly activating outward current, almost identical to cardiac IKs.  They performed further 
experiments that involved co-expression of KCNQ1 and KCNE1 in Xenopus oocytes, which 
resulted in currents with much greater current amplitude than currents from KCNE1 expression 
alone.  From these results, both groups concluded that KCNE1 is not a K+ channel itself, but is 
an accessory subunit that assembles with KCNQ1 in order to produce the slow outward 
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potassium current.  The experiments initially characterizing KCNE1 were performed in oocytes, 
and to explain the current that was exhibited by from these cells, it was concluded that KCNE1 
was assembling with an endogenous K+ channel to produce current.  Thus, the link between the 
LQT associated gene, KCNQ1, and IKs was established and gave physiological significance to 
this current in the heart.   
 
Long QT Syndrome 
Long QT Syndrome (LQTS) is a disorder of the cardiac repolarization process, in which 
there is prolongation of the QT interval (QTc ≥ 0.46 seconds) affecting every 1 in 7,000 people 
of the general population.  LQTS is associated with recurrent syncope due to a transient, rapid, 
polymorphic ventricular tachycardia, also known as torsade de pointes, and sudden death.  This 
disorder can be acquired or inherited.  Acquired LQT can result from treatment with many types 
of drugs, including certain anti-arrhythmic medications or treatment for metabolic abnormalities.  
The inherited form of LQTS is predominantly an autosomal dominant disorder, known as 
Romano-Ward Syndrome, and can be caused by specific mutations in ion channel genes.  LQTS 
was found to be mapped to different loci in the human genome and these loci have been named 
chronologically in order of their discovery.  Subsequently, using linkage analyses, the genes for 
LQT2 was discovered to be linked to the hERG potassium channel (Curran et al., 1993) and 
LQT3 was found to be linked to the cardiac SCN5A sodium channel (Wang et al., 1995).  
However, the gene for LQT1 was determined later and was found to be linked to the cardiac 
KCNQ1 potassium channel gene (Wang et al., 1996b).  The most common mutations occur in 
the first 3 identified LQT genes (LQT1-LQT3), with more than 50% occurring in KCNQ1, 
which is associated with LQT1.  Currently, there are 13 inherited forms of LQT identified.   
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There is also an autosomal recessive variant of LQTS known as Jervell and Lange-Nielson 
syndrome, which is characterized by QT prolongation and hearing loss.   
 
Atrial Fibrillation  
 
Atrial fibrillation (AF) is characterized by rapid and irregular activation of the atrium. It 
is caused mainly by multiple circuit-reentry, due to shortening of the action potential and 
reduction of the effective refractory period (Nattel, 2002).  AF affects nearly 1% of the general 
population and prevalence increases with age.  Many disease associated gain-of-function 
mutations have been found in KCNQ1.  These disease phenotypes include short QT syndrome 
(Bellocq et al., 2004), sudden infant death syndrome (Rhodes et al., 2008), and atrial fibrillation 
(Chen et al., 2003c; Hong et al., 2005; Lundby et al., 2007; Das et al., 2009).  Two mutations that 
cause atrial fibrillation, S140G and V141M, are of interest to us because they are both located in 
the S1 transmembrane region of KCNQ1 and have little or no effect on IKs channel function 
unless KCNQ1 is co-assembled with the beta subunit, KCNE1.   This will be the subject of 
Chapter II of the current investigation. 
In the study by Chen et al, a missense mutation in KCNQ1, S140G, was identified in 16 
members of a single family (Chen et al., 2003c).  This group characterized this mutation in a 
heterologous system and showed that co-expression of KCNQ1 S140G assembled with KCNE1 
resulted in constituitively open channels, which exhibited instantaneous activation in response to 
membrane depolarization.  They conclude that the S140G mutation causes a shortened action 
potential because of the increased outward K+ current due to the slow closing of channels, which 
in turn, was driving the membrane potential back to the resting membrane potential more quickly, 
thus shortening the repolarization phase of the atrial action potential.  Another report of a point 
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mutation associated with AF, V141M, was studied a few years later (Hong et al., 2005).  Here, a 
case of AF and short QT syndrome was diagnosed in utero.  The functional phenotype of the 
V141M mutation, co-assembled with KCNE1, produced channels similar to that which was 
described for channels containing the S140G mutation, exhibiting voltage-independent currents.  
However, recently, it was shown that both of these mutations are in fact, not voltage-independent, 
but actually exhibit extremely slow deactivation kinetics, so that it requires a longer time course 
for the channels to close (Restier et al., 2008).   Further examination of these mutant channels 
show that the instantaneous current seen previously (Chen et al., 2003c; Hong et al., 2005), was 
due to the accumulation of open channels caused by incomplete deactivation between 
depolarizing pulses due to mutation-altered channel deactivation kinetics.   In the study by 
Lundby et al, the functional consequences of point mutation, Q147R, in KCNQ1 was 
characterized, in which a patient exhibited AF and QT prolongation (Lundby et al., 2007).  
Q147R was found to cause loss-of-function when co-expressed with KCNE1 and gain-of-
function when co-expressed with KCNE2.  This group hypothesized that depending on the 
distribution of KCNE1 and KCNE2 subunits in the heart, the Q147R mutation in KCNQ1 could 
offer an explanation for AF and prolonged QT interval in the same patient.  In Das et al, the 
S209P mutation located in the S3 domain of KCNQ1 mutation was characterized (Das et al., 
2009).  Compared to the wild-type KCNQ1/KCNE1 channel, the S209P mutant activates more 
rapidly, deactivates more slowly, and exhibits a hyperpolarizing shift in the voltage dependence 
of activation. What is interesting about all these AF-associated mutations is that all report that 
co-assembly with KCNE1 is needed to see mutation-altered changes in channel function.   
 
Other physiological roles of KCNQ1  
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KCNQ1 is expressed mainly in the heart, but also in the kidney, intestine, pancreas, and 
the inner ear (Yang et al., 1997b).  A KCNQ1 knockout mouse study reported that in KCNQ1 -/- 
mice, no cardiac abnormalities were observed, but they exhibited deafness, cochlear disruption 
and gastric hyperplasia (Lee et al., 2000).   This study illustrates that KCNQ1 is important in the 
inner ear, and that loss-of-function in this gene can lead to Jervell-Lange Nielson syndrome 
(JLNS), which is associated with deafness and QT prolongation.   
 
KCNQ1 in the inner ear 
 In the ear, endolymphatic fluid produced by the stria vascularis surrounds the sensory hair 
cells of the cochlea and has a high concentration of potassium and a low concentration of sodium.  
IKs channels are necessary to maintain the high resting potential of +100 mV of the inner ear 
(Tyson et al., 1997).   Mutations in either subunit of the IKs channel can lead to JLNS-associated 
deafness due to the absence of K+ secretion into the endolymph of the scala media of the inner 
ear (Neyroud et al., 1997; Schulze-Bahr et al., 1997; Drici et al., 1998).   Complete homozygous 
functional loss of the pore-forming KCNQ1 subunit can lead to enough K+ depletion to cause 
deafness. 
 
KCNQ1 in the colon 
 In the intestine, KCNQ1 assembles with KCNE3 and is co-localized in crypt cells to form 
constituitively conducting channels (Schroeder et al., 2000).  They report that KCNQ1/KCNE3 
channels may form the potassium channel that is important for cyclic AMP-stimulated intestinal 
chloride secretion, which could be important in treating secretory diarrhea and cystic fibrosis.  
More recently, it was reported that KCNQ1 also assembles with KCNE2 in the stomach to 
	  	    
7	  
control gastric acid secretion (Dedek and Waldegger, 2001).  One group shows that targeted 
deletion of the KCNE2 subunit gene ablates gastric acid secretion and predisposes mice to 
gastric neoplasia (Roepke et al., 2010). They report that there is a balance between KCNE2 and 
KCNE3 and that if KCNE2 is depleted in gastric cells, KCNE3 is upregulated and vice versa.  
They indicate that KCNQ1 cannot function in the absence of both KCNE2 and KCNE3 in gastric 
parietal cells.  
 
Voltage-gated K+ Channels 
Voltage-gated ion channels are membrane embedded pore-forming proteins that help 
establish and control the voltage gradient across the plasma membrane of cells by allowing the 
flow of ions down their electrochemical gradient. They are activated by changes in electrical 
potential difference near the channel.  They are present in the membranes of many different cell 
types and are especially important in neurons and cardiomyocytes. 
Voltage gated K+ channels represent the most diverse family of ion channels in the heart 
and are the targets of several anti-arrhythmic drugs that help prolong the action potential duration 
(Tamargo et al., 2004).  The first voltage gated K+ channel was successfully cloned from 
Drosophila and is currently known as the Shaker channel (Jan and Jan, 1997).  Flies displayed 
abnormal leg shaking in response to ether exposure and they seemed to be missing a K+ current 
in their leg and flight muscles, so it was postulated that the defect was due to a K+ channel gene.  
This was the starting point of the investigations that led to the discovery of the diverse family of 
K+ channels we know of today. The K+ channel family is diverse due to the wide range of hetero-
tetramers that can be formed utilizing different subunits from within the same K+ channel family.  
This diversification is even more increased due to their ability to co-assemble with non-pore 
forming accessory beta subunits, also known as the KCNE proteins.   
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KCNQ1 belongs to the classical voltage-gated potassium channel family, consisting of 
676 amino acids, which forms six membrane-spanning domains, including the pore region 
(Figure 1-1).  This main K+ channel pore-forming protein is translated from a single gene, but the 
channel is made up of four separate subunits, which come together in the membrane to form 
functional channels (MacKinnon, 1991; Papazian, 1999).  To date, there are five known 
members of the KCNQ1 family (KCNQ1 – 5).   KCNQ proteins contain six TM domains, in 
which S1-S4 make up the voltage-sensing domain (VSD) and S5-S6 constitute a single pore-
domain.  All KCNQ proteins have six positively charged amino acids in the S4 domain located at 
every 3rd residue, except for KCNQ1, which only has four charges.  Membrane depolarization 
causes a physical outward movement of S4, which induces further conformational changes that 
open the channel to allow K+ permeation. The p-loop contains the pore signature sequence, 
(TxTTx)GYG, that dictates K+ selectivity, and is now considered the K+ selectivity signature 
motif (MacKinnon, 1995).   
 
 
Figure 1-1.  KCNQ1 and KCNE1 comprise the IKs channel.  (A) Schematic of KCNE1 (blue) 
and KCNQ1 (green).    




KCNE1, on the other hand, is a single membrane-spanning protein of only 129 amino 
acids (Figure 1-1).  There are five members of the KCNE family (KCNE1-5), in which KCNE1 
is the founding member of this family and subsequently, KCNE2-KCNE5 were discovered by 
homology searching using databases (Takumi et al., 1988; Abbott et al., 1999; Piccini et al., 
1999). The KCNQ1 channel is unique in that it can be modulated by all 5 KCNE1 proteins.  
KCNE2, aside from associating with the hERG channel to form IKr, the rapidly activating inward 
rectifier current, also assembles with KCNQ1 to form a voltage-independent channel (Tinel et al., 
2000).  KCNE2 co-assembly with KCNQ1 leads to currents with an apparently instantaneous 
activation, a rapid deactivation process; and a linear current±voltage relationship. In addition to 
the gating effects, there was a decrease in the amplitude of the outward current (Tinel et al., 
2000). Aside from the heart, there is evidence demonstrating that KCNE2/KCNQ1 channels are 
expressed in the stomach and may play a role in gastric acide secretion and gastric cancer cell 
proliferation (Roepke et al., 2010).  Similarly, KCNE3 associates with KCNQ1 to form a 
constituitively open channel, important for gastric K+ secretion (Schroeder et al., 2000).  KCNE4 
is an inhibitor of KCNQ1 channel activity (Grunnet et al., 2002).  To date, the function of the 
KCNE5 protein has not been established, but functional studies show that KCNE5 induces both a 
time- and voltage-dependent modulation of the KCNQ1 current. Interaction of the KCNQ1 
channel with KCNE5 shifts the voltage activation curve of KCNQ1 by more than 140 mV in the 
positive direction (Angelo et al., 2002).  
 
Functional Characteristics of KCNQ1/KCNE1 
 
The IKs channel is formed by co-assembly of KCNQ1 and KCNE1 (Barhanin et al., 1996; 
Sanguinetti et al., 1996).  The biophysical properties of the KCNQ1 current are dramatically 
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altered when this subunit associates with KCNE1 (Figure 1-2). In the presence of KCNE1, there 
is an increase in current amplitude, a slow onset of activation, a depolarizing shift in the voltage 
dependence of activation, an increase in the single channel conductance, and removal of 
inactivation. IKshas a linear current voltage relationship, in contrast to the KCNQ1 current alone.  
   
 
Figure 1-2.  KCNE1 co-assembly with KCNQ1 dramatically alters channel biophysical 
properties.  Family of current traces for KCNQ1 (A) and KCNQ1 + KCNE1 (B).  Cells were 
depolarized from -40 mV to +80 mV in 20 mV increments for 2 s and then repolarized to -40 
mV for 2 s. Interpulse holding potential was -80 mV.  
 
 
KCNQ1 subunits can form functional channels on their own. These homomultimeric 
channels are characterized by their rapidly activating currents, reaching full activation within 1 
second (Sanguinetti et al., 1996; Yang et al., 1997b; Wang et al., 1998) and undergoing 
inactivation during depolarization.  An inactivation hook can be seen in recordings as a hook in 
the tail currents, which is produced because the rate of recovery from inactivation is faster than 
deactivation, thus what we see are channels opening upon repolarization followed by a very slow 
rate of deactivation (Pusch et al., 1998; Tristani-Firouzi and Sanguinetti, 1998).  The extent of 
inactivation can be quantified by measuring these inactivation hooks.   
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The mechanism of how KCNE1 modulates KCNQ1 is unclear. Many studies have been 
done to determine points of contact between KCNE1 and KCNQ1 (Haitin et al., 2008; Shamgar 
et al., 2008; Xu et al., 2008; Chung et al., 2009; Lvov et al., 2010; Zheng et al., 2010). There is 
evidence showing that the transmembrane region of KCNE1 interacts with the KCNQ1 pore to 
regulate channel activity (Tapper and George, 2000; Melman et al., 2004) and that the C-
terminus controls deactivation kinetics (Takumi et al., 1991; Tapper and George, 2000; Chen et 
al., 2009). These findings will be reviewed in more detail as they are important in the current 
investigation in trying to understand and determine a unifying mechanism for KCNE1 
modulation of KCNQ1 channels.   
 
Regulation of IKs 
  The sympathetic nervous system is responsible for up- and down-regulating many  
homeostatic mechanisms in living organisms, including increasing the rate and force of 
contraction in the heart. Cardiovascular diseases, such as hypertension and heart failure, are often 
associated with sympathetic nervous system (SNS) overactivity. Conversely, exercise has been 
shown to reduce hypertension and decrease elevated SNS activity.  
 SNS stimulation leads to activation of beta-adrenergic receptors, which results in protein 
kinase A (PKA) - mediated phosphorylation of IKs channels.  The functional regulation of the IKs 
channel by PKA requires the A kinase-anchoring protein (AKAP) Yotiao (Marx et al., 2002). 
Yotiao forms a macromolecular complex with the channel and recruits key enzymes such as 
PKA and protein phosphatase 1 (PP1) to control the phosphorylation state of IKs.  Voltage-gated 
K+ channels do not exist only as independent proteins responding to changes in the 
transmembrane potential, but as macromolecular complexes that are able to integrate a wide 
range of cellular signals which can fine tune channel activities (Marx et al., 2002).   
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Structural Characteristics of IKs 
The question of how KCNE1 modulates KCNQ1 has been a question concerning 
investigators since it was first discovered that this accessory subunit assembles with KCNQ1 to 
recapitulate the cardiac IKs current (Barhanin et al., 1996; Sanguinetti et al., 1996).   Although 
there are many hypotheses on this subject, there is no unifying answer as to how this accessory 
subunit is able to cause such dramatic changes on channel function.  However, the following 
review will summarize many of the studies attempting to address the mechanism of KCNE1 
modulation, including studies involving stoichiometry, structural models, and structure-function 
studies of KCNE1/KCNQ1 interactions.   
 
Stoichiometry 
It was determined 20 years ago that voltage-gated K+ channels are comprised of a 
tetramer of alpha subunits that come together to form a single ion conduction pore (MacKinnon, 
1991).  During this time, it was still being debated whether KCNE1 was the only subunit in the 
IKs channel complex, so the initial studies were not the best, but they helped us understand how 
to address the question of stoichiometry.  Wang and Goldstein first attempted to determine the 
stoichiometry of KCNE1 in the channel complex (Wang and Goldstein, 1995).  This group used 
various ratios of KCNE1 mutants (D77N) co-expressed with wild-type KCNE1, which produced 
non-conducting channels.  They concluded that there are two functional KCNE1 subunits in each 
channel based on binomial distribution analysis.  Another study determined that there were at 
least 14 KCNE1 subunits in each channel (Tzounopoulos et al., 1995).  However, their 
investigation was flawed due to their use of a KCNE1 mutant (S69A) expressed with wild-type 
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KCNE1, which caused variable expression.  Their error is possibly a result of not controlling for 
the changes in current amplitude with this particular mutant. 
After it was discovered that KCNQ1 assembles with KCNE1 to constitute the IKs channel 
complex (Barhanin et al., 1996; Sanguinetti et al., 1996), many groups started to investigate the 
number of KCNE1 subunits that could associate with the tetrameric KCNQ1 channel.  IKs gating 
kinetics are affected by the amount of KCNE1 cRNA that is injected into Xenopus oocytes 
(Blumenthal and Kaczmarek, 1994), so it is likely that the assembly and stoichiometry of 
KCNE1 and KCNQ1 subunits is important in determining how these subunits come together to 
exhibit the slow activating IKs current.  The Kass lab addressed this question by using tandem 
constructs, forcing a fixed stoichiometry of either 1:1 or 2:1 ratios of KCNQ1 to KCNE1 
subunits (Wang et al., 1998).  Using the 1:1 fusion protein, where one KCNE1 subunit is linked 
to one KCNQ1 subunit, (named mK24 for minK K+ channel 2,400 base pairs), they find that it 
exhibits current identical to IKs.  In addition, they find that channels formed by the mK24 
constructs can be further modulated by co-expression of additional KCNE1 protein.  For the 2:1 
fusion protein, two KCNQ1s linked to one KCNE1, they again observe currents similar to IKs.  
These results suggest that since KCNE1 is able to modulate the mK24 fusion protein, there is the 
possibility of multiple stoichiometries when this channel is expressed at the cell surface 
membrane.    
The Goldstein group revisited the stoichiometry question in 2003, where they came to the 
conclusion that the ratio of KCNQ1:KCNE1 in the channel complex was 4:2, consistent with 
their original finding.  Using a charybdotoxin (CTX) sensitive KCNQ1 construct, they assess 
KCNE1 stoichiometry in IKs channels using biophysical and biochemical techniques. CTX is a 
useful probe of K+ channels because it binds with one-to-one stoichiometry to occlude the ion 
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conduction pore (Miller et al., 1985; MacKinnon and Miller, 1988; Goldstein and Miller, 1993).  
They observe that CTX block of KCNQ1/KCNE1 channels formed from a fixed 2:1 
stoichiometric construct (two KCNQ1s and one KCNE1) matched the inhibition from channels 
formed from KCNQ1 and KCNE1 co-expression, whereas constructs formed from a 1:1 
construct (one KCNE1 and one KCNQ1) did not exhibit similar block.  Using biochemical 
methods, they used a monoclonal antibody to quantify radiolabled CTX channels formed from 
either 2:1 or 1:1 tandem constructs on the cell surface.  They confirmed with these experiments 
that they believe the stoichiometry to be 4:2.  However, the idea of multiple stoichiometries was 
not ruled out in this investigation because they were using fixed constructs.   
A study done by the Kobertz group reports a 4:2 KCNQ1:KCNE1 stoichiometry in 
Xenopus oocytes (Morin and Kobertz, 2007, 2008).  They use a modified CTX sensitive KCNQ1 
construct and were able to count individual KCNE1 subunits in the channel complexes.  They 
modify CTX to specifically react with cysteine residues in the N-termini of KCNE1 subunits.  In 
addition, they modify CTX to become a cysteine reactive inhibitor by engineering a maleimide 
group to the CTX mutant (CTX-Mal).  Maleimide groups protect cysteines because they form an 
irreversible thioether bond with the cysteine and make it stable to reducing agents.  In these 
experiments, they use an iterative subunit counting approach, where they apply CTX-Mal to the 
channels, in which the maleimide group should react with an N-terminal cysteine residue on 
KCNE1.  From this reaction, the KCNE1 cysteine residue is permanently modified and is 
prevented from reacting with subsequent CTX-Mal treatments.  At this point, the CTX block is 
irreversible until the CTX-Mal is washed out and the maleimide group is cleaved off of CTX 
with a reducing agent (TCEP).   The whole cycle is repeated until the CTX block becomes 
completely reversible with washout.  With this method, they were able to determine the 
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stoichiometry to be 4:2.  However, they performed their functional experiments at a voltage (+20 
mV), which did not allow all channels to be open.  The V1/2 of activation for IKs channels is 7.5 ± 
0.9 mV (Sanguinetti et al., 1996), so at +20 mV, all available channels are not open yet, so 
without fully activating all channels, it is hard to say whether all the channels are fixed in this 4:2 
ratio.  In addition, they injected only a single KCNQ1/KCNE1 injection ratio so it is possible that 
at this one particular ratio, only a 4:2 stoichiometry is feasible, but with other ratios, there could 
be variable stoichiometries.   
The most recent investigation concerning the stoichiometry of KCNQ1/KCNE1 was 
published by the Isacoff group (Nakajo et al., 2010).  In this study, the authors present the 
finding that the stoichiometry of the KCNQ1 and KCNE1 complex is variable, ranging from 4:1 
to 4:4, in which up to 4 KCNE1 subunits can associate with the KCNQ1 tetramer.  They say that 
the stoichiometry is dependent on the expression densities of KCNQ1 and KCNE1.  Total 
Internal Reflection Fluoresence (TIRF) is used to observe the fluorescence of a single molecule 
to count individual KCNE1 subunits in the KCNQ1 complexes.  In this study, they counted 
bleaching steps of fluorescently tagged KCNE1 proteins and were thus able to count the number 
of subunits in each complex.  When the tagged KCNE1 was co-expressed with KCNQ1, they 
observed a large number of complexes with three or four bleaching steps, indicating that more 
than two KCNE1 subunits could assemble with the channel complex.  They also tested a fusion 
protein with two KCNQ1s linked to one KCNE1, thus a forced 4:2 stoichiometry and found this 
complex could be further modulated with additional KCNE1 protein, but the fusion protein with 
one KCNQ1 and one KCNE1 could not be further modulated, indicating that 4 is the maximal 
number of KCNE1 subunits that can associate with the KCNQ1 tetramer.   
 
Structural models 
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Structural information about a protein provides a foundation for interpreting current 
functional and biochemical studies and provides a road map for future studies.  To date, there is 
no crystal structure of the IKs channel due to technical limitations (Van Horn et al., 2011).  
However, many Kv channels have been successfully expressed and purified for crystallization 
and we have been able to generate testable hypotheses using these models and apply them to the 
IKs channel.   
The first crystal structure of a potassium channel was KcsA and although this channel is a 
two membrane-spanning K+ channel, its amino acid sequence is actually very similar to those of 
eukaryotic six membrane-spanning K+ channels.  In particular, its sequence in the pore region, 
located between the membrane-spanning segments and containing the K+ channel signature 
selectivity sequence, is almost identical to that found in the Drosophila Shaker and vertebrate 
voltage-gated K+ channels, (Doyle et al., 1998).  Mackinnon’s group went on to reach a number 
of important conclusions about the architecture of the potassium channel using site-directed 
mutagenesis, electrical measurements, and crystallization techniques. They crystallize the 
bacterial K+ channel, KvAP (Jiang et al., 2003a) and the first mammalian Kv channel, Kv1.2, 
which is a member of the Shaker K+ channel family (Long et al., 2005a).  From the latter study, 
this group was able to determine the structural basis of voltage sensing and gating, which 
involves an electromechanical coupling of the S4 voltage sensor to the pore through the S4-S5 
linker.  This linker constricts or dilates the pore in order to open and close the channel.  However, 
at this point, these K+ channel structures only reflect the channel in the open states because of the 
absence of a hyperpolarized electrical potential during crystallization, so a closed state model of 
a K+ channel is yet to be determined.  Yet, there have been several structural models based on 
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biophysical and structure-function studies that have allowed us to speculate on the closed states 
of the K+ channel (Smith et al., 2007).   
To study the KCNQ1 channel, the Kv1.2 open state crystal structure was used as a 
template for homology modeling (Figure 1-3) (Smith et al., 2007).  In the initial study of Kv1.2, 
the electron density for specific regions of the channel, including the loops connecting S1-S2, 
S2-S3, and S3-S4 and the voltage sensor, were weak.  In order to fill in the gaps of the Kv1.2 
template, Rosetta software was used and an ensemble of possible structures was generated to 
help predict a model for the entire channel.  A closed state model of KCNQ1 was also generated 
based on previous closed state models of Kv1.2 (Yarov-Yarovoy et al., 2006).  From this 
KCNQ1 structural model, Smith and colleagues predicted a location for KCNE1, hypothesizing 
that KCNE1 could sit in an intersubunit cleft, involving the S1-S3 segments in the KCNQ1 
channel.  Interestingly, this cleft is associated with many known gain-of-function (gof) disease 
mutations, which have been reported to depend on KCNE1 (Chen et al., 2003c; Hong et al., 
2005; Lundby et al., 2007).  They offer an explanation for how these gof mutations could 
stabilize the open state in the presence of KCNE1.   
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Figure 1-3. Extracellular view of KCNQ1 Tetramer.  
   
Following the KCNQ1 model, the Sanders group published another study where they 
incorporate KCNE1 into the channel complex, based on the known functional and biochemical 
studies at the time (Kang et al., 2008).  They dock KCNE1 to KCNQ1, showing that the 
extracellular end of KCNE1 forms an interface with the upper regions of S1, S5, and S6 of three 
different KCNQ1 subunits in the open state.  They also generate a closed state model, where they 
suggest that KCNE1 sits on and restricts movement of the S4-S5 linker, the element that 
connects the voltage sensor to the gate.  They conclude that, the point of contact between 
KCNE1 and the S4-S5 linker, is an adhesive interaction that must be overcome in order to 
transition from the closed to open states, offering an explanation for the slow activation of IKs 
(Kang et al., 2008).   
The structure of KCNE1 was studied by a number of groups using solution nuclear 
magnetic resonance (NMR) methods.  NMR spectroscopy and scanning mutagenesis studies 
indicate that the TMD of KCNE1 (residues 44-67) adopt an alpha helical structure (Aggeli et al., 
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1998; Chen and Goldstein, 2007; Tian et al., 2007b). Aggeli and Yang performed NMR studies 
of a 27-residue stretch (42-68) of the TM domain of this protein.  The NMR studies established 
that the TMD residues have an R-helical conformation, the helix being looser near the N-termini 
and more stable in the central region of the molecule (Aggeli et al., 1998).  In another study, 
KCNE1 was overexpressed in E. coli and purified. KCNE1 was then reconstituted in detergent 
micelle solutions and injected into Xenopus oocytes.  Several concerns with this technique are 
whether KCNE1 is correctly folded in these micelles and whether they could associate with and 
modulate KCNQ1 channels.  However, this group successfully performed NMR experiments 
with these KCNE1 micelles and concluded that the KCNE1 TMD (residues 45-71) includes 
several alpha helices, at which there is a break in helicity at residues 59-61 and that the distal C-
terminus (107-129) is disordered (Tian et al., 2007a).  Chen and Goldstein perform serial 
perturbation analysis on the first 23 residues of the TMD of KCNE1 (44-66), by substituting 
residues with tryptophan (hydrophobic), asparagine (polar uncharged) and arginines (polar 
charged) and characterizing the resultant functional changes.  Their results suggest the presence 
of different secondary structures within the transmembrane domain of KCNE1.  In agreement 
with previous studies, they also conclude that there is a break in helicity in the mid TMD around 
residue 56.  Their results suggest that the proximal region of the KCNE1 TMD (residues 44-55) 
is alpha helical and sits at the lipid-protein boundary and that the distal portion (residues 56-66) 
interacts within the channel center, coming close to the ion conduction pathway, in agreement 
with this groups previous investigations into the location of KCNE1 (Goldstein and Miller, 1991; 
Wang et al., 1996a; Sesti et al., 2000; Chen et al., 2003b). 
The Kobertz group investigated the secondary structure of the C-terminus of KCNE1 
(Rocheleau et al., 2006).  Using alanine and leucine scanning mutagenesis, they observed two 
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classes of KCNE1 mutants, which were segregated into those that had high or low impact 
changes on gating properties. They conclude that the cytoplasmic C-terminus of KCNE1 is a 
kinked alpha helix and is broken into two segments by a proline residue (P77). 
KCNE1 proteins have two well conserved N –linked glycosylation sites, N5 and N26, 
indicating that KCNE1 can be differentially glycosylated and can exist in immature or mature 
forms.  In one study, Chandrasekhar et al. demonstrates that the majority of KCNE1 proteins 
localize to the endoplasmic reticulum (ER) when expressed alone in mammalian cells and thus 
exist in the immature form (Chandrasekhar et al., 2006).  However, coassembly of KCNE1 
proteins with KCNQ1 channel subunits promotes KCNE1 protein trafficking to the cell surface.  
Subsequently, glycosylation of KCNE1 will occur at the cell surface and the mature form of 
KCNE1 will be expressed, producing functional KCNQ1/ KCNE1 channels.     
 
 Structure Function Studies 
The structural mechanisms by which KCNE1 modulates K+ channels are important in 
determining their roles in human physiology and cardiac related diseases.   There have been a 
number of investigations addressing the question of KCNE1 modulation, which will be reviewed 
here, including the location of KCNE1 in the channel complex, the sites of interaction between 
KCNQ1 and KCNE1, and the role of these possible sites of interaction.   
 
 
Studies on KCNE1 
 
Location in the IKschannel complex 
 
 For many years, there was considerable controversy concerning whether KCNE1 lined 
the inside of the ion conduction pathway or was located outside of the pore. Investigators used 
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cysteine scanning mutagenesis studies or pore-blocking drugs to determine the location of the 
TMD of KCNE1 within the KCNQ1 channel complex.  Drugs, such as tetraethylammonium 
(TEA), was used in functional studies because it blocked K+ channel pores (MacKinnon and 
Yellen, 1990; Yellen et al., 1991). One group observed that prior treatment of TEA to channels 
slowed methanethiosulfate-ethylsulfonate (MTSES) blockade with cysteine mutations in KCNE1 
(Wang et al., 1996a).  MTSES reagents normally react with exposed cysteines (Akabas et al., 
1992; Kurz et al., 1995; Pascual et al., 1995) and the Wang group argued that these reagents 
could not react with the KCNE1 cysteine mutations because TEA was already blocking the 
channel pore.  Therefore, they concluded that KCNE1 must be located in the pore.  Another 
group came to the same conclusion that KCNE1 lines the pore by studying cysteine mutations in 
KCNE1 and using the thiol reactive transition metal, cadmium (Cd2+), to monitor accessibility.  
Mutated KCNE1 residues in the TMD (F54C, G55C) exhibited Cd2+ blockade, so they 
hypothesized that this could only happen if Cd2+ was binding in and occluding the pore.  The 
mutation at G55C also altered ion selectivity in the channel, so they concluded that KCNE1 must 
lie in the pathway of ion conduction (Tai and Goldstein, 1998).  However, this group neglected 
the presence of a native cysteine, 331, in the KCNQ1 pore.  So what they saw in their results was 
due to Cd2+ block in the pore, but it was likely due to the native cysteine residue that was actually 
located in the pore, and not in KCNE1.    
Other studies show that KCNE proteins lie outside of the conduction pathway. Studies by 
Tapper and George recognized that the cysteine residue in the pore, C331, was responsible for 
Cd2+ sensitivity and that KCNE1 does not lie in the permeation pathway of the channel (Tapper 
and George, 2001). Kurokawa and Kass Lab colleagues studied TEA-sensitive KCNQ1 mutants 
(K318I, V319Y) and argued that blockade of the channel by TEA does not affect the 
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accessibility of KCNE1 residue 54 and 55 to external cadmium (Kurokawa et al., 2001).  The 
Kass Lab showed that engineering a TEA sensitive site into pore region did not affect TEA 
sensitivity, in the absence or presence of KCNE1. When these TEA-sensitive constructs were co-
expressed with cysteine substituted KCNE1 constructs, G55C and F54C, the channel showed 
increased sensitivity to Cd2+, indicating there was a pore-independent mechanism of block by 
Cd2+.  Currently, the location of KCNE1 is generally accepted to be peripheral to the KCNQ1 
channel as evidenced by KCNE1/KCNQ1 structural models (Kang et al., 2008).   
Recently, there have been many investigations trying to determine the specific 
interactions between KCNE1 and KCNQ1.  Two groups show that KCNE1 makes contacts with 
KCNQ1 in their extracellular loops by monitoring spontaneous disulfide formation between 
various cysteine substitutions in both subunits (Xu et al., 2008; Chung et al., 2009).  Chung and 
colleagues establish the location of KCNE1 to be situated between S1 and S6 of opposing 
KCNQ1 subunits.  
These studies demonstrate that we have a general idea of where KCNE1 is located within 
the channel complex, in the periphery of the channel complex, with proximity to the S1 domain 
of one subunit and the S6 domain of another subunit.  However, KCNE1 must associate with 
KCNQ1 in a specific manner in order to modulate gating and current amplitude, thus it is 
important to identify where KCNE1 is interacting with KCNQ1.  These KCNQ1/KCNE1 
interactions may involve one or many subregions of KCNE1 in order for modulation to occur, 
which will be reviewed shortly.  
 
N-terminus 
Although, the role of the N-terminus of KCNE1 has been implicated in affecting pH 
sensitivity of KCNQ1 assembled channels (Peretz et al., 2002; Heitzmann et al., 2007) and 
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involved in determining stoichiometry of the assembled channel (Chen et al., 2003b; Morin and 
Kobertz, 2008), the KCNE1 N-terminus has not been studied in terms of modulation of the 
KCNQ1 channel.  Stilbenes and fenamates, small molecule activators of the IKs channel complex, 
were found to be dependent on the KCNE1 amino terminus for their pharmacological effect 
(Abitbol et al., 1999).  Mutation or deletion of residues 39-42 in the N-terminus abolish these 
activators effects and suggest that this region of KCNE1 may be involved in interactions with 
KCNQ1.  
 
Transmembrane domain (TMD)  
 
 The importance of the KCNE1 transmembrane domain (TMD) in terms of KCNQ1 
modulation remains unresolved.   One group engineered synthetic peptides that included just the 
TM domain of KCNE1 and expressed them with KCNQ1 channels (Aggeli et al., 1998).  
However, these channels exhibited fast activating currents reminiscient of KCNQ1 channels 
expressed alone, indicating that the TMD alone cannot control modulatory activity of the channel.  
On the other hand, Melman and colleagues published a series of studies, emphasizing the 
importance of the TMD of KCNE1 and its role in controlling activation properties of the 
KCNQ1 channel.  They studied modulation of KCNQ1 by KCNE1 and KCNE3, where they 
generated chimeras of KCNE1 and KCNE3, and swapped the TMD residues 57-59 in KCNE1 
(FTL) with the equivalent residues 71-73 in KCNE3 (TVG) (Melman et al., 2001).  They 
demonstrated that these three TMD residues in both KCNE1 and KCNE3 were responsible for 
conferring activation properties when co-assembled with the KCNQ1 channel.  In this study, 
when KCNQ1 was co-assembled with KCNE1 chimera containing residues TVG, they observed 
a constituitively open channel, reminiscient of KCNQ1/KCNE3 channels (Schroeder et al., 2000).   
Conversely when KCNQ1 was expressed with KCNE3 containing FTL residues, they saw a 
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slowly activating channel, typical of a KCNQ1/KCNE1 channel (Barhanin et al., 1996; 
Sanguinetti et al., 1996).  In further studies, the same group named this stretch of amino acids the 
“activation triplet” and identified that a single residue was sufficient to confer the changes in 
activation kinetics, Thr 58 for KCNE1 and Val 72 for KCNE3 (Melman et al., 2002).   
 
C-terminus  
There are many studies investigating the importance of the C-terminus of KCNE1 and its 
modulatory role with KCNQ1 channels.  One group engineered synthetic peptides from the 
carboxy terminal region (aa 67-93) of KCNE1 and injected these peptides into Xenopus oocytes.  
The resultant channels exhibited IKs-like currents, indicating that this region was sufficient for 
potassium channel activity (Ben-Efraim et al., 1996).  However, these studies relied upon the 
modulation of an endogenous oocyte K+ channel (Sanguinetti et al., 1996).   It is possible that 
more than one region of KCNE1 is necessary for modulation of KCNQ1 channels.  
In 1991, Takumi was the first to demonstrate that both the TMD and C-terminus of 
KCNE1 was important for potassium channel activity. Using deletion and truncation mutants, 
they measured channel activity of the resultant mutant combinations and found both were 
important for channel activity (Takumi et al., 1991).  Tapper and George demonstrate that the 
TMD of KCNE1 is important for KCNQ1 association, but it is the C-terminus that is necessary 
for channel activity (Tapper and George, 2000).  Co-expression of KCNQ1 with a KCNE1 C-
terminal deletion mutant resulted in rapidly activating potassium current resembling currents 
from channels assembled with only KCNQ1, indicating an important modulatory role for the C-
terminus region of KCNE1.   As a control, they needed to verify that KCNE1 was associating 
with the channel, so they engineer a G55C mutation, located in the TMD, which confers 
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susceptibility to cadmium block.  Currents recorded from KCNQ1 and the KCNE1 G55C /C-
terminal deletion mutant exhibited cadmium block, indicating that KCNE1 is associated with the 
channel, but perhaps the C-terminus is needed to control channel activity.  To determine which 
regions of KCNE1 were necessary for both association and modulation, this group created 
chimeras between KCNE1 and a Na+ channel beta1 subunit.  They concluded that both the TMD 
and the C-terminus of KCNE1 are necessary for modulation and that the C-terminus alone is not 
sufficient for modulating channel activity, contrary to previous reports (Ben-Efraim et al., 1996).  
However, the Melman group would argue the opposite, that the TMD is important for 
modulatory activity and that the C-terminus anchors and positions the KCNE1 subunit into the 
channel (Melman et al., 2001).  In 2004, the Kobertz group set out to determine whether the 
TMD or C-terminus was responsible for modulation with the KCNQ1 channel, using chimeras of 
KCNE3 and KCNE1 (Gage and Kobertz, 2004).  For KCNE3, they find that the TMD was 
sufficient for assembly and modulation because the activation triplet, actively modulated 
KCNQ1 activation, in agreement with the results from Melman’s group.  However, for KCNE1, 
they find that the equivalent activation triplet in TMD of KCNE1 is passive, and that the KCNE1 
C-terminal domain is the region that controls gating.   
More recent work on the IKs channel has focused primarily on the importance of the C-
terminus in altering deactivation properties of the channel.  The MacDonald group suggests that 
the KCNE1 C-terminus may be involved in modulating KCNQ1 channel deactivation and be 
important for assembly (Chen et al., 2009).  This group analyzed the effects of the C-terminal 
mutant, D76N, and truncation of the entire C-terminus on channel function and assembly.  They 
observed that truncation of the C-terminus reduced the association of KCNE1 to KCNQ1 
channels, resulting in less channels expressed at the surface, as evidenced by a western blot 
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showing that the KCNE1 with the C-terminus deleted does not produce fully mature KCNE1 
protein.   Functional studies of channels assembled with KCNQ1 and KCNE1 with the C-
terminus deleted, reduced current density and shifted the voltage dependence in the depolarizing 
direction.  They conclude that there are several roles of the C-terminus of KCNE1 with KCNQ1 
channel function, including channel assembly and control of deactivation kinetics.  Thus far, it is 
likely that both the TMD and C-terminus of KCNE1 are necessary for its modulatory properties 
with the KCNQ1 channel. 
There are several groups who have characterized specific interactions of the C-terminus 
of KCNE1 and different regions of the KCNQ1 channel.  The Romey group first reported that 
the C-terminus, but not any other region of KCNE1, physically interacts with the pore-loop of 
KCNQ1 using a yeast two-hybrid screen (Romey et al., 1997).  Haitin et al uses fluorescence 
resonance energy transfer (FRET) to show that the KCNQ1 C-terminal helix C tetramerization 
domain interacts with the C-terminus of KCNE1 (Haitin et al., 2008).  Lvov et al finds that the 
C-terminus of KCNE1 interacts with S6 and the S4-S5 linker using cysteine crosslinking (Lvov 
et al., 2010).  Zheng et al characterizes a physical interaction between the intracellular C-termini 
of both KCNE1 and KCNQ1 (Zheng et al., 2010).  Using deletion mutants of both the KCNQ1 
and KCNE1 C-termini and co-immunoprecipitation methods, they indicate that the KCNE1 C-
terminus binds to a region of KCNQ1 just after the S6 TM segment but before the 
tetramerization domain.  The tetramerization domain of KCNQ channels is located in the distal 
portion of the C-terminus (Howard et al., 2007; Wiener et al., 2008).    
There have been studies investigating other roles of the C-terminus of KCNE1 besides 
modulation of KCNQ1.  Rochealeau and Kobertz published a study that supports a protein-
protein interaction with the C-termini of KCNE1/KCNQ1 (Rocheleau et al., 2006). Using 
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alanine and leucine scanning mutagenesis, they functionally observe two classes of KCNE1 
mutants, which are segregated into those that had high or low impact changes on gating 
properties.  Based on the functional data, they conclude that the cytoplasmic C-terminus of 
KCNE1 is a kinked alpha helix and is broken into two segments by a proline residue (P77).  In 
accordance with previous crystal structures of voltage gated K+ channels, the high impact face of 
KCNE1 is involved in protein-protein interactions with the voltage-sensing domain (Jiang et al., 
2003a; Jiang et al., 2003b; Long et al., 2005b).  These results provide a structural region in which 
studies involving KCNQ1 gating and intracellular regulation can be investigated.  Studies 
investigating regulation of IKs channel function support an important role for the C-terminus of 
KCNE1.  Mutations in the cytoplasmic domain of KCNE1 have also been shown to disrupt PKA 
mediated modulation of the KCNQ1 channel (Kurokawa et al., 2003; Kurokawa et al., 2009).  
The C-terminus also has effects in channel trafficking and recycling (Seebohm et al., 2007; Xu et 
al., 2009).   
 
 
Current working model of KCNE1 modulation of KCNQ1 
 
In the closed state, the S4-S5 linker interacts with the C-terminal end of S6 from another 
subunit to lock it in closed conformation, while the N-terminal end makes contacts between the 
voltage sensor and pore domains. The Sanders group speculates that KCNE1 slows channel 
activation by interacting with and restricting the movement of the S4-S5 linker, when the 
channel opens (Kang et al., 2008).    
 
 
Studies on KCNQ1  
 
S6 (Pore)   
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The process by which voltage-gated ion channels open in response to changes in 
membrane potential is activation.  The activation gate is the key element that physically opens 
and closes the ion conduction pathway.  In KCNQ1 channels, the S5-S6 helices make up the pore 
domain in one subunit, and it is essential that four subunits come together to form a single ion 
permeation pathway.  Interactions between KCNE1 and the S6 domain of KCNQ1, which 
constitutes part of the pore region, are not surprising.  Due to the unique properties that are 
exhibited when KCNE1 associates with KCNQ1, including slowing activation kinetics, it is 
likely that KCNE1 would have a physical interaction with the activation gate in order to slow 
opening.  The discovery of the crystal structure of KcsA provided much of the initial information 
about the position and nature of the gate, since this channel consists of only two domains, which 
constitute the pore region (Doyle et al., 1998).   
Several interactions between KCNE1 and the S6 domain of KCNQ1 have been identified.  
Studies from our group and others demonstrate that the extracellular residues flanking the TM 
region of the S6 domain (V324C) form spontaneous crosslinks with KCNE1 residue (L42C) (Xu 
et al., 2008; Chung et al., 2009).  Melman et al. showed that KCNE1 TMD residues 57-59 
interact with S6 KCNQ1 residues 338-340, using electrophysiological and biochemical methods 
(Melman et al., 2001; Melman et al., 2002).  In another study, an interaction between TMD of 
KCNE1 and S6 segment KCNQ1 was identified (Tapper and George, 2001).  They found that 
Cd2+ coordinated two cysteines, L51C in KCNE1 and I328C in S6 KCNQ1.   In addition, a 
prediction of the KCNE1 helix showed that other residues exhibit proximity: TMD residues on 
KCNE1 (F54 and G55) are close to the pore domain of KCNQ1 (Cys331) (Tapper and George, 
2001).  The yeast two-hybrid studies by Romey et al also support a KCNE1/ S6 KCNQ1 
interaction (Romey et al., 1997).  The Melman group continued their studies on KCNE1 
	  	    
29	  
regulation of KCNQ1 channel gating by determining sites of interaction between the two 
subunits (Melman et al., 2004).  They generated chimeras of KCNQ1 and K+ channels that do 
not associate with KCNE1.  Using co-immunoprecipitation studies, they concluded that KCNE1 
binds to the S6 segment of the pore to mediate control of gating.  Using tryptophan scanning 
mutagenesis and functional studies, Panaghie and Abbot confirm Melman’s results and conclude 
that a point of interaction exists between the TMD of KCNE1 (T58) and the S6 pore domain of 
KCNQ1 (F340) (Panaghie et al., 2006).  Although many putative interaction points have been 
identified between KCNE1 and the S6 domain of KCNQ1, a crystal structure of this complex 
channel would be helpful in defining an interface between the KCNE1 and the KCNQ1 subunits.  
 
S4 (Voltage Sensor)  
 
The mechanism by which voltage-gated channels detect changes in membrane potential 
and translate this to the activation gate to open the channel is the subject of many investigations.  
The KV1.2 structure provides detailed information about the organization of the voltage-sensing 
domain (VSD), consisting of S1-S4 helices, and how it surrounds the pore (Long et al., 2005a).  
The gate is controlled by the S4 voltage sensor, which contains charges, known as gating charges, 
that move when the membrane electric field changes.  There are roughly four to eight positively 
charged residues, mostly arginines, located at every third position in the S4 helix.  When the 
gating charges move across the electric field, due to changes in membrane voltage, they generate 
an electric current called gating current.  This gating current is a useful readout for voltage 
sensor movement.   
Some investigators believe that these voltage-sensing arginines face the hydrophobic core 
of the lipid bilayer (Jiang et al., 2003b), while others believe they face a polar protein crevice  
(Ahern and Horn, 2004; Durell et al., 2004; Bezanilla, 2005).   Others showed that the S4 
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arginines could interact with negatively charged residues in other VSD helices (Papazian et al., 
1995; Tiwari-Woodruff et al., 2000).  There are three models of voltage sensing that have been 
proposed in the past decade, in which the transporter model and the helical screw model argue 
that the arginines are protein exposed, while the paddle model argues that the argnines are lipid 
exposed.  In the transporter model, the S4 helix rotates and tilts as it moves from one crevice to 
another, totaling a movement of 2-3 Å across the membrane.  In the helical screw model, the S4 
helix rotates and translocates along its axis, while moving its gating charges across the electric 
field upon depolarization, with a net movement of 5-13 Å.  In the paddle model, S4 and the 
extracellular part of S3 (S3b) form a helical hairpin, or paddle.  In the resting state, the paddle is 
located deep in the membrane almost in contact with the intracellular solution, and upon 
depolarization, the paddle makes a net movement of 15-20 Å across the membrane to the 
extracellular side.  In a more recent study, a group solved the crystal structure of a ‘paddle 
chimaera model’, which includes the voltage sensor paddle from KV2.1 transferred into KV1.2 
(Long et al., 2007).   They conclude from the crystal structure that one entire face of the paddle is 
exposed to lipid membrane.  Although there are many theories supporting that the lipid 
environment surrounds the voltage sensor, the matter remains is still to be determined.  
There have been studies investigating how KCNE1 affect the kinetics of S4 voltage 
sensor movement and equilibration rate.  State dependent accessibility studies using MTS 
reagents have previously been used to assess movement S4 segment in several voltage gated 
channels (Larsson et al., 1996; Yang et al., 1997a; Bell et al., 2004; Vemana et al., 2004).  There 
is biochemical evidence showing a physical interaction with one of the arginines in S4 (A226C) 
KCNQ1 and an extracellular residue on KCNE1, E44C (Nakajo and Kubo, 2007).   However, the 
investigators neglected to mutate out a native cysteine, located at position 136, in the S1 domain.  
	  	    
31	  
Their results may not reflect a true physical interaction between the S4 segment and KCNE1 
because the results could be mixed with crosslinking between S1 (C136) and KCNE1 (E44C), 
which is a possibility (Xu et al., 2008; Chung et al., 2009).  However, the Nakajo and Kubo 
group also demonstrate that in the presence of KCNE1, MTSET modification rates for S4 
cysteine mutants were 10 fold slower in the presence of KCNE1 vs. in the absence of KCNE1, 
indicating that S4 movement is slow and that S4 is responsible for the slow gating kinetics of the 
IKs channel.  However, Rochealeau and Kobertz perform a study to address voltage sensor 
equilibrium and rates in K+ channels in response to Nakajo and Kubo’s study (Rocheleau and 
Kobertz, 2008).  They find that MTSET modification rates for the S4 cysteine mutants were 
independent of depolarization pulse duration.  They find that upon depolarization, the voltage 
sensors reach equilibrium quickly in the presence of KCNE1 and conclude that the slow gating 
of the channel complex is not due to slow moving voltage sensors, but could be due to the 
cytoplasmic domain of KCNE1 slowing gate opening.  It is undetermined whether the 
modulatory effects of KCNE1 on the voltage sensor or the activation gate is through a direct or 
allosteric mechanism, but these studies suggest KCNE1 involvement may be through an 
allosteric mechanism.   
Panaghie and Abbott performed an alanine scan of S4 and came across two findings:  
they find that there is charge paucity in the carboxy end of the S4 segment and that the KCNQ1 
activation gate is coupled to S4 in KCNQ1/KCNE3 channels (Panaghie and Abbott, 2007).  They 
compared the effective charge on KCNQ1 and homologous K+ channels and found that KCNQ1 
had the least amount of positive S4 charge.  They added arginine to two sites on KCNQ1 and 
found that they could convert originally constitutive KCNQ1/KCNE3 channels to non-
constitutive channels.  They did the converse to KCNQ4/KCNE3 channels. KCNQ4 has two 
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extra arginines than KCNQ1 and when they removed these two C-terminal arginines, they found 
that non-constitutive KCNQ4/KCNE3 channels converted to constituitive channels.   Thus, 
charge paucity in C-terminal region of S4 is responsible for unique gating properties of KCNQ1 
and KCNE1.  
More recently, there have been studies monitoring voltage sensor movement of the 
KCNQ1 channel.   In a recent study from our group, voltage clamp fluorometry studies showed 
that the presence of KCNE1 alters voltage sensor movement that is necessary to open the 
channel gate (Osteen et al., 2010).  When KCNE1 is present, multiple voltage sensors must move 
before the channel can open. In the absence of KCNE1, there are two possibilities, either all four 
KCNQ1 voltage sensors move at the same time to allow the transition to the fully open state or 
the four KCNQ1 voltage sensors move independently but the KCNQ1 channel transitions to the 




 There has been interest in the S1 domain of KCNQ1 because of it is the location of 
several gain-of-function mutations (Chen et al., 2003c; Hong et al., 2005; Lundby et al., 2007).  
Following the publication of the initial KCNQ1 structural models, several groups published 
results investigating interactions between KCNE1 and the S1 domain of KCNQ1 (Xu et al., 
2008; Chung et al., 2009).  In Xu et al, they show that KCNE1 makes different contacts with 
KCNQ1 in the open and closed states using cysteine crosslinking and functional measurements.  
The authors conclude that these state dependent contacts are caused by a rotation of KCNE1 as 
the KCNQ1 channel opens and that KCNE1 is located between S1, S4 and S6 of three different 
KCNQ1 subunits.  However, their functional experiments may be flawed because the pseudo 
wild-type KCNQ1 construct that they use clearly has slowed deactivation kinetics compared with 
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wild-type KCNQ1.  So it is likely that their state dependent experiments are unclear due to the 
fact that the construct they use exhibits slow deactivation kinetics, thus allowing the channel to 
be stabilized in the open state.  In the study by Chung and colleagues, we monitored spontaneous 
disulfide formation between cysteine-substituted residues in the extracellular flanking regions of 
KCNE1 and KCNQ1.  Our group positions KCNE1 between the S1 and S6 domains of opposing 
KCNQ1 subunits (Chung et al., 2009).    
 Haitin and colleagues investigate a role for the S1 domain in steering S4 voltage sensor 
movement during channel gating (Haitin et al., 2008).  They substitute cysteines in S4 residues 
(S225, I227, R228) and monitor channel currents in Xenopus oocytes.  They find that there are 
several intra and inter subunit interactions, namely between voltage sensors of two different 
subunits (I227C-I227C) and also between cysteines substituted at S4 (R228C) residues and S1 
(C136) residues within one subunit.   
Restier and colleagues demonstrate that two KCNQ1 gof mutant (S140G and V141M) 
channels close when held at hyperpolarized voltages for extended periods of time, indicating a 
defect in deactivation of the channel (Restier et al., 2008).   A salt bridge mechanism was used to 
explain how these mutant channels become trapped in the open state either due to stabilization of 
an open state salt bridge or slowing the formation of a closed state salt bridge between the S2 and 
S4 domains in the KCNQ1 channel.  Although this mechanism is one possibility for how these 
mutant channels become trapped in the open state, the mechanism of how KCNE1 is involved in 
these salt bridge interactions and how it is involved in slowing the deactivation process in the 
presence of these KCNQ1 mutations, remains unresolved.   
There are several studies suggesting that the S1 domain is involved in channel gating.  In 
one study, Lee and colleagues propose that there are two interfaces involved in the gating of KV 
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channels, one which involves the S4-S5 linker that guides voltage sensor movement directly to 
channel opening and closing, and the other involves S1 of the voltage sensor and the pore-loop 
helix near the extracellular surface. They postulate that this 2nd interface acts as an anchor point 
to allow effective communication between the voltage sensor and gate (Lee et al., 2009).  They 
use disulfide cross-linking to find proximity between S1 and the pore-loop, and specifically a 
cross-link between T47C and V183C in KvAP was found (Lee et al., 2009).  Although these 
residues are in a bacterial K+ channel, they correspond to residues Thr144 in S1 and Tyr299 in 
the Pore-loop of Kv7.1. If Thr144 (S1 Q1) and Tyr 299 (Pore-loop) residues crosslink in the Q1 
channel, it would support a role for S1 in constraining the pore region in order to control gating. 
These interactions between S1 and the pore region are also implicated in the KCNQ1 structural 
models (Smith et al., 2007).  The KCNQ1 structural model predicts an interface between S1 and 
S5/p-loop regions of two adjacent subunits in the open state.  This interface includes four of five 
known gain of function mutations in KCNQ1: S140G and V141M in S1, I274V in S5, A300T in 
the p-loop helix (the fifth mutation is V307I, not included in interface).  This group hypothesizes 
that the interface helps to stabilize the open state and could help explain the mutation-induced 
changes in channel function.   
Although there is evidence indicating that existence of many interactions between 
KCNE1 and KCNQ1, the mechanism of KCNE1 modulation is still unclear. By determining the 
positioning of KCNE1 in the channel complex, we can use this information to determine the 
stoichiometry of the KCNQ1 and KCNQ1 subunits, the binding sites of KCNE1, and eventually 
the mechanism of how KCNE1 modulates gating of the IKs channel.  
 




Molecular biology and cell culture 
Human KCNE1 (Murai et al., 1989) was subcloned into the p3XFLAG-CMV-14 Expression 
Vector (Sigma-Aldrich E4901, St. Louis, MO) to generate a C-Terminal FLAG-tagged KCNE1.  
Human KCNQ1 (Sanguinetti et al., 1996) was subcloned into the pCDNA3.1 Expression Vector 
(Sigma).  Pseudo wild-type KCNQ1 C136V / C214A / C331A (pWT) was generated for both 
functional and biochemical experiments.  All mutations were engineered into pWT KCNQ1 and 
KCNE1 cDNA with the QuikChange Site-Directed mutagenesis kit (Agilent Technologies, Santa 
Clara, CA).  Biochemical experiments were conducted with these constructs.  Human KCNE1 
with an N-terminal HA tag was used for functional studies. Chinese hamster ovary (CHO) cells 
(American Type Culture Collection, Manassas, VA) were cultured in Ham’s F-12 culture media 
with 10% FBS in a 37°C incubator with 5% CO2. 
 
EQ and EQQ Tandem Constructs 
 
EQ construct was engineered by linking the C-terminus of KCNE1 to the N-terminus of KCNQ1.  
EQQ construct was engineered by inserting an additional KCNQ1 subunit into the EQ construct.  
Cys substitutions were made in a pseudo-wild-type background (pWT: C214A, C331A) for the 
following EQ constructs: EK41CQI145C; EL42CQV324C and EQQ constructs: EK41CQI145CQ; 
EK41CQQI145C; EL42CQV324CQ. The human rhinovirus (HRV-3C) protease (Novagen) consensus 
cleavage site, LEVLFQGP, which is cleaved between the Q and G, was inserted into the C-
terminus of KCNE1 to create a cleavage site between KCNE1 and KCNQ1.   
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Electrophysiology 
CHO cells were transfected with wild-type (WT) or mutant KCNQ1 alone or co-transfected with 
WT or mutant KCNE1, and with eGFP (0.4 µg of each cDNA) and plated on 35 x 10 mm tissue 
culture dishes as previously described (Marx et al., 2002).  Electrophysiological measurements 
were carried out 48h after transfection.  Currents were recorded at 25°C using the whole-cell 
patch clamp configuration with an Axopatch 200A amplifier (Molecular Devices, Union City, 
CA) as previously described (Kurokawa et al., 2003). Series resistance was 2-3 MΩ.  The 
physiological K+ external solution contained (in mM): 132 NaCl, 4.8 KCl, 1.2 MgCl2, 1 CaCl2, 5 
glucose, 10 HEPES, pH was adjusted to 7.4 with NaOH.  Internal solution contained (in mM): 
110 K+ aspartate, 1 MgCl2, 1 CaCl2, 11 EGTA, 5 K2ATP, 10 HEPES.  Cells were chosen based 
on eGFP fluorescence.   
 
As indicated in the text, in some experiments recordings were carried out in solutions containing 
elevated K+ concentration (120 mM) to increase the driving force and allow resolution of 
deactivating tail currents over a broad range of negative voltages. The elevated K+ external 
solution contained (in mM): 17.8 NaCl, 120 KCl, 1.2 MgCl2, 1 CaCl2, 5 glucose, 10 HEPES, pH 
was adjusted to 7.4 with NaOH.  In all other experiments, recordings were carried out in a 
solution containing physiological K+ concentration (5 mM).   
 
Data Analysis 
Data were collected using Clampex 8.0 (Molecular Devices, Union City, CA) and analyzed as 
described previously (Kurokawa et al., 2003) with Clampfit 8.0 (Molecular Devices) and Origin 
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7.0 (OriginLab Corp, Northampton, MA).Statistical data analysis was assessed with Student's t 
test; differences at p < 0.05 were considered to be significant. 
 
Voltage Clamp Protocols 
To record the conductance–voltage (G–V) relationship for IKs, cells were voltage clamped at a 
negative holding potential (−80, -100 mV, or −120 mV). Test potentials were applied to a series 
of isochronal activation voltages with a fixed incremental increase between successive pulses 
(e.g. −100 to +40 mV in 20 mV steps) for 2 s, and activation was determined from deactivating 
tail currents measured at voltages indicated in the text for specific experiments.  The interval 
between test pulses was 15 or 20 s, as described in figure legends. 
To compare activation kinetics for channels with differing voltage dependences, voltages were 
chosen where open probabilities were similar. Time to half activation (t1/2) was measured during 
2 s pulses, taken at the voltage closest to the V1/2 acquired from the G-V relationship for each 
subunit combination.  To calculate the t1/2, the current at the beginning of the test pulse (Io) was 
subtracted from the maximal outward current at the end of the pulse (Imax) and this value was 
divided by 2.  The time (in seconds) corresponding to this calculated value is used as the t1/2 
value. 
Kinetics of deactivating tail currents were analyzed using 2 s depolarizing steps to +20 mV 
triggered every 15 seconds from a holding potential of –100 mV and followed by 2 s repolarizing 
steps ranging from –80 to –120 mV (20-mV increments). IKs rate of deactivation (τdeact) 
measured at –80mV, -100 mV, and -120 mV was obtained by fitting the tail current with a single 
exponential. 
Crosslinking 
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The cross-linking procedure and the calculation of the cross-linking band have been described 
previously (Chung et al., 2009).  CHO cells were co-transfected with mutant cDNAs of KCNQ1 
C136V/C214A/C331A (pWT KCNQ1) and FLAG-KCNE1 (1.0 µg each) using PLUS reagent 
and Lipofectamine (Invitrogen, Carlsbad, CA). Cells were incubated for 48h at 37°C in the 
presence of 5% CO2. Crosslinking occurred in the presence of ambient oxygen; no external 
oxidizing agents were added. The adherent cells were surface-biotinylated with EZ-Link Sulfo-
NHS-LC-Biotin (Thermo Fisher Scientific, Waltham, MA), the reaction was stopped with 
glycine methyl ester, the cells were lysed, and, after sedimentation of insoluble material, the 
supernatant was mixed with Ultralink Immobilized NeutrAvidin Protein Plus beads (Thermo 
Fisher Scientific) to bind the biotin-labeled membrane proteins, which were eluted from the 
beads by treatment for 3 min at 90°C in 8 M Urea, 4% SDS, 200 mMTris pH 8.0, and 2 mM 
EDTA, all as previously described (Liu et al., 2008b).  Dithiothreitol (DTT) to a final 
concentration of 20mM was added to half of each eluate.  Samples were incubated at 50°C for 20 
min, bromophenol blue was added, and the samples in SDS sample buffer were electrophoresed 
on 4–20% acrylamide gels. The gels were transferred to nitrocellulose, and the blot was blocked 
with Blocking Buffer for Near Infrared Fluorescent Western Blotting (Rockland 
Immunochemicals Inc, Gilbertsville, PA) and incubated with goat anti-KCNQ1 C-20 antibody 
(1:1000, Santa Cruz Biotechnology, Santa Cruz, CA) and mouse anti-FLAG M2 antibody 
(1:2000, Sigma-Aldrich, St. Louis, MO). Membranes were washed and incubated with donkey 
anti-goat AlexaFluor 680-labeled antibody (1:5000, Invitrogen, Carlsbad, CA) and donkey anti-
mouse IRDye 800-labeled antibody (1:5000, LI-COR Biosciences, Lincoln, NE). Fluorescent 
signals were detected using the Odyssey Infrared Imager (LI-COR).  
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Crosslinking with EQ and EQQ Constructs  
 
The cell lysate was mixed with Neutravidin-Sepharose beads (Pierce Chemical Co.) for 60 min 
at 4°C. In a typical sample, cell lysate from a 25 cm2 flask in 500-µl lysis buffer was mixed with 
60 µl of a 50% slurry of Neutravidin beads, previously washed and suspended in lysis buffer. 
The beads were washed seven times with lysis buffer (without NEM and protease inhibitors) and 
two additional times with HRV buffer (in mM, 150 NaCl, 50 Tris, pH 7.5, 1 EDTA, 0.5% Triton 
X-100). The beads were mixed with 5 U of HRV-3C protease (Novagen) in 50 µl HRV-3C 
buffer and nutated overnight at 4°C. To elute bound protein and fragments released by cleavage, 
we added 100 µl 8 M urea, 4% SDS, 200 mM Tris, pH 8, and heated the mixture to 90°C for 2 
min. After a short spin, the supernatant was collected. A 30-µl portion was treated with 2 µl of 
400 mM DTT to reduce disulfides. Both the unreduced and the reduced portions were 
electrophoresed, transferred to nitrocellulose, and immunoblotted by sequential treatment with 
anti-KCNQ1 antibody (Santa Cruz Biotechnologies) and mouse anti-FLAG M2 antibody (1:2000, 
Sigma-Aldrich, St. Louis, MO). Membranes were washed and incubated with donkey anti-goat 
AlexaFluor 680-labeled antibody (1:5000, Invitrogen, Carlsbad, CA) and donkey anti-mouse 
IRDye 800-labeled antibody (1:5000, LI-COR Biosciences, Lincoln, NE). Fluorescent signals 
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CHAPTER II 




Background and Significance 
Several studies that report spontaneous crosslinking between substituted cysteine residues 
on KCNE1 and KCNQ1 have positioned KCNE1 between the first and sixth transmembrane 
helices (S1 and S6, respectively) of opposing KCNQ1 subunits, consistent with the current 
KCNQ1 structural model (Kang et al., 2008; Xu et al., 2008; Chung et al., 2009).  In this 
segment of S1, two gain-of-function (gof) disease mutations associated with atrial fibrillation 
(AF), S140G and V141M, are located in adjacent residues.  When KCNQ1 containing either AF-
associated mutation in S1 (S140G or V141M) is co-expressed heterologously with KCNE1, the 
resultant channels activate immediately in response to depolarizing pulses applied from holding 
potentials similar to typical myocyte resting potentials (Chen et al., 2003c; Hong et al., 2005). 
Subsequent analysis has revealed that the instantaneous current is due to accumulation of open 
channels caused by incomplete deactivation between pulses at these holding potentials (Restier et 
al., 2008).  To date, this channel property is believed to be manifested only in the presence of 
KCNE1 for both mutations (Restier et al., 2008).  
Here, we explore the role(s) of KCNE1 in translating the effects of the KCNQ1 AF 
mutations S140G and V141M into pathological channel function by characterizing the mutations 
in the absence and presence of KCNE1.  We have explored the structural proximity of KCNE1 
relative to the two AF mutations located in S1 KCNQ1, using a biochemical assay to monitor 
disulfide bridge formation between introduced cysteines.  Our results demonstrate that even 
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though both mutations exhibit extremely slow deactivation kinetics in the presence of KCNE1, 
they have distinct dependencies on this accessory subunit.  The V141M mutation, but not S140G, 
requires co-assembly of KCNQ1 and KCNE1 to alter channel deactivation kinetics.  The S140G 
mutation in the KCNQ1 channel itself is sufficient to dramatically slow the deactivation process.  
Biochemical evidence correlates function with structure, revealing orientation of the two subunit 
proteins such that on S1 KCNQ1, V141 but not S140 is positioned close to KCNE1, providing a 
structural basis for the distinct subunit dependence of channel function conferred by these two 
AF mutations. 
Results 
Part I – KCNQ1 AF Mutants (S140G and V141M) Depend Differently on KCNE1 
 
 
Function of S140G and V141M in the absence of KCNE1 
The functional effects of the S140G and V141M mutations were characterized in cells 
expressing only KCNQ1 channels.  Because previous studies (Chen et al., 2003c; Bendahhou et 
al., 2005) have shown that tail currents for the S140G mutation are difficult to measure in 
physiological K+ solution (5 mM), the following experiments were carried out in external 
solutions containing elevated K+ concentration (120 mM, see Methods).  This environment 
allowed the resolution of tail currents over a broader range of negative voltages.  Control 
experiments (Figure 2-1) verified that elevated K+ did not affect the voltage-dependence of 
KCNQ1 channel function compared with experiments in physiological K+ solution.  As had been 
shown for V141M channels in Xenopus oocytes (Hong et al., 2005), we confirm that channels 
encoded by V141M resemble WT KCNQ1 channels, both in voltage dependence of activation 
and deactivation kinetics (Figure 2-2A and 2-2C).  However, the V1/2 of activation for S140G 
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channels is significantly more negative than WT KCNQ1 channels, with a hyperpolarizing shift 
of -30 mV from WT KCNQ1 (Figure 2-2D). In addition, S140G channels exhibited significantly 
slower deactivation at -100 mV compared to both WT KCNQ1 and V141M channels (Figure 2-
2E).  
 
Figure 2-1.  Function of wild-type KCNQ1 and wild-type KCNE1 (120 mM K+ vs. 5 mM 
K+)  (A) G-V relationship  and (B) Deactivation tau for KCNQ1/KCNE1 measured in 120 mM 
K+ vs. 5 mM K+ external solution.  KCNQ1/KCNE1 (120 mM K+): Holding potential = -120 mV. 
Cells were depolarized from -120 mV to + 80 mV in 20 mV increments.  Tail currents were 
measured at -120 mV for 5 s (left inset). KCNQ1/KCNE1 (5 mM K+): Holding potential = -80 
mV. Test pulses were applied once every 11 seconds from -60 mV to +80 mV.  Tail currents 
were measured at -40 mV for 2 s (right inset).  
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Figure 2-2. S140G but not V141M slows deactivation of homomeric KCNQ1 channels. 
Representative families of currents traces in cells expressing WT KCNQ1 (A), S140G (B), and 
V141M (C) in the absence of KCNE1. Currents in response to 2 s pulses from -100 mV to +40 
mV in 20 mV increments from a -100 mV holding potential. (D) Normalized isochronal (2 s) 
activation curves for KCNQ1 (squares), S140G (circles), and V141M (triangles).  (E) 
Deactivation time constant (tau) obtained at -100 mV from single exponential fits to tail currents 
following conditioning pulses (+20 mV, 2 sec). For all current traces of vertical scale is 50 
pA/pF and horizontal scale is 1.0 s. Data are shown as mean ± s.e.m.  * (p < 0.05) 
 
Function of S140G and V141M in the presence of KCNE1 
Activation Kinetics 
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The impact of KCNE1 co-expression on channel properties was investigated with 
KCNQ1 carrying either of these two AF-associated mutations.  A pulse protocol consisting of 2-
s isochronal activating pulses to +20 mV was applied at a very slow rate (once every 20 seconds) 
to ensure that the majority of channels were closed prior to the next test pulse as we measured 
the impact of KCNE1 co-expression on activation gating.  Representative current traces for 
S140G and V141M, assembled with KCNE1, reveal channels that exhibit the slow onset of 
activation seen in WT IKs channels (Figure 2-3A to 2-3C). The voltages for half maximal 
(isochronal) activation for channels consisting of KCNE1 co-expressed with three KCNQ1 
variants were measured to compare voltage dependence of activation gating.  Both S140G / 
KCNE1 channels (V1/2 = 1.5 ± 2.7 mV, n=4) and V141M / KCNE1 channels (V1/2 = 2.4 ± 1.0 
mV, n=3) exhibit hyperpolarizing shifts in voltage dependence, compared to WT KCNQ1 / 
KCNE1 channels (V1/2 = 17.5 ± 2.6 mV, n=6) (Figure 2-3D).  Next, IKs activation kinetics were 
compared by measuring the time (t1/2) at which IKs current is half maximally activated at the 
voltage closest to the V1/2 for each subunit combination. KCNE1 co-expression caused no 
significant change in activation kinetics of the S140G (t1/2 = 1.5 ± 0.04 s, n=4) and V141M (t1/2 = 
1.45 ± 0.06 s, n=4) assembled channels (p > 0.05 for S140G / KCNE1 vs. V141M / KCNE1).  
Although activation kinetics of both S140G and V141M channels assembled with KCNE1 were 
statistically significant from KCNQ1/KCNE1 (t1/2 = 1.15 ± 0.31 s, n=6) (Figure 2-3E), this was 
not important.  
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Figure 2-3.  S140G and V141M mutations minimally affect KCNQ1/KCNE1 activation 
kinetics.  Representative current traces are shown for KCNQ1 (A), S140G (B), and V141M (C), 
each co-expressed with KCNE1. Holding potential = -80 mV (KCNQ1) and -100 mV (S140G 
and V141M). Cells were pulsed to -120 mV (KCNQ1 and S140G) and -140 mV (V141M) to 
ensure that all channels were closed prior to the depolarizing pulse (+20 mV, 2 sec).  (B) 
Normalized isochronal (2 s) activation curves for KCNQ1 (squares), S140G (circles), and 
V141M (triangles). (C) Activation t1/2 for KCNQ1, S140G, and V141M.  For all current traces: 
vertical scale is 100 pA/pF and horizontal scale is 0.5 s. Dotted lines indicate zero current. Data 
are shown as mean ± s.e.m.  * (p < 0.05)  
 
Deactivation Kinetics  
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Deactivation kinetics of the S140G and V141M mutant channels co-expressed with 
KCNE1 were subsequently investigated.  To compare deactivation kinetics for the different 
KCNQ1/KCNE1 pairs, the deactivation time constants (tau) were measured from tail currents at 
-120 mV in response to a 2 s depolarizing pulse (Figure 2-4A and 2-4B).  Deactivation for 
S140G / KCNE1 channels (τdeact = 4.09 ± 0.23 s, n=5) is significantly slower than that for WT 
KCNQ1 / KCNE1 channels (τdeact= 0.24 ± 4.2 s, n=6, p < 0.05 for S140G / KCNE1 vs. KCNQ1/ 
KCNE1).  For V141M / KCNE1 channels, deactivation is significantly slower than both KCNQ1 
and S140G assembled channels (τdeact = 6.71 ± 0.64 s, n=4, p < 0.05 vs. KCNQ1 / KCNE1 and p 
< 0.05 vs. S140G / KCNE1) (Figure 2-4C).   
Another way to evaluate the effect of KCNE1 on channel deactivation is to examine the 
fold change in deactivation of the KCNQ1 mutations in the absence and presence of KCNE1.  
The fold change is the ratio of deactivation tau from the KCNQ1 / KCNE1 subunit conditions: 
deactivation tau from the KCNQ1 subunit alone.  These results are summarized in a log plot, 
showing deactivation at -120 mV for all KCNQ1 variants and KCNE1.  KCNE1 co-expression 
on V141M subunits reveals a dramatic effect, slowing deactivation roughly fifty fold compared 
to KCNQ1/KCNE1 channels (V141M: 51.39 ± 5.57, n=8 and KCNQ1 = 2.74 ± 0.14, n=9) 
(Figure 2-4C). The fold change in deactivation for S140G / KCNE1 channels (S140G: 7.75 ± 
0.99, n=9) is also significantly greater than that of WT KCNQ1/KCNE1 channels. 
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Figure 2-4.  KCNE1 slows deactivation of V141M heteromeric channels to a greater extent 
than S140G channels.  Representative current traces are shown for S140G (A) and V141M (B), 
each co-expressed with KCNE1. Arrows indicate the tau for each subunit combination. (C) 
Deactivation time constant (tau) at -120 mV is represented in a log plot for KCNQ1, S140G, and 
V141M, each co-expressed without and with KCNE1 (n = 4-9). Hatched bars represent KCNQ1, 
S140G, and V141M without KCNE1.  For S140G/KCNE1 and V141M/KCNE1 current traces: 
vertical scale is 50 pA/pF and 100 pA/pF, respectively, and horizontal scale is 2.5 s. Dotted lines 
indicate zero current. Data are shown as mean ± s.e.m. * (p < 0.05)  
 
Crosslinking of KCNQ1 (S140C or V141C) to KCNE1 
The functional data suggest possible physical differences in the location of KCNQ1 
residues S140 and V141 relative to KCNE1 in assembled channels. We thus sought to determine 
the proximity of S140 and V141 relative to KCNE1 at the level of the membrane interface by 
individually substituting cysteines in KCNQ1 and KCNE1 and monitoring spontaneous disulfide 
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bridge formation.  These residues (S140 and V141) are located one turn into the helix of the S1 
transmembrane domain and when mutated to cysteines, they are believed to be exposed to water, 
ready to deprotonate to the reactive thiolate form.  Due to their proximity to the membrane, they 
are also subject to spontaneous oxidation in the endoplasmic reticulum or on the cell surface (Liu 
et al., 2008a).   
Two KCNQ1 Cys-substituted mutants (S140C and V141C) and twelve KCNE1 Cys-
subsituted mutants (G40C to L51C) were generated. S140C and V141C were made in a pseudo-
wild-type (pWT) construct in which the three native cysteines in the transmembrane domain of 
KCNQ1 were mutated out: C136 was mutated to valine, while C214 and C331 were mutated to 
alanines.  These mutations did not alter function significantly in the channel (Figure 2-5A and 2-
5B).  It was necessary for C136 to be mutated out in order to prevent crosslinking within the S1 
domain to S140C or V141C (Figure 2-5C).   
 
Figure 2-5.  Function of Pseudo-WT KCNQ1 (pWT).  (A) Family of current traces for pWT 
construct with mutations (C136V, C214A, C331A).  (B) Plot of instantaneous current (pA/pF) 
measured from the first pulse (white bars) and the tenth pulse (gray bars) for various pWT 
constructs. Number of observations is noted above bars. (C) Schematic illustration of S1 KCNQ1 
with residues C136 and S140 highlighted in red to demonstrate proximity within the helix.  
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The extent of crosslinking was calculated as follows: (KCNQ1/KCNE1 + X/2)/ 
(KCNQ1/KCNE1 + KCNQ1 + KCNQ12 + X).  Calculations were based on the intensities of four 
bands: the monomeric KCNQ1 band (~74 kD), the crosslinked KCNQ1/KCNE1 band (~110 kD), 
the KCNQ12 band (KCNQ1 dimer ~150 kD), and a band labeled X (~250 kD) (Figure 2-6) 
(Chung et al., 2009). For each condition, averaged data are expressed as mean ± S.E. Statistical 
data analysis was assessed with Student’s t-test: differences at p < 0.05 were considered to be 
significant. 
 
Figure 2-6. Full Length Blot of Crosslinking Bands. 
KCNQ1 is represented as a red signal and KCNE1 as a green signal. The merged red and green 
in the cross-linked KCNQ1/KCNE1 band is yellow. The samples in the right lanes were reduced 
with DTT in sample buffer. X indicates a band of molecular weight greater than 250 kDa. The 
molecular weights of the markers are in kDa.  
 
The KCNE1 residues were chosen for cysteine substitution due to their location in the 
region of KCNE1 predicted to be aligned with the region where S140 and V141 are located 
(Kang et al., 2008; Chung et al., 2009). The crosslinking percentage is plotted for the twenty-four 
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cysteine pairs tested (Figures 2-7B and 2-7C).  Sample immunoblots are shown for crosslinking 
results obtained from S140C and V141C, in the absence and presence of a reducing agent, 
dithiothreitol (DTT).   The extent of crosslinking is summarized for S140C and twelve KCNE1 
Cys mutants, in which there is <10% disulfide bond formation (Figure 2-7B).  This result 
suggests that S140 is not positioned towards KCNE1.  However, this is not the case for V141.  In 
this case, there is evidence of disulfide bond formation between V141C and two Cys mutants on 
KCNE1: E43C and A44C.  V141C / E43C exhibited 35 ± 4.3% (n=5) crosslinking, while V141C 
/ A44C exhibited 78 ± 2.4% (n=11) cross-linking (Figure 2-7C), which are comparable to the 
high degree of crosslinking that was found for the extracellular flanks between KCNE1 and the 
S1 and S6 domains of two KCNQ1 subunits (Chung et al., 2009).  The extent of crosslinking is 
taken as a measure of relative proximity of the substituted cysteines (Liu et al., 2008a).  These 
results are consistent with the predicted three-dimensional arrangement of the transmembrane 
helices of KCNQ1 and the placement of KCNE1 within the channel complex (Smith et al., 2007; 
Kang et al., 2008). 
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Figure 2-7. Crosslinking of substituted cysteines in KCNQ1 and KCNE1 reveals orientation 
of S140 and V141 relative to KCNE1.  (A) Schematic illustration of S1 domain of KCNQ1 and 
KCNE1, indicating the region that was tested for cross-linking, as shown by green (KCNE1 
residues) and red (KCNQ1 residues) dots.  The numbers represent amino acid position. The 
dashed line above KCNQ1 indicates continuation of the channel. (B and C) Sample immunoblots 
are shown for the indicated pairs of Cys mutants of KCNQ1 and KCNE1.  KCNQ1 is shown as a 
red signal and KCNE1 is shown as a green signal. The merged red and green signals indicate the 
crosslinked KCNQ1/KCNE1 band, which is shown as a yellow signal.  The samples in the right 
lanes were reduced with 10 mM DTT in sample buffer. (B) Bar graph showing percentage of 
spontaneous crosslinking for S140C with KCNE1 residues G40-L51 (n = 3-6); (C) Bar graph 
showing percentage of spontaneous crosslinking for V141C with KCNE1 residues G40-L51 (n = 
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4-11). Calculations were based on the intensities of the bands, as described in Methods.  Data are 
shown as mean ± s.e.m. Symbols (*, #) indicate a significant difference (p < 0.05) using 
Student’s t-test.  
 
Function of Single Cysteine Mutants 
The functional characteristics of the single cysteine mutants were tested for the residues 
that exhibited crosslinking: V141C, A44C, and E43C.  Substitution of a cysteine at position 
V141 did not alter activation but slowed deactivation, in agreement with previous oocyte 
recording (Restier et al., 2008) (Figure 2-8). The KCNE1 mutations at positions 43 and 44 did 
not alter channel function on their own, in the absence and presence of DTT.  However, in the 
presence of DTT, there is a depolarizing shift in voltage dependence of activation for all single 
cysteine mutants, consistent with the effect of DTT alone in the pseudo WT channel (Chung et 
al., 2009).  Further, the presence of DTT did not significantly alter deactivation time constants 
for all the single cysteine mutants tested.  
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Figure 2-8.  Functional Consequences of Single Cysteines.  (A) Activation V1/2 measured from 
normalized isochronal (2 s) activation curves: KCNQ1 / KCNE1 (dashed line), V141C / KCNE1 
(- / +DTT), KCNQ1 / A44C (- / + DTT), V141C / E43C (- / + DTT), and KCNQ1 / E43C.  (B) 
Deactivation time constant (tau) measured at -100 mV: KCNQ1 / KCNE1 (dashed line), V141C / 
KCNE1 (- / + DTT), KCNQ1 / A44C (- / + DTT), and V141C / E43C (- / + DTT) (n = 3-5). Data 
are shown as mean ± s.e.m.  
 
Function of Crosslinking Pairs: V141C/A44C and V141C/E43C 
The functional consequences of crosslinking V141C / A44C or V141C / E43C were minor.  
When these pairs are co-expressed, impact of crosslinking was a DTT-sensitive slowing of 
deactivation for V141C / A44C channels compared to KCNQ1 / KCNE1 channels (Figure 2-9A). 
There were DTT-sensitive shifts in the voltage dependence of activation (V141C / A44C (-DTT) 
V1/2 = 34.9 ± 2.7 mV, n=5, p < 0.05 vs. V141C / A44C (+DTT): V1/2 = 46.3 ± 2.9 mV, n=5) 
(Figure 2-9B).  This shift, however, is consistent with the effect of DTT alone in the pseudo WT 
channel and likely is independent of the reduction of the crosslink (Chung et al., 2009).  There 
was no significant difference in deactivation at -100 mV for V141C / A44C channels, in the 
absence and presence of the reducing agent, DTT (V141C / A44C (-DTT): τdeact = 1.08 ± 0.06 s, 
n=5, p > 0.05 vs. V141C / A44C (+DTT): τdeact = 0.82 ± 0.21 s, n=5)  (Figure 2-9C). The slow 
deactivation kinetics that we see in the V141C / A44C (+DTT) uncrosslinked channel comes 
from the single cysteine engineered at V141 because there is no significant difference between 
these channels and channels with only a single cysteine at V141 (p > 0.05 for V141C / A44C 
(+DTT): τdeact = 0.82 ± 0.21 s, n=5 vs. V141C / KCNE1: τdeact = 0.66 ± 0.15 s, n=5) (Figure 2-9B 
and Figure 2-8B).  There is also no significant difference in channel deactivation between 
KCNQ1 / A44C channels, with and without DTT, and KCNQ1 / KCNE1 channels indicating the 
cysteine engineered at A44 on KCNE1 does not have a big effect on channel function (Figure 2-
	  	    
54	  
8B).  Thus, crosslinking does not perturb the native conformation of the channel, giving 
confidence in the physiological significance of the cross-link determined orientation of V141 and 
S140 relative to the KCNE1 subunit.   
 
Figure 2-9.  Functional Consequences of Crosslinking Pair V141C / A44C are minor. 
(A) Representative current traces for: V141C / A44C (- DTT) and V141C / A44C  (+ DTT).  
Currents in response to 2 s pulses from -60 mV to +80 mV in 20 mV increments from -80 mV 
holding potential. Tail currents were measured at -40 mV. For DTT conditions, currents were 
measured after 10 minute perfusion of 10 mM DTT. (B) Activation V1/2: KCNQ1/KCNE1 
(dashed line), V141C / A44C (-DTT), and V141C / A44C  (+ DTT).  (C) Deactivation time 
constant (tau) measured at -100 mV: WT KCNQ1/KCNE1 (dashed line), V141C / A44C (- DTT), 
and V141C / A44C (+ DTT), (n = 3-5). Data are shown as mean ± s.e.m.  
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In summary, the results in Part I reveal KCNE1-dependence for the V141M mutation and 
not for S140G. These results are supported by biochemical crosslinking data demonstrating that 
residue V141 is positioned close to and is facing KCNE1, revealing a specific orientation of the 
KCNQ1 and KCNE1 subunits.  The crosslink at V141C and A44C also demonstrates a suggested 
point of close proximity between KCNQ1 and KCNE1, functionally and structurally.  The 
evidence for proximity in the upper TM region of the KCNQ1/KCNE1 channel is unique in that 
this region is structurally close and mutations at these specific residues would perturb the 
channel’s properties.  Another study demonstrated how a functional interaction in this region 
could affect channel function, specifically KCNE1 mutant A44W was coexpressed with the WT 
KCNQ1 channel (Goldstein et al 2008).  The investigators demonstrated that KCNQ1/A44W 
channels exhibited very slow deactivation kinetics, compared to KCNQ1/KCNE1 channels.  
Combined with our results, these two particular residues, V141 on KCNQ1 or A44 on KCNE1, if 
either residue is mutated to a larger residue, the data demonstrate that channel deactivation is 
altered, at least in the case of V141M or A44W.  Whether KCNE1 is affecting channel function 
in its other regions, in the TM domain by interacting with the channel pore (Melman et al 2008) 
or the C-terminus by interacting with the S4-S5 linker (Smith et al., 2007), these functional 
interactions in the upper TM region of the channel are affecting the normal mechanism of 
channel gating, with a preferential effect on deactivation kinetics.   
 
Part II – KCNQ1 Intersubunit Crosslinking with S140C  
Our data from Part I revealed crosslinking between KCNQ1 residue, V141C, and KCNE1 
residues, 43 and 44, demonstrating proximity between S1 KCNQ1 and KCNE1 in this 
	  	    
56	  
extracellular region. This proximity suggests that V141 may have a direct interaction with 
KCNE1, and that the interaction between KCNE1 A44 / KCNQ1 V141 could be the structural 
basis for the mutation-induced slowing of deactivation kinetics in the V141M mutant channel.  
There was no evidence of crosslinking between S140C and any residues from the N-terminal 
region of KCNE1, suggesting that S140 is not close enough or positioned correctly to interact 
directly with KCNE1.  This result is consistent with the fact that S140G does not depend on 
KCNE1 to disrupt channel function, so how is this mutation able to cause such dramatic changes 
in channel deactivation within the KCNQ1 homo-multimeric channel?   We set out to investigate 
what regions in the channel complex residue S140 could be facing and interacting with, by 
substituting cysteines into candidate regions that could be in close proximity with S140 and then 
monitored disulfide bond formation.   
Previous reports have suggested that S140 and V141 make contacts across the subunit-
subunit interface with residues located near the tops of S5 from one KCNQ1 subunit and the 
pore-loop helix (p-helix) from a second KCNQ1 subunit (Smith et al., 2007).  Specifically, they 
hypothesize that L137 in S1 KCNQ1 makes contact with I274 in S5 of another KCNQ1 subunit 
(Figure 2-10A).  In the S1 domain of KCNQ1, S140 is located one turn up the helix from L137, 
and hypothetically could make contacts with Y278 in S5 of another KCNQ1 subunit.  If this is a 
point of interaction, then it could offer one explanation for how the S140G mutation is able to 
stabilize the open state by interacting with the pore domain of KCNQ1 in the absence of KCNE1.  
In another study, disulfide crosslinking was used to find proximity between the S1 segment and 
the pore-loop, and a crosslink between T47C (S1) and V183C (pore-loop) in KvAP was found 
(Lee et al., 2009).  Although these residues are in a bacterial K+ channel, they correspond to 
residues T144 in the S1 segment and Y299 in the pore-loop of Kv7.1.  Since S140 is pointing 
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into the channel, towards the VSD, it is possible that this residue is positioned near the pore.  If 
T144 (S1 KCNQ1) and Y299 (pore-loop) residues crosslink in the KCNQ1 channel, it supports 
the hypothesis that the S1 helix is close to the p-helix and could explain how the S140G mutation 
is slowing deactivation kinetics in the channel in the absence of KCNE1.  However, when 
KCNE1 is assembled with the S140G mutant channel, how is the behavior of KCNE1 affected 
by the S140G mutation in KCNQ1?  Preliminary results have been obtained for crosslinking 
between KCNE1 and the p-helix (Figure 2-10B), so KCNE1 could be further slowing 
deactivation kinetics of the S140G mutation by making contact with the p-helix (Figure 2-10C).  
Here, we investigated the possibility that S140C KCNQ1 would be in close proximity to the p-
helix residues or the S5 segment of the adjacent KCNQ1 subunit.   
    
Figure 2-10.  Potential sites of interaction between the S1, S5, and pore-loop helices of two 
KCNQ1 subunits. (A) Schematic illustration of S1 helix (left, dark gray) and S5 and pore-loop 
helices (right, light gray) from two adjacent KCNQ1 subunits.  Potential sites of interaction: 
L137 (green) and I274 (blue), S140 (red) and Y278 (orange), T144 (yellow) and Y299 (purple), 
amino acids are represented in stick representations.  (B) KCNE1 crosslinks to P-loop Helix of 
KCNQ1: western blot of crosslinking pair F296C KCNQ1 and L42C KCNE1, in the absence and 
presence of 10 mM DTT. (C) Schematic illustration of possible interactions between the S1, S5, 
pore-loop, and KCNE1 helices.   
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Crosslinking to Pore-loop helix residues (E295-A300) 
KCNQ1 Cys-substituted mutants (E295C – A300C) were engineered into the S140 
KCNQ1 pWT construct in which three native cysteines in the transmembrane domain of KCNQ1 
were mutated out, as described previously.  For these experiments, it was necessary to generate 
double cysteine mutant KCNQ1 constructs in order to properly assay intersubunit crosslinking.  
The limitation of only one cysteine in each KCNQ1 subunit is that we would only be able to 
observe half the amount of crosslinking because these proteins normally form a tetramer.  If 
there are two cysteines in each subunit, one in S1 and one in the pore-loop, we should be able to 
see a tetramer if there is crosslinking (Figure 2-11). 
       vs.     
Figure 2-11.  Proposed crosslinking between the S1 and S5 helices of two KCNQ1 subunits. 
Schematic illustration of hypothetical crosslinking in KCNQ1 tetramer with double cysteine 
mutations (A) and single cysteine mutations (B) in S1 (filled circles) and S5 (open circles).   
Each KCNQ1 subunit is represented as a rectangle (blue) with S1, S4, and S5 regions labeled. 
  
The pore-loop helix residues were chosen for cysteine substitution due to their location in 
the channel predicted to be aligned with the region where S140 is located (Figure 2-10A) (Kang 
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et al., 2008).  The immunoblots are shown for crosslinking results obtained between S140C and 
p-helix residues E295C to A300C, in the absence and presence of a reducing agent, dithiothreitol 
(DTT) (Figure 2-12).   We see a DTT-sensitive crosslinking band (~150 kD) for pairs 
S140C/G297C and S140C/S298C (Figure 2-12A).  Additionally, we monitored p-helix 
crosslinking with V141C and observed DTT-sensitive crosslinking to the same p-helix residues, 
V141C/G297C and V141C/S298C (Figure 2-12B). Although we expected to see this KCNQ1 
crosslinked dimer band (~150 kDa) between S140C and a p-helix residue, an important negative 
control did not turn out.  When KCNQ1 constructs containing only G297C or S298C were tested, 
we observed a band that was DTT-sensitive at the same molecular weight (~150 kDa) (Figure 2-
12C).  We could not separate out the p-helix cysteine substituted residues that were crosslinking 
to each other and those that were crosslinking to S140C or V141C.  Thus, we could not proceed 
with these p-helix cysteine residues to assay intersubunit crosslinking to the S1 segment of 
KCNQ1.   
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Figure 2-12.  S140C does not crosslink to the pore-loop helix.  Western blots of S140C (A) 
and V141C (B) double cysteine KCNQ1 mutants tested for crosslinking, in the absence and 
presence of 10 mM DTT.  Controls included: KCNQ1 tetramer and V141C + A44C co-
expression.  Molecular weights: KCNQ1 monomer (~70 kD), KCNQ1 dimer (~150 kD), 
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KCNQ1 tetramer (~300 kD).  (C) Control western blot of single cysteine mutants: S140C, 
V141C, G297C, and S298C.   
 
Crosslinking to S5 residues (S276-L282) 
 
The S5 residues (S276 – L282) were chosen for cysteine substitution due to their location 
in the channel predicted to be aligned with the region where S140 is located (Figure 2-10A) 
(Kang et al., 2008).  Again, here we engineered double cysteine mutants to assay intersubunit 
crosslinking.  Crosslinking results were obtained for pairs S140C/ S276C to S140C/ L282C, in 
the absence and presence of a reducing agent, dithiothreitol (DTT) (Data not shown).   All 
cysteine pairs exhibited little to no crosslinking, however the KCNQ1 monomer expressed well, 
indicating that the protein was being expressed.  There was faint crosslinking for a specific pair, 
S140C / Y278C, so we hypothesized whether there was crosslinking but we couldn’t see it 
because expression was low.   One explanation for the low expression could be because the 
KCNQ1 proteins are crosslinked in the ER and could not traffic to the membrane surface.  
Because these proteins are crosslinked, the channels could be in a conformation that renders it 
not functional, thus the proteins stay trapped in the ER.  So far, all crosslinking experiments have 
been selecting for surface membrane proteins, so we do not know if there are proteins trapped in 
the ER.  To test the above hypothesis, we repeated the same crosslinking experiments, this time 
without selecting for surface proteins and instead collected the whole cell lysates.  The 
immunoblots now show increased expression for the KCNQ1 monomer and for specific KCNQ1 
pairs: S140C / Y278C and S140C / F279C (Figure 2-13A and 2-13B).  However, the results were 
not repeatable and inconsistent so it was difficult to interpret the results.  In conclusion, we 
decided not to pursue with these experiments.   
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Figure 2-13.   S140C does not crosslink to the S5 helix.  Western blots of  (A) biotinylated and 
non-biotinylated mutant S140C/ Y278C. (B) Double cysteine KCNQ1 mutants tested for 
crosslinking, in the absence and presence of 10 mM DTT.  Molecular weights: KCNQ1 
monomer (~70 kD), KCNQ1 dimer (~150 kD), KCNQ1 tetramer (~300 kD).  (C) Control 
western blot of single cysteine mutants: S140C, V141C, S276C-F279C.    
 
Part III - State Dependence of Crosslinking  
Thus far, we have not determined what regions in the KCNQ1 channel complex that 
residue S140 may be interacting with to induce slow deactivation kinetics.  In the experiments 
performed so far, crosslinking is presumably happening in the closed state of the channel, so we 
set out to investigate whether we could monitor crosslinking in the open states of the channel.  It 
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is believed that disulfide bonds are formed and rearranged in the endoplasmic reticulum of the 
cell (Woycechowsky and Raines, 2000), where the membrane potential is relatively negative 
(Hwang et al., 1992).  Thus, at this hyperpolarized -130	  mV potential, voltage gated K+ channels 
are closed.  All crosslinking results so far are happening in the closed state of the channel.  
However in previous reports, experiments were done to test state dependence of crosslinking and 
one study suggested that certain crosslinks could be formed in either the open or closed states of 
the channel (Xu et al., 2008; Chung et al., 2009).    We set out to test the state dependence of 
crosslinking with our cysteine-substituted residues to determine whether we observe crosslinking 
of S140C or V141C to any KCNE1 residues in the open state of the channel.  We used an 
elevated K+ environment and engineered open state mutations into the KCNQ1 channel to 
monitor crosslinking in the open state.   
Crosslinking Residues 
The KCNQ1 Cys-substituted mutants (S140C and V141C) and the five KCNE1 Cys-
subsituted mutants (G40C to A44C) were used for the following experiments.  The crosslinking 
pair, V141C + A44C, was used as a positive control because it exhibited ~80% crosslinking.  
High K+ External Solution 
Previously, elevated K+ concentration (120 mM) was used for functional experiments to 
increase driving force and allow resolution of deactivating tail currents over a broad range of 
negative voltages.  In this high K+ environment, the reversal potential is 2.32 mV and given that 
voltage gated KCNQ1 channels have a V1/2 of 17.5 mV, there should be open channels in this 
depolarized environment.  Thus, we set out to test crosslinking in the open state using these 
conditions for crosslinking pairs: V141C + A44C and S140C + A44C.  We find that there is no 
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significant difference in crosslinking for V141C + A44C in 5 mM K+ versus 120 mM K+ (Figure 
2-14).   S140C + A44C did not exhibit any crosslinking in either K+ environment (Data not 
shown).  
 
Figure 2-14.  Different K+ concentrations do not reveal open state crosslinking.  (A) Western 
blot of  V141C + A44C in 5 mM K+ vs 120 mM K+ , in the absence and presence of 10 mM DTT. 
(B) Bar graph showing percentage of spontaneous cross-linking for V141C and A44C. 
Calculations were based on the intensities of the bands, as described in Methods.   
 
S1 Open State Mutant 
Another method to assay state dependent crosslinking was to engineer open state 
mutations into the background of the KCNQ1 channel.  For these experiments, the S140G and 
V141M mutations were chosen as the open state mutants because we had previously 
characterized them functionally.  These channels have a V1/2 of 1.5 mV (S140G/KCNE1) and 2.4 
mV (V141M/KCNE1) and thus would preferentially have channels in the open state in 
physiological (5mM) K+ concentrations, where the reversal potential is ~-80 mV.  In these 
experiments, we find that there is no crosslinking observed for S140C and Cys-KCNE1 residues 
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in the background of the open state mutation (V141M) (Figure 2-15A).  For V141C and Cys-
KCNE1 channels with open state mutation (S140G), we observe the same amount of 
crosslinking as channels without the open state mutation (Figure 2-15B).  This method also was 
not successful as a proper way to assay state dependent crosslinking.   
 
Figure 2-15. Open state mutation in S1 does not reveal open state crosslinking.  (A) Western 
blot of crosslinking pairs with open state mutations listed above immunoblot, in the absence and 
presence of 10 mM DTT. (B) Bar graph showing percentage of spontaneous crosslinking for 
crosslinking pairs. Calculations were based on the intensities of the bands, as described in 
Methods.  Data are presented as mean ± s.e.m.  
 
S4 Open State Mutant 
Although S140G and V141M were favored as open state mutations, they weren’t the 
most appropriate choice for our experiments.  The residues that were chosen for cysteine 
substitution were adjacent to the open state mutation, S140G V141C and S140C V141M.  Thus, 
the S140G and V141M mutations might inhibit or affect the crosslinkng because they are right 
next to the cysteine substituted residue, so we had to find an open state mutation that was further 
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away from the cysteine residue.  Previously, Panaghie and Abbott reported that the loss of single 
S4 charges at positions R231 or R237 produced constitutively active KCNE1/KCNQ1 channels 
(Panaghie and Abbott, 2007).  We chose R231A to use for our experiments.  We find that S140C 
channels with the S4 open state mutation did not produce any crosslinking results with the 
KCNE1 cysteine substitutions tested (Figure 2-16).  While crosslinking with V141C and KCNE1 
residues produced similar results with or without the S4 R231A mutation in the background.  
This method did not prove to help us monitor crosslinking in the open state either.   
 
Figure 2-16.   Open state mutation in S4 does not reveal open state crosslinking.  (A) 
Western blot of S140C and V141C crosslinking pairs with R231A open state mutation, in the 
absence and presence of 10 mM DTT. (B) Bar graph showing percentage of spontaneous 
crosslinking for crosslinking pairs. Calculations were based on the intensities of the bands, as 
described in Methods.   
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Discussion 
We find that KCNE1 plays a critical role in distinguishing two independent effects 
underlying the atrial fibrilliation-associated KCNQ1 mutations S140G and V141M.  While both 
mutations disrupt deactivation in the presence of KCNE1, our experiments establish that S140G 
is able to slow channel deactivation in the absence of this subunit, in contrast to previous reports 
(Chen et al., 2003c).  We find that the V141M mutation in the KCNQ1 subunit alone is 
indistinguishable from the WT KCNQ1 subunit, confirming previous reports that this mutant 
phenotype requires the presence of KCNE1 (Hong et al., 2005).  The marked impact of KCNE1 
on deactivation of the V141M channel occurs despite that fact that there is no effect of the 
mutation on WT KCNQ1 homomeric channel function.  This indicates an important role for 
KCNE1 in determining the disease phenotype of the V141M assembled channels.  
Based on our functional experiments, biochemical crosslinking was performed in order to 
establish a structural basis for the differential KCNE1 dependence of these two mutant 
phenotypes.   KCNE1 has previously been shown by spontaneous disulfide crosslinking to be 
positioned in the IKs channel in a manner that allows KCNE1 communication with S1 and S6 of 
different KCNQ1 subunits (Xu et al., 2008; Chung et al., 2009).  Our crosslinking results build 
onto this placement of KCNE1 within the assembled channel.  We demonstrate that V141C, but 
not S140C, spontaneously crosslinks with cysteines introduced in KCNE1 at positions 43 and 44.  
These results reveal a specific orientation of S1 whereby V141 is in close proximity to KCNE1, 
consistent with the KCNQ1 structural model (Figure 2-17) (Kang et al., 2008).  With this 
positioning, it is clear why there is such a dramatic effect on channel function when KCNQ1 
with the V141M mutation is assembled in the tetrameric channel in the presence of KCNE1.  In 
the absence of KCNE1, it is likely that the V141 residue is not close to any region of the channel 
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where it could affect channel function, which is in agreement with this mutation having no 
functional impact on KCNE1-free homomeric KCNQ1 channels.  On the other hand, S140 is the 
neighboring residue on the S1 alpha helix and its position can be inferred to be rotated back 
towards the S2-S4 helices within its own subunit.  Thus, it is not in a favorable position to form 
crosslinks with KCNE1 residues, but points in a direction that would allow it to impact the 
environment where S2 and S4 are located (Figure 2-17B).    This prediction is consistent with 
our functional results showing that mutation of the S140 residue alone is sufficient to slow 
deactivation of homomeric KCNQ1 channels in the absence of KCNE1.    
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Figure 2-17. Predicted Orientation of S1 KCNQ1 relative to KCNE1. 
(A) Extracellular view of KCNQ1 tetramer and KCNE1 transmembrane domain in  
the open state from Kang et al. (B) Extracellular view of KCNE1 (red) and S1 KCNQ1 (green) 
from Kang et al. V141 (blue) and S140 (orange) in S1 KCNQ1 and A44 (yellow) in KCNE1 are 
in space-fill representations.  V141 points towards A44, while S140 points towards S2-S4 
domains of the same KCNQ1 subunit (gray).  (C) Side view of KCNE1 and single subunit of 
KCNQ1 taken from Kang et al. open state model.  
 
The functional consequences of the crosslink at V141C / A44C and V141C / E43C were 
observed to be minor, indicating that crosslinking does not perturb the native conformation of the 
channel; consequently these residues are likely in a relatively fixed position in the native state of 
the channel.  Taken together, our results suggest an important region of proximity between the 
amino terminal end of KCNE1, near the transmembrane region and the extracellular end of 
KCNQ1 S1, that is particularly important in controlling deactivation kinetics of the 
KCNQ1/KCNE1 assembled channel.  Based on these results, we propose that this KCNE1 / 
KCNQ1 S1 interaction may mediate the KCNE1-induced changes in WT KCNQ1 deactivation.   
The requirement of KCNE1 for the most severe phenotype observed with these inherited 
mutations raises the interesting and important question of whether the pathological phenotype of 
these mutations may depend on the relative expression of KCNE1 in the heart and the resulting 
stoichiometry of KCNE1 in these channels.  Mutation carriers in the S140G family have varied 
clinical phenotypes from no effect to AF to mild Long QT (Chen et al., 2003c).  The molecular 
mechanism of AF involves multiple-circuit-reentry, which is due to shortening of the action 
potential duration (APD) and reduction of the effective refractory period (ERP) (Nattel 2002).  In 
the Chen et al. study, the S140G mutation caused an increase in outward potassium current at 
depolarized potentials, which would stabilize the resting membrane potential, leading to a 
shortening of the atrial ERP, thus leading to a shorter QT interval.  However, it is harder to 
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explain why some patients exhibited prolonged QT intervals. Several hypotheses include the 
effect of another mutation in the atria, which could contribute to long QT phenotype, inadequate 
correction of the QT interval, or the alteration of other ionic currents, such as Ca2+ or Na+, which 
may prolong the APD, thus leading to a net prolongation of the QT interval.  
Whether the stoichiometric ratio of KCNE1 to KCNQ1 is fixed at 2/4 as suggested by the 
work of the Kobertz group (Morin and Kobertz, 2008) or variable as suggested by recent single 
molecule imaging experiments (Nakajo et al., 2010); our work would strongly suggest a 
mandatory proximity of KCNQ1 to a nearby KCNE1, especially in the case of V141M, subunit 
if the assembled channel is to be characterized by the key pathological phenotype: markedly 
slowed deactivation. In heterozygote patients, the number of KCNQ1 subunits carrying the 
disease causing mutation will vary from 1 to 4 in assembled channels, and thus alter the potential 
contributions of KCNE1/KCNQ1 interactions underlying arrhythmia risk.  Similarly, if, in fact 
KCNE1/KCNQ1 stoichiometry is variable and may even vary during disease (Mustapha et al., 
2007), then the severity of the disease phenotype, particularly for V141M mutation carriers, will 
be highly variable. Further, by this mechanism, chamber specific variation in KCNE1 (Soma et 
al. 2010) may well play a role in these mutations predominant effect occurring in the atria.  
Testing the impact of subunit assembly, availability and stoichiometry on the severity of the 
underlying disease mechanism therefore represents a major goal of future studies. 
In summary, our work reveals KCNE1-dependence for the V141M mutation and not for 
S140G. These results are supported by biochemical crosslinking data demonstrating that residue 
V141 is positioned close to and is facing KCNE1, revealing a specific orientation of the KCNQ1 
and KCNE1 subunits.  The crosslink at V141C and A44C also demonstrates a suggested point of 
close proximity between KCNQ1 and KCNE1, functionally and structurally. Additionally, the 
	  	    
71	  
dependence on a neighboring KCNE1 for the full functional phenotype presents a mechanism by 
which diverse chamber specific or patient specific functional effects can occur.  
The attempts to monitor intersubunit and state dependent crosslinking were not 
successful.  However, the hypotheses surrounding the idea that residue S140 is interacting with a 
part of the channel to induce slow deactivation kinetics could provide insight into the mechanism 
of how this mutation functions.  These hypotheses will likely require experimentation with 

















Amino-terminus of KCNE1 Controls Deactivation Kinetics 
 
Background and Significance 
 
Kang et al. describes that the N-terminus of KCNE1 is situated in the gain-of-function 
(gof) cleft (including four of five known mutations, S140G, V141M, I274V, and A300T) and 
that this placement stabilizes the open state of the channel (Kang et al., 2008).  Our biochemical 
crosslinking studies revealed proximity between KCNQ1 V141C / KCNE1 A44C and KCNQ1 
V141C / KCNE1 E43C, which may be important in acting as part of the anchor point involved in 
closed to open transitions in Kv channel gating (Lee et al., 2009).  These findings and our data 
draw attention to the N-terminal region of KCNE1 and its impact on channel function.   
Results 
N-terminal KCNE1 Mutations  
The amino terminus of KCNE1 was screened for residues that might counter the 
functional consequences of the two KCNQ1 AF mutations, S140G and V141M.  KCNE1 
residues starting at the extracellular end of the predicted KCNE1 helix (residues A44 through 
L51) were mutated because it was previously demonstrated that there is close proximity of this 
region of KCNE1 to KCNQ1 S1 (Figure 3-1A) (Chung et al., 2009).  The specific mutations 
made on KCNE1 were initially designed to impact a putative KCNE1/KCNQ1 interface based 
on volume compensation.  For the S140G mutation, there is a loss of volume when the residue is 
mutated from a serine to glycine, resulting in a volume loss of ~29.3 Å3.  In order to compensate 
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for this loss on KCNQ1 S1, one set of residues, starting from A44 - L51 in KCNE1, were 
mutated to have an added volume of ~29.3 Å3.   For the V141M mutation, the same set of 
residues (A44 - L51) on KCNE1 were mutated to have a loss of volume of ~29.3 Å3 to 
compensate for the V141M mutation.   
We transiently co-expressed S140G KCNQ1 or V141M KCNQ1 with the appropriate 
volume compensated KCNE1 mutant in CHO cells and recorded currents by whole cell patch 
clamp.  Recordings were done in a physiological K+ solution.  A series of depolarizing pulses 
were applied from -60 mV to +80 mV from a holding potential of -80 mV and repolarizing 
currents were measured at -40 mV.  The pulse protocol was applied at 0.1Hz, and thus channels 
that open upon depolarization, but fail to close during the interpulse interval at the -80 mV 
holding potential generate time-independent currents that resemble "constituitively open 
channels".  For channels that do close during the interval between test pulses, there is no open 
channel activity at the beginning of the test pulse.  Normalized pedestal current (Io/I defined in 
Methods) is used as a measure of restoration of KCNQ1/KCNE1 channel activity.  For 
comparison, expression of WT KCNQ1/KCNE1channels yields Io/I ratio of close to zero; 
expression of S140G/KCNE1 and V141M/KCNE1 channels yields Io/I of 1.   
 
L45F and Y46W KCNE1 Mutations Alter Deactivation in both KCNQ1 AF Mutations 
KCNE1 residues, when co-expressed with KCNQ1 S140G, were screened for activity 
that reduced the accumulation of open channels during repetitive stimulation.  Representative 
recordings are shown for S140G KCNQ1 co-expressed with KCNE1 residues: A44T and L45F 
(Figure 3-1B).  The following KCNE1 mutations exhibited little open channel activity at the 
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beginning of the test pulse and were able to partially correct the markedly slow deactivation 
characteristic of the S140G mutation: L45F (0.24 ± 0.026 pA, n=15), Y46A (0.31 ± 0.014 pA, 
n=3) and Y46W  (0.33 ± 0.029 pA, n=14). The functional impact of these and other mutations is 
summarized in a bar graph (Figure 3-1B).   
When mutated KCNE1 subunits were co-expressed with KCNQ1 V141M, there was no 
change in channel function with any volume-compensated KCNE1 mutants (Data not shown).  
From the above results, we observed that KCNE1 mutations, L45F and Y46W, altered channel 
activity with the S140G mutation.  Since S140G and V141M are adjacent residues, we tested 
whether L45F and Y46W would also have an effect on V141M. Representative recordings show 
that these two KCNE1 mutations also correct the slowed deactivation kinetics of the V141M 
mutation and the functional impact of these mutations is summarized in a bar graph (Figure 3-
1C). Similar to the effects with the S140G mutation, these KCNE1 mutants co-expressed with 
V141M help restore channel activity towards a wild-type IKs-like phenotype.   
These results suggest that a region on KCNE1, located on the amino terminus, is critical 
for altering channel function with the S140G and V141M mutations.  To explore what aspect of 
function these KCNE1 mutations alter, we systematically compared co-expression of Y46W and 
L45F KCNE1 subunits with WT, S140G and V141M KCNQ1subunits. We compared the impact 
of these KCNE1 mutations on activation kinetics, absolute deactivation kinetics measured at -
120 mV, and the fold difference in deactivation at -120 mV.   
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Figure 3-1.  Amino-terminal KCNE1 mutations preferentially impact deactivation: greater 
impact on V141M vs. S140G KCNQ1 subunits.   (A) Cartoon of KCNE1 and S1 KCNQ1, 
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with black dots indicating location of residues that were mutated and numbers represent amino 
acid position. The dashed line above KCNQ1 indicates continuation of the channel.  
(B and C) Representative current traces are shown for the indicated S140G/KCNE1 pairs (B) and 
V141M/KCNE1 pairs (C). Recordings were done in 5 mM external K+ solution. Holding 
potential = - 80 mV.  Cells were depolarized from -60 mV to +80 mV in 20 mV increments for 2 
s.  Tail currents were measured at -40 mV for 2 s. The bar graph shows the normalized 
instantaneous current (Io/I) measured at the beginning of the pulse at + 60 mV with each 
KCNQ1/KCNE1 pair.  Twelve KCNE1 mutations were co-expressed with S140G.  Eight 
KCNE1 mutations were co-expressed with V141M.  The dashed line indicates the WT 
KCNQ1/KCNE1 condition.  Data are shown as mean ± s.e.m. Symbols (*, @, #) indicate a 
significant difference (p < 0.05) using Student’s t-test.  
 
Characterization of KCNE1 Y46W co-expression with KCNQ1 Variants 
Co-expression of Y46W with S140G or V141M exhibited little open channel activity at 
the beginning of each test pulse.  To examine how Y46W is causing this effect in 
KCNQ1/KCNE1 channels, we compared the following parameters: voltage dependence of 
activation, kinetics of activation, and kinetics of deactivation upon co-expression with all 
KCNQ1 variants.  
Co-expression of Y46W with all KCNQ1 variant channels resulted in slow activating, 
time-dependent currents for all assembled channels, however deactivation kinetics differed for 
these three subunit combinations (Figure 3-2A to 3-2C).  There was a depolarizing shift in 
voltage dependence for KCNQ1/Y46W (V1/2 = 91.5 ± 8.8 mV, n=5) compared to 
KCNQ1/KCNE1 (V1/2 = 17.5 ± 2.6 mV, n=7) (Table 1).  However, there is no significant 
difference in voltage dependence of activation for V141M/Y46W (V1/2 = 20.8 ± 3.2 mV, n=3) 
and KCNQ1/KCNE1 (p < 0.05 for V141M/Y46W vs. KCNQ1/KCNE1).  In contrast, for S140G/ 
Y46W (V1/2 = -25.3 ± 3.4 mV, n=5), there was a hyperpolarizing shift in voltage dependence that 
is significant from KCNQ1/KCNE1.  Co-expression of Y46W with all KCNQ1 variants resulted 
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in similar kinetics of activation, while KCNQ1/KCNE1 Y46W resulted in a slightly faster time 
to half activation (KCNQ1/Y46W: 0.87 ± 0.29 s, n=6, S140G/Y46W: 1.09 ± 0.54 s, n=6, 
V141M/Y46W: 1.17 ± 0.31 s, n=8) (Figure 3-2D).  Deactivating tail currents at -120 mV showed 
that the time course of deactivation for KCNQ1/ Y46W channels (τdeact = 0.21 ± 0.05 s, n=5) is 
similar to KCNQ1/KCNE1 channels (τdeact = 0.24 ± 0.004 s, n=9).   In contrast, V141M/Y46W 
(τdeact = 0.72 ± 0.04 s, n=9) and S140G/Y46W (τdeact = 1.1 ± 0.13 s, n=6) channels both 
deactivate significantly slower than KCNQ1/KCNE1 channels. 
There were differences in deactivation kinetics that are most dramatically seen in the 
comparison of the fold change in deactivation rate measured at a fixed voltage (-120 mV).  
Similar to the effect of WT KCNE1 expressed with KCNQ1, Y46W slows deactivation when co-
expressed with each KCNQ1 variant.  However, the impact on slowing deactivation from the 
Y46W mutant subunit is roughly 9-fold greater when co-expressed with V141M (8.94 ± 0.55, 
n=9) compared with either KCNQ1 (2.6 ± 0.62, n=6) or S140G (2.87 ± 0.28, n=6) (Figure 3-2E).   
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Figure 3-2.  Y46W co-expression has greater impact on deactivation kinetics for V141M vs. 
S140G KCNQ1 subunits.  (A to C) Representative current traces are shown for KCNQ1, S140G, 
and V141M, each co-expressed with Y46W. Recordings were done in 120 mM external K+ 
solution.  Stimulation protocols are shown above the trace. Activation t1/2  (D) and fold change 
for τdeact at -120 mV (E) was measured for KCNQ1, S140G, and V141M, each co-expressed with 
Y46W. The dashed line indicates WT KCNQ1/KCNE1. Data are shown as mean ± s.e.m.  
Asterisks indicate a significant difference (p < 0.05) using Student’s t-test.  
 
In the experiments investigating characteristics of Y46W co-expression, we co-expressed 
this residue with the WT KCNQ1 channel, which caused a large depolarizing shift (~70 mV) in 
voltage dependence of activation, compared to WT KCNQ1/KCNE1 channels.  However, the 
time course of deactivation is roughly the same for WT KCNQ1/KCNE1 and WT 
KCNQ1/Y46W channels.  Here, we first demonstrate a mutation that only affects activation 
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properties of the assembled channel, thus separating the mechanism of activation from 
deactivation.    However, the story gets complicated when Y46W is co-expressed with either 
S140G or V141M channels.  It seems that there are differential effects of the Y46W mutation 
with either mutation.  
With S140G/Y46W channels, KCNE1 behaves like a less functional version of this 
subunit.  We assume that the role of KCNE1, when co-expressed with KCNQ1 channels, is to 
slow deactivation and cause depolarizing shifts in voltage dependence.   S140G/Y46W channels 
exhibit a depolarizing shift in voltage dependence, compared to S140G channels alone, but the 
shift is not as big as S140G/KCNE1 channels (Figure 3-3A).  For deactivation, S140G/Y46W 
channels exhibit a slower time course of deactivation, but not nearly as slow as S140G/KCNE1 
channels (Figure 3-3B).   
For V141M/Y46W channels, again, we see separate of effects from activation versus 
deactivation.  For activation, we observe a ~50 mV depolarizing shift in voltage dependence, 
compared to V141M channels alone (Figure 3-3C). This shift is similar to that of 
KCNQ1/KCNE1 channels, compared to KCNQ1 alone.  This result demonstrates that Y46W co-
expressed with V141M is behaving like KCNE1 with WT KCNQ1 channels.  However, for 
deactivation, we again see a less functional version of KCNE1, where the time course of 
deactivation is slow for V141M/Y46W channels, but not nearly as slow as V141M/KCNE1 
channels (Figure 3-3D).    
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Figure 3-3.  The Y46W Mutation exhibit differential effects when co-expressed with S140G 
and V141M mutations.  Δ V1/2 (A) and fold change in deactivation tau (B) plotted for WT 
KCNE1 and Y46W co-expressed with S140G compared to S140G expressed alone.  Δ V1/2 (A) 
and fold change in deactivation tau (B) plotted for WT KCNE1 and Y46W co-expressed with 
V141M compared to V141M expressed alone.   
 
 




Table 1.  Voltage Dependence of Activation, Deactivation, and slope parameters for 
KCNQ1/KCNE1 subunit pairs used in study.   
 
Characterization of KCNE1 L45F co-expression with KCNQ1 Variants 
KCNE1 L45F co-expression with KCNQ1 variants all exhibited slow activating, time 
dependent currents.  However, for S140G/ L45F and V141M/ L45F channels, tail currents 
deactivated more slowly than KCNQ1/L45F (Figure 3-4A to 3-4C).  L45F caused a minor 
depolarizing shift when co-expressed with KCNQ1 (V1/2 = 23.8 ± 3.1 mV, n=4) compared to 
KCNQ1/KCNE1 (V1/2 = 17.5 ± 2.6 mV, n=7), though not nearly as large as the Y46W mutation 
(V1/2 = 91.5 ± 8.8 mV, n=5).  L45F co-expression resulted in hyperpolarizing shifts for the 
S140G (V1/2 = -31.3 ± 6.8 mV, n=4) and V141M mutations (V1/2 = -18.3 ± 3.2 mV, n=5) 
compared to KCNQ1/KCNE1.    Co-expression of L45F with all KCNQ1 variants resulted in 
kinetics of activation that are comparable to KCNQ1/KCNE1 channels (Figure 3-4D).  
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Deactivating tail currents were slower for S140G/L45F (τdeact = 1.27 ± 0.29 s, n=4) and 
V141M/L45F channels (τdeact = 1.09 ± 0.13 s, n=9), compared to KCNQ1/KCNE1 channels 
(τdeact = 0.24 ± 0.004 s, n=9).  The time course of deactivation for KCNQ1/L45F channels (τdeact 
= 0.24 ± 0.03 s, n=6) was not significantly different from KCNQ1/ KCNE1.  There is a 
differential response of V141M vs. S140G channels that is seen in the comparison of the L45F-
induced fold change in channel deactivation kinetics.  Here the impact of the KCNE1 subunit is 
roughly 14-fold greater when expressed with V141M (13.6 ± 1.64, n=9) compared with S140G 
(1.71 ± 0.36, n=4) or WT (2.91 ± 0.4, n=6) KCNQ1 subunits (Figure 3-4E).  These results are 
similar to the Y46W mutation, where the impact of the KCNE1 subunit is much more substantial 
when co-expressed with the V141M mutation.   All of the above functional results point to a 
much closer interdependence of channel function on assembly with KCNE1 for V141M vs. 
S140G KCNQ1 subunits.  
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Figure 3-4.  L45F co-expression has greater impact on deactivation kinetics for V141M vs. 
S140G KCNQ1 subunits.  (A to C) Representative current traces are shown for KCNQ1, S140G, 
and V141M, each co-expressed with L45F. Recordings were done in 120 mM external K+ 
solution.  Stimulation protocols are shown above the trace. Activation t1/2  (D) and fold change 
for τdeact at -120 mV (E) was measured for KCNQ1, S140G, and V141M, each co-expressed with 
L45F. The dashed line indicates WT KCNQ1/KCNE1. Data are shown as mean ± s.e.m.  
Asterisks indicate a significant difference (p < 0.05) using Student’s t-test.  
 
 
The L45F mutation, when co-expressed with KCNQ1, results in channels with similar 
voltage dependence and deactivation time course to KCNQ1/KCNE1 channels.  Already, the 
L45F and Y46W mutations do not behave the same when co-expressed with the WT KCNQ1 
channel.  However, what is interesting is that both mutations co-expresssed with the AF mutants 
produce channels resembling IKs channels.   
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 When L45F is co-expressed with either S140G or V141M, we see channels that are 
roughly the same in voltage dependence and deactivation time course (Figure 3-5).  In both 
S140G/L45F and V141M/L45F channels, the L45F mutant behaves like a less functional version 
of KCNE1.  For voltage dependence of activation, the L45F mutation causes a depolarizing shift 
in voltage dependence for S140G and V141M channels, but nearly as much as WT KCNE1 with 
S140G or V141M.  Similarly, for time course of deactivation at -120 mV, the L45F mutation 
slows deactivation with both S140G and V141M channels, but not nearly as slow as the WT 
KCNE1 subunit.   
 
Figure 3-5.  The L45F Mutation exhibit similar changes in channel function when co-
expressed with S140G and V141M mutations.  Δ V1/2 (A) and fold change in deactivation tau 
(B) plotted for WT KCNE1 and L45F co-expressed with S140G compared to S140G expressed 
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alone.  Δ V1/2 (A) and fold change in deactivation tau (B) plotted for WT KCNE1 and L45F co-
expressed with V141M compared to V141M expressed alone.   
 
 
Function of KCNE1 Mutations with WT KCNQ1  
The functional characteristics of the single KCNE1 mutants were tested with WT 
KCNQ1.  Substitutions of amino acids in residues A44T – L51F in KCNE1 co-expressed with 
KCNQ1 exhibited subtle changes in activation and deactivation kinetics, but all resembled 
currents similar to IKs (Figure 3-6). 
 
Figure 3-6.  Amino-terminal KCNE1 mutations co-expressed with WT KCNQ1.  Families of 
current traces shown for KCNQ1 co-expressed with KCNE1 residues: A44T, L45F, Y46W, 
V47L, L48F, M49F, V50L, and L51F.  Currents in response to 2 s pulses from -60 mV to +80 
mV in 20 mV increments from -80 mV holding potential. 
   
Effect of Different Size Amino acids at positions L45 and Y46 
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From the initial experiments done in Figure 3-1, it was clear that our origninal volume 
hypothesis to compensate for volume change in the V141M mutations was unsuccessful, so we 
wanted to investigate the effect of different sized amino acids as a factor in compensating 
function of the channel.  We tested the effects of substituting various sized amino acids at 
positions L45 and Y46 to see whether these two KCNE1 residues caused changes in function due 
to the amino acid or due to its position on the KCNE1 helix relative to the mutations in the S1 
segment of KCNQ1.  Prevously, we had substituted phenylalanine at position L45, which when 
co-expressed with S140G or V141M, restored IKs-like channel activity.  Here we substituted the 
leucine at position 45 with alanine, threonine, and tyrosine (Figure 3-7A).  Alanine was chosen 
because it was a reduction in volume.  Threonine was chosen because it incurs a similar volume 
change as the phenylalanine, but without the aromatic ring.  Tyrosine was chosen because it has 
an aromatic ring like the phenylalanine, but also incurs a larger volume change.  Here, we find 
that the substitution of smaller and larger amino acids at positon L45 on KCNE1 did not 
compensate the effects of the S140G mutation.  Additionally, we see that substitution of a 
threonine at L45 did not alter S140G channel function.  To summarize, the L45F mutation is 
specific and unique in its ability to compensate for both the S140G and V141M mutations.   
For residue Y46, we substituted the tyrosine with alanine to investigate a reduction in 
size at this position (Figure 3-7B).  We find that Y46A resembles the effects of Y46W, when 
each are co-expressed with the S140G mutation.  These results indicate that the specific amino 
acid, tryptophan, substituted at Y46 is not unique in compensating the AF KCNQ1 mutants, 
because substituting an alanine at Y46 produces the same functional results.  However, these 
data suggest that the specific position of Y46 in KCNE1 is significant in affecting S140G 
channel function.   
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A) L45 Mutations 
 
B) Y46 Mutations 
 
Figure 3-7.  Effects of different sized amino acids at positions L45 and Y46 on KCNE1. 
Families of current traces recorded for S140G co-expressed with KCNE1 mutations made on 
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L45:  Alanine, Threonine, Phenylalanine, Tyrosine (A) and made on Y46: Tryptophan, Alanine 
(B).  Cells were depolarized from -60 mV to +80 mV in 20 mV increments for 2 s.  Tail currents 
were measured at -40 mV for 2 s.  
 
Discussion 
Until recently, the amino-terminus of KCNE1 has not been studied in detail in terms of 
modulation of KCNQ1 channels.  It was thought that this region was not necessary for control of 
channel gating (Takumi et al., 1991; Romey et al., 1997).  The Kass lab group and others first 
show evidence that this region is involved in interactions with the S1 domain and the pore region 
of KCNQ1, shown through crosslinking studies (Xu et al., 2008; Chung et al., 2009).  Here, we 
demonstrate for the first time that the amino-terminus of KCNE1 is likely an important region 
for control of deactivation kinetics and may play a role in modulation of the KCNQ1 channel.   
  We scanned the KCNE1 amino-terminus for mutations that could restore channel 
function when co-expressed with the KCNQ1 AF mutants, S140G and V141M.  We looked for 
mutations that fixed the slow deactivation effect of the mutations, thus resulting in channels that 
would exhibit less pedestal current during repetitive pulses.  Two mutations, L45F and Y46W, 
when co-expressed with either S140G or V141M, both helped to fix the slow deactivation defect 
and produced channels that resembled WT IKs channels.  Upon further analysis, we find that the 
Y46W mutation, when co-expressed with WT KCNQ1 separates the effects of activation from 
deactivation in the channel.  
 Altogether, these results point out several findings: (1) the Y46W mutation in KCNE1 
separates the effects of activation from deactivation and (2) L45F is a unique mutation able to 
alter S140G and V141M channel function, (3) Y46 is in a specific location able to alter S140G 
and V141M channel function, and (4) the L45F and Y46W mutations behave like a less 
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functional KCNE1 subunit.  These results highlight this region of KCNE1 as an important region 
of modulatory control of the KCNQ1 channel.   
 Previously, in Chapter II, we demonstrated that the V141M mutation relies on KCNE1 
co-expression for the channel to exhibit slow deactivation kinetics and additionally, there is a 
structural proximity of KCNE1 to this residue.  Based on these results, it is understandable that 
mutations made at the upper TM region of KCNE1, L45F and Y46W, would have large effects 
on channel function.  In this case, these two KCNE1 mutants are located in the same upper TM 
region where there is structural proximity and functionally, they fix the slow deactivation defect 
when co-expressed with the V141M mutation, by allowing channels to be closed during the 
interpulse interval (11 s) at a relatively physiological holding potential (-80 mV), thus producing 
channels that resemble IKs.   
Co-expression of the L45F and Y46W mutations with the S140G mutation could be 
rescuing the channels via a different route, which can also be applied to the V141M mutation.  In 
a previous study, it was demonstrated that certain salt bridge interactions were involved in the 
mechanism of slowing of the S140G and V141M mutations (Restier et al 2008).  It is possible 
that the L45F and Y46W mutations could be affecting the stability of the salt bridges formed 
between S2 and S4.  For the L45F mutation specficially, this leucine residue is mutated to a 
larger phenylalanine residue, which may alter the packing of the KCNQ1 channel complex.  This 
residue is also oriented towards the S1 domain, so it could be directly pushing on the S1 domain, 
which could alter the salt bridge interactions that seem to stabilize the open states of the S140G 
or V141M mutations (Smith et al., 2007).   For the Y46W mutation, the tyrosine residue is also 
mutated to a larger residue, tryptophan, and is facing the other direction, away from the S1 
domain and is oriented towards S6, based on the current KCNQ1 structural model.  It is possible 
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that the Y46W mutation could be interacting the pore domain in the upper TM region and 
affecting channel gating via a different route.   This hypothesis is supported by evidence 
indicating proximity of the S6 domain and KCNE1 in the extracellular regions flanking the TM 
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CHAPTER IV 
Functional Studies of the KCNQ1 S140T Mutation 
 
Background and Significance 
 
Ion channels must maintain a specific intra-membrane structure, with specific 
interactions between its individual transmembrane segments.  Mutation of residues, which are 
involved in these specific interactions, are expected to disrupt the structure and thus the function 
of the protein.  In Chapter II, two mutations in the KCNQ1 channel (S140G and V141M) were 
investigated and shown to specifically disrupt channel deactivation kinetics.  In Chapter III, 
scanning mutagenesis of amino-terminal KCNE1 residues were characterized for mutations that 
would restore channel function in the S140G and V141M mutations.  We find that several 
KCNE1 mutations fit this role, L45F and Y46W.  However, one question that remains is why are 
those specific mutations, S140G and V141M, able to disrupt channel deactivation so 
dramatically?  One group substituted various amino acids at positions 140 and 141 to see what 
were the effects of other mutations, but they concluded that only the S140G and V141M 
mutations caused the most dramatic changes in channel deactivation (Restier et al., 2008).  Here, 
we characterize the functional effects of one mutation in KCNQ1, S140T, which causes a 
significant change in channel function.  In contrast to the S140G mutation, the functional effects 
include a large depolarizing shift in voltage dependence of activation, and very rapid 
deactivation kinetics.   
Residue S140 was mutated to a polar residue, Threonine, and the biophysical changes in 
channel function were characterized in a mammalian expression system.  The S140T channels 
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expressed well in CHO cells in contrast to a previous report of this mutation, S140T, which was 
reported to cause a complete loss of KCNQ1 function.  However, those experiments were 
conducted in Xenopus oocytes, in which depolarizations to voltages greater than +60 mV could 
not be performed due to possible activation of endogenous K+ currents (Restier et al., 2008).  
Threonine was chosen as the amino acid for substitution at position 140 based on the volume 
change it would incur: the S140T mutation would have an added volume of 27 Å3, in contrast to 
the loss of 29 Å3 with the S140G mutation.  
 
Results 
Functional Characterization of S140T in the absence of KCNE1 
The functional effects of the S140T mutation were characterized in cells expressing only 
KCNQ1 channels (Figure 4-1B).  The following experiments were carried out in external 
solutions containing physiological K+ concentration (5 mM).  These experiments were also done 
in elevated K+ solution (120 mM) to better evaluate the tail currents, but the data produced the 
same results as those shown here.  Channels assembled with the S140T mutation resemble WT 
channels (Figure 4-1A and 4-1B).  S140T channels (V1/2 = -24.08 ± 0.9 mV, n=4) and WT 
KCNQ1 channels (V1/2 = -26. 27 ± 1.8 mV, n=6) exhibited similar activation V1/2’s, in contrast 
to that of S140G channels with (V1/2 = - 57.5 ± 1.3 mV, n= 5) (Figure 4-1D).  Deactivation 
kinetics were significantly different for S140T channels (τdeact = 0.21 ± 0.018 s, n=6) compared 
with both WT KCNQ1 (τdeact = 0.081 ± 0.014 s, n=6) and S140G channels (τdeact = 0.67 ± 0.11 s, 
n=6) (Figure 4-1E).   
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Figure 4-1.  S140T, in contrast to S140G, resembles homomeric WT KCNQ1 channels. 
Representative families of currents traces in cells expressing WT KCNQ1 (A), S140T (B), and 
S140G (C) in the absence of KCNE1. Currents in response to 2 s pulses from -60 mV to +80 mV 
in 20 mV increments from a -80 mV holding potential. (D) Normalized isochronal (2 s) 
activation curves for KCNQ1 (squares), S140T (circles), and S140G (triangles).  (E) 
Deactivation time constant (tau) obtained at -120 mV from single exponential fits to tail currents 
following conditioning pulses (+20 mV, 2 sec). Data are shown as mean ± s.e.m.   
 
Functional Characterization of S140T in the presence of KCNE1 
The impact of KCNE1 co-expression on channel properties was investigated with 
KCNQ1 carrying the S140T mutation.  A pulse protocol consisting of a series of 2 s isochronal 
activating pulses (-60 mV to + 80 mV) was applied as we measured the impact of KCNE1 co-
expression on activation gating.  Representative current traces for S140T KCNQ1, assembled 
with KCNE1, reveal channels that do not exhibit much activation using the voltage protocol 
shown above trace, in contrast with WT IKs channels (Figure 4-2A and 4-2B).  Because of this, 
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we applied a different protocol, consisting of 2 s activating pulses starting from +20 mV to +160 
mV, applied at the same rate as the original protocol.  We observed more channel opening in 
S140T/KCNE1 channels using this depolarized voltage range (Figure 4-2C).   
 
Figure 4-2.  S140T exhibits depolarizing shift in voltage dependence and fast deactivation 
kinetics.  Representative families of currents traces in cells expressing WT KCNQ1/KCNE1 (A) 
and S140T/KCNE1 (B and C) using stimulation protocol shown above traces.  
 
The voltages for half maximal (isochronal) activation for channels consisting of KCNE1 
co-expressed with three KCNQ1 variants were measured to compare voltage dependence of 
activation gating.  S140T/KCNE1 channels (V1/2 = 112 ± 1.86 mV, n=5) exhibited a significant 
depolarizing shift in voltage dependence from WT KCNQ1/KCNE1 channels (V1/2 = 17.5 ± 2.6 
mV, n=6) in contrast to S140G/KCNE1 (V1/2 = 1.5 ± 2.7 mV, n=4) channels, which exhibited a 
hyperpolarizing shift from WT KCNQ1/KCNE1 channels (Figure 4-3A).  Next, IKs activation 
kinetics were compared by measuring the time (t1/2) at which IKs current is half maximally 
activated at the voltage closest to the V1/2 for each subunit combination.  Activation kinetics for 
the S140T/KCNE1 channel (t1/2 = 0.6 ± 0.06 s, n=4) are two-fold faster than WT 
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KCNQ1/KCNE1 channels (t1/2 = 1.1 ± 0.031 s, n=4), and nearly three-fold faster than 
S140G/KCNE1 channels (t1/2 = 1.5 ± 0.035 s, n=4) (Figure 4-3B).   
Deactivation kinetics of the S140T mutant channels with KCNE1 were subsequently 
investigated.  To compare deactivation for the different KCNQ1/KCNE1 pairs, the deactivation 
time constants (tau) were measured from tail currents at -120 mV in response to a 2 s 
depolarizing pulse.  The deactivation tau for S140T / KCNE1 (τdeact = 0.045 ± 0.006 s, n=4) is 
significantly faster than both KCNQ1 / KCNE1 channels (τdeact= 0.24 ± 0.004 s, n=5) and S140G 
(τdeact= 4.09 ± 0.2 s, n=6) (Figure 4-3C).   
 
Figure 4-3.  S140T and S140G channels exhibit contrasting biophysical effects in the 
presence of KCNE1.  (A) Normalized isochronal (2 s) activation curves for KCNQ1 (squares), 
S140T (circles), and S140G (triangles) in the presence of KCNE1.  Activation t1/2 (B) and 
deactivation time constant (tau) (C) obtained at -120 mV from single exponential fits to tail 
currents following conditioning pulses (+20 mV, 2 sec). Data are shown as mean ± s.e.m.           
* (p <0.05)  
 
Influence of KCNE1  
Expression of the S140T mutation in KCNQ1 subunits alone exhibited properties similar 
to WT KCNQ1 channels.  However, upon KCNE1 co-expression, S140T channels exhibited a 
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large shift in voltage dependence and a speeding of deactivation, so we wanted to compare the 
impact of KCNE1 co-expression in all KCNQ1 variants.  To evaluate the effect of KCNE1 on 
the channel’s voltage dependence, we measured the Δ V1/2 by subtracting the V1/2 from KCNQ1 
subunits alone from the V1/2 of KCNQ1 subunits in the presence of KCNE1 (Figure 4-4A).  The 
co-expression of KCNE1 with S140T channels exhibited a 137 ± 0.62 mV (n=5) depolarizing 
shift in voltage dependence, while KCNE1 co-expression with WT KCNQ1 or S140G channels 
exhibit similar shifts of 45 ± 0.6 mV (n=6) and 48 ± 2.2 mV (n=6), respectively.  Next, to 
evaluate the effect of KCNE1 on channel deactivation, we examined the fold change in 
deactivation time constants of the KCNQ1 mutations in the absence and presence of KCNE1.  
The fold change is the ratio of deactivation tau from the KCNQ1 / KCNE1 channels: 
deactivation tau from the KCNQ1 subunit alone.  S140T/KCNE1 channels exhibited less than 
0.5 fold difference in channel deactivation, in contrast to S140G/KCNE1 channels, which 
exhibited a 8-fold difference (Figure 4-4B). 
 
Figure 4-4.  The impact of KCNE1 exhibits opposing effects when co-expressed with  
S140T vs. S140G.  Δ V1/2 (A) and fold change in deactivation time constant (tau) (B) analyzed 
for KCNQ1, S140T, and S140G to demonstrate the influence of KCNE1 on voltage dependence 
of activation and deactivation kinetics.  Data are shown as mean ± s.e.m.  
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Amino-Terminal KCNE1 Mutations 
 As had been previously described in Chapter III, the amino terminus of KCNE1 was 
screened for residues that might counter the functional consequences of the S140T mutation.  
KCNE1 residues starting at the extracellular end of the predicted KCNE1 helix (residues A44 
through L51) were mutated to amino acids that would incur a loss of volume of 27 Å3 at that 
residue.   
 KCNE1 mutations, when co-expressed with S140T KCNQ1, were tested for activity that 
restored channel activity similar to WT IKs channels.  Representative recordings are shown for 
S140T KCNQ1 co-expressed with KCNE1 residues: A44G, L45V, Y46L, V47T, L48V, M49V, 
and L51V (Figure 4-5).   
Figure 4-5.  Amino-terminal KCNE1 mutations co-expressed with S140T mutation.  
Families of current traces shown for S140T KCNQ1 co-expressed with KCNE1 residues: A44G, 
L45V, Y46L, V47T, L48V, M49V, and L51V.  Currents in response to 2 s pulses from -60 mV 
to +80 mV in 20 mV increments from -80 mV holding potential. 
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Among the KCNE1 mutants tested, the Y46L KCNE1 mutation exhibited more open 
channel activity at the beginning of the test pulse.  The functional impact of these mutations on 
voltage dependence of activation is summarized in a graph (Figure 4-6A).  S140T/Y46L 
channels (V1/2 = 19.8 ± 1.7 mV, n=4) exhibited a hyperpolarizing shift in voltage dependence 
from S140T/KCNE1 channels (V1/2 = 114 ± 3.7 mV, n=6), bringing the V1/2 closer to that of WT 
KCNQ1/KCNE1 channels (V1/2 = 17.5 ± 2.6 mV, n=6).  Other KCNE1 mutations expressed with 
S140T exhibited a range of voltage dependences of activation, indicating biophysical changes 
from those mutations.   
Deactivation kinetics of the KCNE1 mutations co-expressed with S140T were analyzed 
next.  The tau of deactivation was measured from repolarizing currents at – 40 mV in response to 
2 s depolarizing pulses at +60 mV and the results are summarized in a bar graph (Figure 4-6B).  
Co-expression of WT and mutant KCNE1 subunits with S140T speeds deactivation dramatically 
compared with WT IKs channels.  However, Y46L co-expression with S140T exhibited a slower 
deactivation tau (τdeact = 0.13 ± 0.005 s, n=6) compared to the rest of the mutations (τdeact < 0.1 s).    
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Figure 4-6.  Y46L KCNE1 mutation co-expressed with S140T produce channels that 
resemble WT KCNQ1/KCNE1 channels.  V1/2 of activation (A) and deactivation time constant 
(tau) measured at -40 mV (B) for KCNE1 mutations co-expressed with S140T mutation.  Dashed 
line indicates WT KCNQ1/KCNE1 channels. 
 
Function of Single KCNE1 Mutations with WT KCNQ1 
The functional characteristics of the single KCNE1 mutants were tested with WT 
KCNQ1 (Figure 4-7A).  Substitutions of amino acids in residues A44 – L51 in KCNE1 co-
expressed with KCNQ1 exhibited various shifts in voltage dependence of activation (Figure 4-
7B).   These mutations caused various effects on channel gating, but this data did not contribute 












Figure 4-7.   Function of single KCNE1 mutations co-expressed with WT KCNQ1 channels. 
Representative families of current traces (A) and V1/2 of activation (B) summarized for KCNE1 
mutations co-expressed with WT KCNQ1.   
 




 Here, we find distinct effects of two mutations engineered at the same residue S140.  A 
glycine at position 140 causes a hyperpolarizing shift in voltage dependence of activation gating 
and markedly slow deactivation kinetics.  In contrast, a threonine at position 140 causes the 
opposite effects, a depolarizing shift in voltage dependence and a speeding of deactivation 
kinetics.  Originally, we had set out to investigate whether the partial dependence on KCNE1 of 
the S140G mutation and its effects on KCNQ1 homomeric channel function is due to the specific 
glycine mutation at this position.  We find that the S140G mutation is distinct from the S140T 
mutation in that S140G alters homomeric KCNQ1 channel function, while S140T does not. 
S140T expressed in KCNQ1 channels resembles WT KCNQ1 channel behavior, both in voltage 
dependence of activation and deactivation kinetics.   
 In Chapter II, we had demonstrated a unique dependence on KCNE1 for two different 
mutations, S140G and V141M, which we correlated with the orientation of the two residues 
relative to KCNE1.  V141M is positioned next to KCNE1, while S140G is positioned away from 
KCNE1.  However, here we demonstrate that a mutation at S140T is dependent on KCNE1 for 
its dramatic biophysical changes on channel function.  In the presence of KCNE1, we see a large 
depolarizing shift of about ~90 mV in voltage dependence and a five-fold speeding of 
deactivation, compared to WT IKs channels.  Due to the contrasting dependencies on KCNE1 for 
two mutations made at the same residue, we cannot explain the mechanism of these mutations in 
terms of orientation relative to the KCNE1 subunit.   
 However, KCNE1 mutations made at residue Y46, when co-expressed with S140G or 
S140T, dramatically alter channel behavior and these assembled channels resemble WT IKs 
channels.  It is hard to say exactly how the mutations in each subunit are interacting to make the 
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channel more wild-type like, but we know that there is some type of interaction between S140 on 
KCNQ1 and Y46 on KCNE1, which may not be a direct physical interaction, but an allosteric 
interaction that has a big effect on altering channel behavior, perhaps by destabilizing salt bridge 
interactions.  Another hypothesis for why the Y46 residue is a particular hotspot for altering 
channel function is based on predictions from the current KCNQ1 structural model.  Using this 
model, the Y46 residue on KCNE1 is predicted to be oriented away from the S1 domain where 
S140 is located and is instead oriented towards the S6 domain.  These predictions suggest that 
mutations made on the Y46 residue could somehow be interacting with the channel pore and 
affect channel gating via this route.   
 To summarize, the S140G mutation is a unique mutation that is interacting with a region 
of the channel that controls KCNQ1 channel function, and is not completely dependent on 
KCNE1 for these changes.  S140T is a mutation that dramatically alters channel function, but 
these changes are dependent on the presence of KCNE1.  The behavior of both mutations can be 
changed with co-expression of a mutant at Y46 on KCNE1, in which the assembled channels 
resemble WT IKs channels.  Altogether, residue S140 is sensitive to mutation and must be located 










	  	    
103	  
CHAPTER V 
Significance of KCNE1 Location and Assembly in the IKs Channel Complex 
 
Background and Significance 
 
Currently, there is no evidence for coordinated transcription of KCNQ1 and KCNE1 
genes.  However, there have been studies investigating the transcriptional control for the KCNQ1 
or KCNE1 genes, individually.  In a study by Mustapha et al 2007, this group characterized the 
promoter for the cardiac KCNE1 gene.  They demonstrate that there are specific regions in the 
KCNE1 promoter, which are important for transcriptional and tissue specific control.  
Additionally, differences in the core promoter sequences for KCNE1 for different species may 
account for the species variation in KCNE1 expression, such as in mouse there is low IKs density 
vs. in human, where there is much higher IKs density.   In another study characterizing the 
transcriptional control of both hERG and KCNQ1 genes, it was concluded that both promoters of 
these potassium channel genes were GC-rich, contained multiple Sp1 (stimulating protein) 
binding sites and lacked consensus TATA boxes (Luo et al. 2008).    These three elements of the 
promoter for two potassium channel genes were also found to be present in the KCNE1 promoter 
(Mustapha et al. 2007).  Although it has not been investigated, it is possible that there is 
coordinated transcriptional control of the KCNQ1 and KCNE1 genes due to the similarity in 
promoter elements for both genes.   
 Following the transcription of both KCNQ1 and KCNE1 genes, how exactly do these 
proteins coassmeble to form IKs channels?  A recent study demonstrated that co-expression with 
KCNQ1 subunits promotes KCNE1 trafficking to the cell surface (Chandrasekhar et al. 2006).  
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They also show that KCNQ1 coassembles with KCNE1 early in the secretory pathway and that 
KCNE1 subunits alone do not get fully glycosylated unless they are assembled with KCNQ1.  
After co-assembly of KCNQ1 and KCNE1 subunits, how is the stoichiometry determined for 
these channels?   
The co-assembly of a KCNQ1 tetrameric channel with two KCNE1 subunits is sufficient 
for modulation of channel function (Chen et al., 2003a; Morin and Kobertz, 2008), although the 
possibility of multiple stoichiometries was not ruled out in these studies (Wang et al., 1998).   A 
recent study reported that the stoichiometry of the KCNQ1 and KCNE1 complex is variable, 
ranging from 4:1 to 4:4, in which up to 4 KCNE1 subunits can associate with the KCNQ1 
tetramer (Nakajo et al., 2010).    Currently, there is no evidence of stoichiometry regulation for 
KCNQ1/KCNE1 subunits given that the stoichiometry can vary, indicating that all 
stoichiometries are possible.  In the heart, it is possible that stoichiometry is controlled by the 
relative amount of KCNE1 expressed in a specific chamber (Soma et al. 2010).  In the studies by 
both the Kass and Isacoff groups, they also find that channels formed by tandem 
KCNQ1/KCNE1 constructs could be further modulated by co-expression of additional KCNE1 
protein.  For the 2:1 fusion protein, two KCNQ1s linked to one KCNE1, they observe currents 
similar to IKs that could be modulated with additional KCNE1 protein, altering activation kinetics.  
However, the fusion protein with one KCNQ1 and one KCNE1 could not be further modulated, 
indicating that 4 is the maximal number of KCNE1 subunits that can associate with the KCNQ1 
tetramer.  Now that the stoichiometry of KCNQ1/KCNE1 subunits in the channel complex is 
determined to be variable, the importance of how and where KCNE1 assembles is the next step 
in fully understanding how this subunit modulates the KCNQ1 channel.   
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Results 
Part I – Significance of Location of KCNE1 in Channel Complex  
Recent studies demonstrate variable stoichiometry in the channel complex (Nakajo et al., 
2010), indicating that there will not only be KCNQ1/KCNE1 channels with a 4:4 stoichiometry 
expressed at the cell membrane, but that there could be channels 4:1, 4:2, and 4:3 stoichiometry, 
in which for these channels, not every KCNQ1 subunit will be associated with a KCNE1 subunit.  
We set out to investigate the importance of KCNE1 assembly next to a specific KCNQ1 subunit, 
using the V141M and S140G mutations.   In Chapter II, we learn that the V141M mutation, but 
not S140G, is dependent on the presence of KCNE1, functionally and structurally, for the 
mutation-induced effects on channel function.  In the absence of KCNE1, we observed that 
KCNQ1 channels encoded with V141M exhibit WT KCNQ1 channel behavior.  First, we 
functionally characterize channels with a 4:4 and 4:2 stoichiometries encoded with the S140G 
and V141M mutations.  With the 4:2 channel constructs, we engineer the S140G or V141M 
mutations into the proximal (close to KCNE1) or distal (far from KCNE1) KCNQ1 subunits and 
measure the effects on channel properties (Figure 5-1).  We find that channels with a 4:2 
stoichiometry exhibit less of the mutation-induced slowing of deactivation kinetics on channel 
function, compared with channels with a 4:4 stoichiometry.  Additionally, channels with 4:2 
stoichiometry, in which KCNE1 is assembled next to the mutated KCNQ1 subunit, exhibit 
slower deactivation kinetics, compared to constructs where KCNE1 is not assembled next to the 
mutated KCNQ1 subunit.   
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Figure 5-1.  Schematic of EQQ Tandem Constructs. (A) EQQ with mutation (black circle) in 
proximal KCNQ1 subunit, closest to KCNE1 (B) EQQ with mutation in distal KCNQ1 subunit, 
furthest from KCNE1 
 
Functional Studies  
EQ S140G and EQ V141M (4:4 stoichiometry) 
 We measured the effect of the S140G and V141M mutations in a fusion construct, where 
one KCNQ1 is linked to one KCNE1, thus fixing a 4:4 stoichiometry in channel complexes.  A 
series of 2 s isochronal activating pulses was applied from -60 mV to + 80 mV to measure the 
effect of theses mutations on channel gating.  Current traces shown for both S140G and V141M 
EQ channels display an accumulation of open channels resulting from channels that did not have 
time to close in between depolarizing pulses due to mutation-altered slowing of deactivation 
kinetics (Figure 5-2A and 5-2B).  For channels containing the V141M mutation, current traces 
indicated a time-dependent decay after depolarization, which is typical for these channels 
expressed in CHO cells.  It is possible that after applying a depolarizing pulse, all channels are 
open due to the large pedestal current that is seen on current traces.  Then, during the 
depolarization, a large amount of potassium has exited the cell due to the open channels, causing 
an increase in the extracellular potassium concentration.   So the decay in current could reflect 
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the fact that intra/extracellular potassium concentrations have changed and perhaps the driving 
force for potassium efflux is not as big as it was during the initial depolarization.
 
Figure 5-2.  S140G and V141M Channels in Fixed 4:4 Stoichiometry display constituitive 
currents.  Representative families of currents traces in cells expressing S140G (A) and V141M 
(B) in EQ fusion constructs. Currents in response to 2 s pulses from -60 mV to +80 mV in 20 
mV increments from -80 mV holding potential.  
 
EQQ S140G Proximal vs. EQQ S140G Distal  
The impact of the S140G mutation, engineered into the proximal (EQQ Q1 S140G) or 
distal (EQQ Q2 S140G) KCNQ1 subunit in tandem constructs, on channel properties was 
investigated next.  A pulse protocol consisting of a series of 2 s isochronal activating pulses (-60 
mV to + 80 mV) was applied as we measured the effect of the S140G mutation on different 
KCNQ1 subunits on channel gating.   Representative current traces shown for EQQ Q1 S140G 
constructs reveal channels that exhibit slow deactivation kinetics and some pedestal current 
compared with WT IKs channels, whereas current traces shown for EQQ Q2 S140G channels 
exhibit faster deactivation kinetics than EQQ Q1 S140G channels (Figure 5-3A and 5-3B).  The 
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voltage at which half the channels are activated was measured from tail current amplitudes and 
EQQ Q1 S140G (V1/2 = -2.3 ± 3.39 mV) and Q2 S140G (V1/2 = -5.4 ± 1.99 mV) channels both 
exhibit a slight hyperpolarizing shift in voltage dependence of activation from WT IKs channels 
(V1/2 = 33.6 ± 2.4 mV) (Figure 5-3C).  Further examination of deactivation kinetics indicates that 
the t1/2 of deactivation measured at -120 mV for EQQ Q2 S140G channels (t1/2 = 0.309 s) is not 
significantly different from WT IKs channels (t1/2 = 0.159 s), but for EQQ Q1 S140G channels 
deactivation is much slower than EQQ Q2 S140G channels (t1/2 = 1.306 s) (Figure 5-4A and 5-
4B).   
 
Figure 5-3.  Proximal and Distal S140G Channels in Fixed 4:2 Stoichiometry display similar 
shifts in voltage dependence.  Representative families of currents traces in cells expressing Q1 
S140G (A) Q2 S140G (B) in EQQ fusion constructs. Currents in response to 2 s pulses from -60 
mV to +80 mV in 20 mV increments from a -80 mV holding potential. (C) Normalized 
isochronal (2 s) activation curves for Q1 S140G (squares) and Q2 S140G (circles) and WT 
KCNQ1/KCNE1 (dashed line).  
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Figure 5-4.  S140G Channels in Fixed 4:2 Stoichiometry display slower deactivation kinetics 
in proximal vs. distal KCNQ1 subunit.  (A) Representative tail current traces in cells 
expressing Q1 S140G (A) Q2 S140G (B) in EQQ fusion constructs.  (B) Deactivation t1/2 
obtained at -120 mV from single exponential fits to tail currents following conditioning pulses 
(+20 mV, 2 sec).  
 
EQQ V141M Proximal vs. EQQ V141M Distal  
We next investigated the impact of the V141M mutation, engineered into the proximal 
(EQQ Q1 V141M) or distal (EQQ Q2 V141M) KCNQ1 subunits of tandem constructs.  The 
same pulse protocol consisting of a series of 2 s isochronal activating pulses (-60 mV to + 80 
mV) was applied as we measured the effect of different locations of the V141M mutation with 
respect to the KCNE1 subunit.   Current traces shown for EQQ Q1 V141M constructs reveal 
channels that exhibit slow deactivation kinetics and pedestal current similar to what was seen for 
EQQ Q1 S140G channels.   Current traces shown for EQQ Q2 V141M channels exhibit faster 
deactivation kinetics than EQQ Q1 V141M channels (Figure 5-5A and 5-5B).  The V1/2 of 
activation gating was measured, showing that channels with the V141M mutations assembled 
next to KCNE1 exhibit a hyperpolarizing shift in voltage dependence.  Channels with the 
V141M mutation (V1/2 = 9.91 ± 0.91 mV, n=3) in the distal subunit exhibit similar voltage 
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dependence as WT IKs channels (V1/2 = 13.04 ± 0.75 mV, n=7), while channels with V141M in 
the proximal KCNQ1 subunit exhibit a hyperpolarizing shift in voltage dependence (V1/2 =          
-10.93 ± 1.28 mV, n=3) (Figure 5-5C).  Further examination of deactivation kinetics indicates 
that the tau of deactivation measured at -120 mV for EQQ Q2 V141M channels (τdeact = 0.32 ± 
0.071 s, n=6) is slower than WT IKs channels (τdeact = 0.24 ± 0.004 s, n=7) but is not as slow as 
that for EQQ Q1 V141M channels (τdeact = 0.59 ± 0.05 s, n=7) (Figure 5-6).   
 
Figure 5-5.  Proximal V141M Channels in Fixed 4:2 Stoichiometry exhibit hyperpolarizing 
shift in voltage dependence vs. distal V141M Channels.  Representative families of currents 
traces in cells expressing Q1 V141M (A) Q2 V141M (B) in EQQ fusion constructs. Currents in 
response to 2 s pulses from -60 mV to +80 mV in 20 mV increments from a -80 mV holding 
potential. (C) Normalized isochronal (2 s) activation curves for Q1 V141M (circles) and Q2 
V141M (triangles) and WT KCNQ1/KCNE1 (dashed line).  
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Figure 5-6.  V141M Channels in Fixed 4:2 Stoichiometry display slower deactivation 
kinetics in proximal vs. distal KCNQ1 subunit.  (A) Representative tail current traces in cells 
expressing Q1 V141M (A) Q2 V141M (B) in EQQ fusion constructs.  (B) Deactivation time 
constant (tau) obtained at -120 mV from single exponential fits to tail currents following 
conditioning pulses (+20 mV, 2 sec).  Data expressed as mean ± s.e.m. 
 
Titrating additional KCNE1 Subunits  
  To investigate whether the fusion protein EQQ Q2 V141M could be modulated by 
additional KCNE1, we co-expressed KCNE1 with this fusion protein and characterized channel 
activity. As had been previously demonstrated by two separate groups, co-expression of fusion 
constructs can be further modulated by KCNE1 (Wang and Kass 1998, Nakajo and Isacoff 2010).  
Co-expression with additional KCNE1 slows EQQ Q2 V141M channel activation and 
deactivation kinetics of the EQQ Q2 V141M channels, compared to channels without additional 
KCNE1 (Figure 5-7A and 5-7B). In order to quantify these differences, we measured the voltage 
dependence of activation.  Channels with the EQQ Q2 V141M mutation co-expressed with 
additional KCNE1 (V1/2 = 3.32 ± 4.49 mV, n=4) exhibit a hyperpolarizing shift in voltage 
dependence, in contrast to WT EQQ channels with additional KCNE1 (V1/2 = 43.6 ± 1.47 mV, 
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n=5), which exhibit a depolarizing shift (Figure 5-7C).   WT EQQ (V1/2 = 27.5 ± 4.56 mV, n=7) 
and EQQ Q2 V141M (V1/2 = 22.7 ± 2.77 mV, n=7) channels exhibited similar voltage 
dependences on activation gating.  
 
Figure 5-7.   Additional KCNE1 Subunits can further modulate V141M Channels in Fixed 
4:2 Stoichiometry by slowing activation kinetics. (A) Representative families of current traces 
in cells expressing EQQ Q2 V141M, without additional KCNE1 (A) and with additional KCNE1 
subunits (B).  (C) Normalized isochronal (2 s) activation curves for EQQ (circles), EQQ + 
KCNE1 (triangles), EQQ Q2 V141M (squares) and EQQ Q2 V141M + KCNE1 (inverted 
triangles).  Data expressed as mean ± s.e.m. 
 
To compare the effect of KCNE1 co-expression on deactivation kinetics, the deactivation time 
constant (tau) was measured from tail currents at -120 mV in response to a 2 s depolarizing pulse 
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to + 60 mV.  Addition of KCNE1 to EQQ Q2 V141M channels exhibited much slower 
deactivation compared to cells without additional KCNE1 (Figure 5-8A).  The deactivation time 
constant for EQQ Q2 V141M channels with additional KCNE1 (τdeact = 0.664 ± 0.067 s, n=6) 
reveal a significantly slower time course for deactivation compared to channels without 
additional KCNE1 (τdeact = 0.277 ± 0.017 s, n=7) and WT EQQ channels (τdeact = 0.235 ± 0.024 s, 
n=5) and WT EQQ with additional KCNE1 (τdeact = 0.329 ± 0.011 s, n=5) (Figure 5-8B).   
 
Figure 5-8.  Distal V141M Channels in Fixed 4:2 Stoichiometry are further modulated with 
additional KCNE1 subunits.  (A) Representative tail current traces in cells expressing EQQ Q2 
V141M fusion constructs without additional KCNE1 and with additional KCNE1 (A).  (B) 
Deactivation time constant (tau) obtained at -120 mV from single exponential fits to tail currents 
following conditioning pulses (+20 mV, 2 sec).  Data expressed as mean ± s.e.m. 
 
Part II –Assembly of KCNE1 in Channel Complex  
Crosslinking Studies 
The IKs channel is composed of a tetramer of pore-forming alpha subunits, KCNQ1, and 
accessory beta subunits, KCNE1.  The location of KCNE1 has been positioned between the S1 
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and S6 domains of different alpha subunits (Xu et al., 2008; Chung et al., 2009). However, this 
positioning of KCNE1 is based on co-expression of individual alpha and beta subunits so it is not 
confirmed how the hetero-tetrameric channel assembles.  In order to verify that KCNE1 
assembles between the S1 segment from one KCNQ1 subunit and the S6 segment of an opposing 
KCNQ1 subunit, we monitor crosslinking between substituted cysteines engineered into the 
following tandem constructs: EQ (one KCNE1 tethered to one KCNQ1), and EQQ (one KCNE1 
tethered to two KCNQ1s) to mimic the possibilities of a 4:4 and 4:2 stoichiometries.  If the 
KCNQ1/KCNE1 channel assembles how we believe it does, then we would expect the same 
crosslinks to form in these tandem constructs.  Additionally, we engineered an HRV-3C protease 
cleavage site between the C-terminus of KCNE1 and the N-terminus of the proximal KCNQ1.  
By monitoring the fully assembled KCNQ1/KCNE1 channel complex before and after cleavage, 
we will be able to identify how the channel assembles by monitoring a shift in molecular weights 
on the western blot.   
 In these constructs, we use specific cysteine substitutions shown to have the strongest 
crosslinks (~80%), based on previous work from our group.  To demonstrate crosslinking 
between KCNE1 to S1 in the proximal KCNQ1 subunit, cysteines were substituted for the 
following residues, K41 in KCNE1 and I145 in KCNQ1 and this will be referred to as the S1 
crosslink from now on.  To demonstrate crosslinking between KCNE1 to S6 in the distal 
KCNQ1 subunit, cysteines were substituted for the following residues, L42 in KCNE1 and V324 
in KCNQ1, which will be referred to as the S6 crosslink from here on.   
 
EQ Crosslinking 
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We first set out to demonstrate that KCNE1 is positioned between the S1 and S6 domains 
of two different KCNQ1 subunits using constructs which have a forced 4:4 stoichiometry.  Using 
EQ tandem constructs, with one KCNE1 tethered to one KCNQ1, we tested crosslinking for 
constructs EK41CQI145C to observe a crosslink between the S1 domain and KCNE1 and 
EL42CQV324C to observe a crosslink between the S6 domain and KCNE1.  In these constructs, a 
HRV3C-cleavage site was engineered between the C-terminus of KCNE1 and N-terminus of 
KCNQ1 in order to fix the stoichiometry of channels first and then monitor crosslinking.  Here, 
we observe the expected molecular weight band for the S1 crosslink at ~90 kD (E1: 20 kD + Q1: 
70 kD) (Figure 5-9, top panel).  However, for the S6 crosslink, we observe a high molecular 
weight band ~ 300 kD, which we suspect is an aggregate band consisting of a tetramer or more 
of KCNQ1/KCNE1 subunits.  Upon addition of the HRV-3C protease, we cleave the EQ 
construct into individual subunits, KCNE1 and KCNQ1 to monitor the crosslinks that were 
formed.  Here, we observe DTT-sensitive crosslinking with both the S1 and S6 crosslink 
constructs (Figure 5-9, bottom panel).  The results for the S1 and S6 crosslinks confirm the 
findings from Chung et al 2009.   However, the result that was hard to interpret was the S6 
crosslink before HRV-3C cleavage.  We believe that this channel may be in a conformation in 
which it is aggregated at the top of the gel and cannot be separated out, so it is possible that the 
EQ constructs are tangled up in a knot.  Upon HRV-3C cleavage though, these subunits are 
separated and a crosslink can be monitored between the S6 domain and KCNE1, so the aggregate 
must be due to the linkage between E1 and Q1.   
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Figure 5-9.  EQ Crosslinking demonstrates crosslinking of KCNE1 between S1 and S6 
KCNQ1 subunits.  Western blot of tandem constructs: EK41CQI145C to observe the crosslink 
between S1 and KCNE1 and EL42CQV324C to observe the crosslink between S6 and KCNE1 







Next, we set out to investigate crosslinking using EQQ tandem constructs, fixing the 
KCNQ1/KCNE1 channel in a 4:2 stoichiometry.  The extents of KCNE1 to S1 and KCNE1 to S6 
crosslinking will be determined by the density of the EQQ band at ~160 kD divided by the sum 
of densities of the bands at 70 kD (KCNQ1 monomer) and 280 kD (KCNQ1 tetramer).  There 
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are two possible conclusions that we can draw from these experiments. The first possibility is 
that the tandem EQQ constructs are assembling in an anti-parallel manner to form a 
heterotetramer, as E-Q-Q. We will observe crosslinking between KCNE1 and S1 of the proximal 
KCNQ1 subunit and between KCNE1 and S6 of the distal subunit (Figure 5-10A).  These results 
will support the idea that S1 on the proximal KCNQ1 and S6 on the distal KCNQ1 are not cross-
linking to the same KCNE1 subunit.  The second possibility is that the tandem EQQ construct is 
assembling in a different manner to form a heterotetramer, as Q-E-Q.  In this case, we will 
observe a variety of crosslinks between KCNE1 and S1 of the proximal or distal KCNQ1 
subunits and between KCNE1 and S6 of the proximal or distal subunits.  These results will tell 
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(A)  
      
 
 
Figure 5-10. Schematic Illustration of two possible outcomes for EQQ Tandem Crosslinking.  
(A) Cartoon of expected crosslinking for EK41CQI145CQ and EL42CQQV324C  
 
As expected, we observe a molecular weight band at 160 kD, corresponding to the EQQ 
band for EK41CQI145CQ (Figure 5-11, top panel).   For our two negative controls, EK41CQQI145C 
and EL42CQV324CQ, we observed high molecular weight bands, which we suspect are aggregates 
of the channel.  These two constructs are negative controls because if we expect the S1 crosslink 
to form between the cysteines in KCNE1 and the proximal KCNQ1 subunit, we would expect 
KCNE1 to not form crosslinks with the cysteine in the distal KCNQ1 subunit.  Similarly, if we 
expect the S6 crosslink to form between KCNE1 and the distal KCNQ1 subunit, we would not 
observe crosslinking in the proximal KCNQ1 subunit.   
	  	    
119	  
Upon treatment with the HRV-3C protease, we observe the expected DTT-sensitive 
crosslink band for the EK41CQI145CQ (Figure 5-11, bottom panel).  However, we also observe 
DTT-sensitive crosslink bands for the two negative control constructs, which is unexpected.  
These results suggest two ideas, one is that the channel is not assembling the way we think it is 
and the second is that there are unexpected crosslinks occurring.  
 
Figure 5-11.  EQQ Crosslinking demonstrates crosslinking of KCNE1 and S1 KCNQ1 
subunit.  Western blot of tandem construct, EK41CQI145CQ, to observe the crosslink between S1 
and KCNE1 without (top panel) and with (bottom panel) HRV-3C protease treatement.  
EK41CQQI145C and EL42CQV324CQ are used for negative controls.   
 
Discussion 
In the current study, we studied the significance of KCNE1 assembly in the IKs channel 
complex.  We find that assembly of KCNE1 next to a specific KCNQ1 subunit can determine the 
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severity of two AF KCNQ1 mutations, S140G and V141M.  We functionally characterized the 
effect of having a mutation in a channel with 4:4 stoichiometry, where there are KCNE1 subunits 
assembled next to all KCNQ1 subunits and channels with 4:2 stoichiometry, in which KCNE1 is 
not assembled next to every KCNQ1 subunit.  We observed that channels with 4:2 stoichiometry 
exhibit less severe effects of the mutation, compared to channels with 4:4 stoichiometry.  This 
result demonstrates that having less than 4 KCNE1 subunits produces a channel with a less 
severe phenotype when KCNQ1 contains either AF mutation.   Next, in channels with 4:2 
stoichiometry, we functionally characterized two constructs, one to investigate the effect of 
having KCNE1 assembled next to the mutated KCNQ1 subunit and one where KCNE1 is not 
assembled next to the mutated KCNQ1.  Channels where KCNE1 is assembled next to the 
mutated KCNQ1 subunit exhibit more severe effects of the mutation-induced slowing of 
deactivation kinetics, compared with channels where KCNE1 is not assembled next to the 
mutated KCNQ1.  Due to the variable stoichiometry of KCNQ1/KCNE1 channels, we next 
investigated whether we could change the stoichiometry of the 4:2 channels to 4:4 channels by 
co-expressing additional KCNE1 subunits.  We find that these 4:2 channels can be modulated 
with the addition of extra KCNE1 subunits, supporting the finding that the stoichiometry can be 
variable, ranging from 4:1 and up to 4:4 KCNQ1 to KCNE1 subunits.    




 In the current thesis study, we investigated the nature of KCNQ1 / KCNE1 interactions in 
the IKs channel complex and their roles in altering the channel’s biophysical properties.  Chapter 
II examined two AF-associated KCNQ1 mutations and the complete dependence on the KCNE1 
subunit for the mutation-induced slowing of deactivation kinetics for the V141M mutation, but 
not for S140G.  In this section, biochemical evidence reveals a KCNQ1/KCNE1 interaction that 
is likely important in the mutation-altered channel properties for V141M, highlighting the 
amino-terminal end of KCNE1 and the proximal end of the S1 segment in KCNQ1 as important 
regions for control of channel deactivation.    In Chapter III, we screened the amino-terminal 
region of KCNE1 and found two mutations that restored the slowed deactivation defect in the AF 
channels back towards a WT IKs channel.  Chapter IV focused on the characterization of a 
mutation, S140T, in the proximal end of S1 KCNQ1, which had considerable effects on speeding 
channel deactivation.  Chapter V focuses on the significance of the location and assembly of 
KCNE1 within the IKs channel complex.  The results from these investigations emphasize the 
importance of the presence, proximity, orientation, location, and assembly of KCNE1 within the 
channel complex, which will guide us in eventually determining the mechanism of KCNE1 
modulation of the KCNQ1 channel.      
 In Chapter II, we learn that the AF-associated mutations, S140G and V141M, depend 
differently on the presence of KCNE1 in order to exhibit slow deactivation kinetics.  There are 
two possible mechanisms in which slowing of channel deactivation kinetics can occur, which 
include slowing by affecting the channel gate or slowing by affecting voltage sensor movement.  
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The V141M mutation relies entirely on KCNE1 to see a defect in channel deactivation and 
without this accessory subunit; the channel looks like a wild-type channel.  In this case, KCNE1 
could be interacting with the channel gate in order to slow channel closing which is supported by 
evidence demonstrating proximity between KCNE1 and the S6 domain of KCNQ1 (Chung et al. 
2009).  However, the S140G mutation slows channel closing in the absence of KCNE1, so it 
does not depend entirely on this subunit for changes in channel properties and must rely on a 
different mechanism of slowing deactivation kinetics.  In this case, the S140G mutation could be 
affecting voltage sensor movement based on the predictions from the KCNQ1 structural model 
showing that the S140 residue is oriented towards the S4 domain.   
These are only two examples of AF mutations that previously were both shown to depend 
entirely on KCNE1, but now display differential dependence on this subunit.  There are other 
gain of function mutations, Q147R, S209P, R231C, I274V, A300T, and V307L, that are reported 
to rely on the presence of KCNE1 in order to see the mutation-induced effects on channel 
function, but perhaps more in depth analysis is needed to fully determine whether these 
mutation-altered channels depend on this accessory subunit (Bartos et al. 2009; Bianchi et al., 
2000; Bellocq et al., 2004; Lundby et al., 2007; Rhodes et al., 2008; Das et al., 2009).     
 
Subunit Orientation of KCNQ1 and KCNE1 
Based on our functional experiments in Chapter II, the results of biochemical 
crosslinking results reveal a specific orientation of the S1 KCNQ1 domain, where residue V141 
is in closest proximity to residue A44 on the KCNE1 subunit (Figure 2-17).  
Amino-Terminus of KCNE1 
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Previously, the N-terminus of KCNE1 has been recognized as a region not necessary for 
modulatory control of KCNQ1 channels (Takumi et al., 1988; Tapper and George, 2000; 
Melman et al., 2004; Lvov et al., 2010).   However, the Kass lab group highlighted the 
extracellular N-terminal region of KCNE1 in a crosslinking study, where the discovery of close 
KCNQ1/KCNE1 interactions led to the placement of KCNE1 within the IKs channel complex 
(Chung et al., 2009).  In the current investigation, we emphasize the amino-terminus of KCNE1 
as a region important for control of channel deactivation kinetics.    
In Chapter III, two mutations in the amino terminal region of KCNE1, L45F and Y46W, 
were found to improve the slow deactivation defect characteristic of the AF mutants.  Functional 
characterization of the KCNE1 mutants co-expressed with the AF mutants was done to 
determine how deactivation kinetics was being affected.  The effects of the two mutations, L45F 
and Y46W, when co-expressed with the AF mutants, produce channels that resemble WT I IKs 
channels.  However, upon further analysis of channel properties, these two KCNE1 mutations 
behave differently, when co-expressed with the WT KCNQ1 channel.  The differential effects of 
the L45F and Y46W mutations is likely due to their orientation on the KCNE1 helix, where 
L45F is oriented towards the S1 helix, but Y46W is not.  We conclude that KCNE1 mutations, 
L45F and Y46W, are helping to speed the deactivation process, but the mechanism of this effect 
is undetermined.  Thus far, we have highlighted four residues in KCNE1, E43, A44, L45, and 
Y46, in which each have either a structural and/or functional role in altering KCNQ1 channel 
properties.      
Chapter IV focuses on the significance of position S140 in the S1 helix of KCNQ1.  
Substitution of a glycine at S140 produced channels that exhibited extremely slow deactivation 
kinetics, however substitution of a threonine at S140 produced channels that speed deactivation 
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kinetics greatly.  Here, we demonstrate that the proximal end of the S1 helix is sensitive to 
mutations that greatly alter deactivation kinetics of the channel.   
In order to further test the upper TM region of KCNQ1 and KCNE1 as an area of 
important control of deactivation kinetics, mutations can be engineered into the KCNE1 subunit 
to see whether deactivation kinetics can be specifically controlled.  For example, from our 
experiments in the current investigation, we know the KCNE1 residues A44, L45, and Y46 are 
hotspots in altering channel deactivation properties.  For future experiments, these three residues 
could be mutated to all possible amino acids to see if hydrophobicity or polarity of residue may 
play a role in affecting the ability of the mutated KCNE1 to alter KCNQ1 channel gating 
properties.   
 Having established the importance of proximity of KCNE1 to the S1 segment of KCNQ1, 
we investigated this property in populations of channels where there are multiple stoichiometries 
of KCNQ1: KCNE1 subunits in Chapter V.   We explored the functional consequences of the 
S140G and V141M mutations in channels with a fixed 4:2 stoichiometry, compared to channels 
with a 4:4 stoichiometry.  In channels with a 4:2 stoichiometry, we find that channels where 
KCNE1 is in proximity to the mutation exhibit more mutation-induced changes compared to 
channels where KCNE1 is not assembled next to the mutation.  Thus, when KCNQ1 and KCNE1 
subunits assemble into channels in the endoplasmic reticulum, the location of KCNE1 assembly 
within the KCNQ1 channel complex is important for the resultant channel that traffics to the 
surface, especially if it is a mutation that is dependent on KCNE1 for altering channel properties.  
In the case of S140G, if KCNE1 does not assemble next to this mutation, the resultant channel 
will still have a defect in deactivation.  In contrast, for the V141M mutation, if KCNE1 does not 
assemble next to this mutation, the channel will behave like a WT IKs channel.   
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 In this section, we attempt to confirm the assembly of the IKs channel, using tandem 
constructs in a 4:4 or 4:2 fixed KCNQ1: KCNE1 subunit ratios.  We wanted to demonstrate 
crosslinking of KCNE1 between the S1 and S6 domains of KCNQ1, as had been shown 
previously (Chung et al 2009).  Using the EQ constructs, to fix channels in a 4:4 stoichiometry, 
we were able to clearly demonstrate crosslinking between KCNE1 and the S1 helix.  Similarly, 
with the EQQ constructs, to fix channels in a 4:2 stoichiometry, we observe crosslinking between 
KCNE1 and S1 KCNQ1.  However, for crosslinking with the S6 domain of KCNQ1, the results 
were inconclusive.  
 In order to assemble a more complete story for the tandem constructs in Chapter V, other 
control experiments and constructs must be functionally characterized.  It would be interesting to 
engineer either the S140G or V141M mutations into both KCNQ1 subunits in the EQQ construct 
to see how channel gating is affected and subsequently co-expressing additional KCNE1 
subunits to see if stoichiometry can be maximized.  We would compare these experiments to the 
individual co-expression of KCNQ1 containing either AF mutation and KCNE1.  Another 
experiment would be to see how channels containing either the S140G or V141M mutation in 
both subunits of a QQ dimer construct might behave and comparing these results to our 
functional results testing the mutation in a single KCNQ1 subunit.   
Taken together, the work in this thesis reveals the distinct dependence of KCNE1 for the 
mutation-altered deactivation kinetics of the S140G and V141M mutations.  Not only is the 
presence of KCNE1 within the channel complex important, but also the proximity of this 
accessory subunit to the S1 segment of KCNQ1.  The thesis also establishes a role for the N- 
terminus of KCNE1 in modulation of KCNQ1 channels, specifically in control of deactivation 
kinetics. The modulation of KCNE1 is not only provided by the transmembrane domain and the 
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C-terminus, but also by the association of the N-terminus.  Furthermore, the significance of 
location and assembly of KCNE1 within the channel complex is essential in understanding the 
variable effects that can result from channels with multiple stoichiometries of KCNQ1: KCNE1 















	  	    
127	  
REFERENCES 
Abbott, G.W., F. Sesti, I. Splawski, M.E. Buck, M.H. Lehmann, K.W. Timothy, M.T. Keating, 
and S.A. Goldstein. 1999. MiRP1 forms IKr potassium channels with HERG and is 
associated with cardiac arrhythmia. Cell. 97:175-187. 
 
Abitbol, I., A. Peretz, C. Lerche, A.E. Busch, and B. Attali. 1999. Stilbenes and fenamates rescue 
the loss of I(KS) channel function induced by an LQT5 mutation and other IsK mutants. 
18:4137-4148. 
 
Aggeli, A., M.L. Bannister, M. Bell, N. Boden, J.B. Findlay, M. Hunter, P.F. Knowles, and J.C. 
Yang. 1998. Conformation and ion-channeling activity of a 27-residue peptide modeled 
on the single-transmembrane segment of the IsK (minK) protein. Biochemistry. 37:8121-
8131.  
 
Ahern, C.A., and R. Horn. 2004. Specificity of charge-carrying residues in the voltage sensor of 
potassium channels. J Gen Physiol. 123:205-216.  
 
Akabas, M.H., D.A. Stauffer, M. Xu, and A. Karlin. 1992. Acetylcholine receptor channel 
structure probed in cysteine- substitution mutants. 258:307-310. 
 
Angelo, K., T. Jespersen, M. Grunnet, M.S. Nielsen, D.A. Klaerke, and S.P. Olesen. 2002. 
KCNE5 induces time- and voltage-dependent modulation of the KCNQ1 current. 
Biophysical journal. 83:1997-2006. 
 
Barhanin, J., F. Lesage, E. Guillemare, M. Fink, M. Lazdunski, and G. Romey. 1996. K(V)LQT1 
and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature. 
384:78-80. 
 
Bartos, D.C., S. Duchatelet, D.E. Burgess, D. Klug, I. Denjoy, R. Peat, J.M. Lupoglazoff, V. 
Fressart, M. Berthet, M.J. Ackerman, C.T. January, P. Guicheney, and B.P. Delisle. 2009. 
R231C mutation in KCNQ1 causes long QT syndrome type 1 and familial atrial 
fibrillation. Heart Rhythm. 8:48-55.  
 
Bell, D.C., H. Yao, R.C. Saenger, J.H. Riley, and S.A. Siegelbaum. 2004. Changes in local S4 
environment provide a voltage-sensing mechanism for mammalian hyperpolarization-
activated HCN channels. J Gen Physiol. 123:5-19.  
 
Bellocq, C., A.C. van Ginneken, C.R. Bezzina, M. Alders, D. Escande, M.M. Mannens, I. Baro, 
and A.A. Wilde. 2004. Mutation in the KCNQ1 gene leading to the short QT-interval 
syndrome. Circulation. 109:2394-2397. 
 
Ben-Efraim, I., Y. Shai, and B. Attali. 1996. Cytoplasmic and extracellular IsK peptides activate 
endogenous K+ and Cl- channels in Xenopus oocytes. Evidence for regulatory function. J 
Biol Chem. 271:8768-8771. 
 
	  	    
128	  
Bendahhou, S., C. Marionneau, K. Haurogne, M.M. Larroque, R. Derand, V. Szuts, D. Escande, 
S. Demolombe, and J. Barhanin. 2005. In vitro molecular interactions and distribution of 
KCNE family with KCNQ1 in the human heart. Cardiovasc Res. 67:529-538. 
 
Bezanilla, F. 2005. The voltage-sensor structure in a voltage-gated channel. Trends Biochem Sci. 
  
Bianchi, L., S.G. Priori, C. Napolitano, K.A. Surewicz, A.T. Dennis, M. Memmi, P.J. Schwartz, 
and A.M. Brown. 2000. Mechanisms of I(Ks) suppression in LQT1 mutants. Am J 
Physiol Heart Circ Physiol. 279:H3003-3011. 
 
Blumenthal, E.M., and L.K. Kaczmarek. 1994. The minK potassium channel exists in functional 
and nonfunctional forms when expressed in the plasma membrane of Xenopus oocytes. 
Journal of Neuroscience. 14:3097-3105. 
 
Chandrasekhar, K.D., T. Bas, and W.R. Kobertz. 2006. KCNE1 subunits require co-assembly 
with K+ channels for efficient trafficking and cell surface expression. J Biol Chem.  
 
Chen, H., and S.A. Goldstein. 2007. Serial perturbation of MinK in IKs implies an alpha-helical 
transmembrane span traversing the channel corpus. Biophysical journal. 93:2332-2340.  
 
Chen, H., L.A. Kim, S. Rajan, S. Xu, and S.A. Goldstein. 2003a. Charybdotoxin binding in the 
I(Ks) pore demonstrates two MinK subunits in each channel complex. Neuron. 40:15-23.  
 
Chen, H., F. Sesti, and S.A. Goldstein. 2003b. Pore- and state-dependent cadmium block of I(Ks) 
channels formed with MinK-55C and wild-type KCNQ1 subunits. Biophysical journal. 
84:3679-3689. 
 
Chen, J., R. Zheng, Y.F. Melman, and T.V. McDonald. 2009. Functional interactions between 
KCNE1 C-terminus and the KCNQ1 channel. PLoS One. 4:e5143. 
 
Chen, Y.H., S.J. Xu, S. Bendahhou, X.L. Wang, Y. Wang, W.Y. Xu, H.W. Jin, H. Sun, X.Y. Su, 
Q.N. Zhuang, Y.Q. Yang, Y.B. Li, Y. Liu, H.J. Xu, X.F. Li, N. Ma, C.P. Mou, Z. Chen, J. 
Barhanin, and W. Huang. 2003c. KCNQ1 gain-of-function mutation in familial atrial 
fibrillation. Science. 299:251-254. 
 
Chung, D.Y., P.J. Chan, J.R. Bankston, L. Yang, G. Liu, S.O. Marx, A. Karlin, and R.S. Kass. 
2009. Location of KCNE1 relative to KCNQ1 in the I(KS) potassium channel by 
disulfide cross-linking of substituted cysteines. Proc Natl Acad Sci U S A. 106:743-748.  
 
Curran, M., D. Atkinson, K Timothy, G.M. Vincent, A.J. Moss, M. Leppert, M. Keating. 1993.  
Locus Heterogeneity of autosomal dominant long QT syndrome. J Clin Invest. 92: 799- 
803.   
 
 
	  	    
129	  
Das, S., S. Makino, Y.F. Melman, M.A. Shea, S.B. Goyal, A. Rosenzweig, C.A. Macrae, and P.T. 
Ellinor. 2009. Mutation in the S3 segment of KCNQ1 results in familial lone atrial 
fibrillation. Heart Rhythm. 6:1146-1153.  
 
Dedek, K., and S. Waldegger. 2001. Colocalization of KCNQ1/KCNE channel subunits in the 
mouse gastrointestinal tract. Pflugers Arch. 442:896-902. 
 
Doyle, D.A., J. Morais Cabral, R.A. Pfuetzner, A. Kuo, J.M. Gulbis, S.L. Cohen, B.T. Chait, and 
R. MacKinnon. 1998. The structure of the potassium channel: molecular basis of K+ 
conduction and selectivity. Science. 280:69-77. 
 
Drici, M.D., I. Arrighi, C. Chouabe, J.R. Mann, M. Lazdunski, G. Romey, and J. Barhanin. 1998. 
Involvement of IsK-associated K+ channel in heart rate control of repolarization in a 
murine engineered model of Jervell and Lange- Nielsen syndrome. Circulation Research. 
83:95-102. 
 
Durell, S.R., I.H. Shrivastava, and H.R. Guy. 2004. Models of the structure and voltage-gating 
mechanism of the shaker K+ channel. Biophysical journal. 87:2116-2130.  
 
Folander, K., J.S. Smith, J. Antanavage, C. Bennett, R.B. Stein, and R. Swanson. 1990. Cloning 
and expression of the delayed-rectifier IsK channel from neonatal rat heart and 
diethylstilbestrol-primed rat uterus. Proceedings of the National Academy of Sciences of 
the United States of America. 87:2975-2979. 
 
Gage, S.D., and W.R. Kobertz. 2004. KCNE3 truncation mutants reveal a bipartite modulation of 
KCNQ1 K+ channels. J Gen Physiol. 124:759-771. 
 
Goldstein, S.A., and C. Miller. 1993. Mechanism of charybdotoxin block of a voltage-gated K+ 
channel. Biophysical journal. 65:1613-1619. 
 
Goldstein, S.A.N., and C. Miller. 1991. Site-specific mutations in a minimal voltage-dependent 
K+ channel alter ion selectivity and open-channel block. Neuron. 7:403-408. 
 
Grunnet, M., T. Jespersen, H.B. Rasmussen, T. Ljungstrom, N.K. Jorgensen, S.P. Olesen, and 
D.A. Klaerke. 2002. KCNE4 is an inhibitory subunit to the KCNQ1 channel. The Journal 
of physiology. 542:119-130. 
 
Haitin, Y., I. Yisharel, E. Malka, L. Shamgar, H. Schottelndreier, A. Peretz, Y. Paas, and B. 
Attali. 2008. S1 constrains S4 in the voltage sensor domain of Kv7.1 K+ channels. PLoS 
ONE. 3:e1935.  
 
Heitzmann, D., V. Koren, M. Wagner, C. Sterner, M. Reichold, I. Tegtmeier, T. Volk, and R. 
Warth. 2007. KCNE beta subunits determine pH sensitivity of KCNQ1 potassium 
channels. Cell Physiol Biochem. 19:21-32. 
 
	  	    
130	  
Hong, K., D.R. Piper, A. Diaz-Valdecantos, J. Brugada, A. Oliva, E. Burashnikov, J. Santos-de-
Soto, J. Grueso-Montero, E. Diaz-Enfante, P. Brugada, F. Sachse, M.C. Sanguinetti, and 
R. Brugada. 2005. De novo KCNQ1 mutation responsible for atrial fibrillation and short 
QT syndrome in utero. Cardiovasc Res. 68:433-440. 
 
Howard, R.J., K.A. Clark, J.M. Holton, and D.L. Minor, Jr. 2007. Structural insight into KCNQ 
(Kv7) channel assembly and channelopathy. Neuron. 53:663-675.  
 
Hwang, C., A.J. Sinskey, and H.F. Lodish. 1992. Oxidized redox state of glutathione in the 
endoplasmic reticulum. Science. 257:1496-1502. 
 
Jan, L.Y., and Y.N. Jan. 1997. Voltage-gated and inwardly rectifying potassium channels. The 
Journal of physiology. 505 ( Pt 2):267-282. 
 
Jiang, Y., A. Lee, J. Chen, V. Ruta, M. Cadene, B.T. Chait, and R. MacKinnon. 2003a. X-ray 
structure of a voltage-dependent K+ channel. Nature. 423:33-41. 
 
Jiang, Y., V. Ruta, J. Chen, A. Lee, and R. MacKinnon. 2003b. The principle of gating charge 
movement in a voltage-dependent K+ channel. Nature. 423:42-48. 
 
Kang, C., C. Tian, F.D. Sonnichsen, J.A. Smith, J. Meiler, A.L. George, Jr., C.G. Vanoye, H.J. 
Kim, and C.R. Sanders. 2008. Structure of KCNE1 and implications for how it modulates 
the KCNQ1 potassium channel. Biochemistry. 47:7999-8006.  
 
Kurokawa, J., J.R. Bankston, A. Kaihara, L. Chen, T. Furukawa, and R.S. Kass. 2009. KCNE 
variants reveal a critical role of the beta subunit carboxyl terminus in PKA-dependent 
regulation of the IKs potassium channel. Channels (Austin). 3:16-24.  
 
Kurokawa, J., L. Chen, and R.S. Kass. 2003. Requirement of subunit expression for cAMP-
mediated regulation of a heart potassium channel. Proc Natl Acad Sci U S A. 100:2122-
2127. 
 
Kurokawa, J., H.K. Motoike, and R.S. Kass. 2001. TEA(+)-sensitive KCNQ1 constructs reveal 
pore-independent access to KCNE1 in assembled I(Ks) channels. J Gen Physiol. 117:43-
52. 
 
Kurz, L.L., R.D. Zuhlke, H.J. Zhang, and R.H. Joho. 1995. Side-chain accessibilities in the pore 
of a K+ channel probed by sulfhydryl-specific reagents after cysteine-scanning 
mutagenesis. Biophysical journal. 68:900-905.  
 
Larsson, H.P., O.S. Baker, D.S. Dhillon, and E.Y. Isacoff. 1996. Transmembrane movement of 
the shaker K+ channel S4. Neuron. 16:387-397.  
 
Lee, M.P., J.D. Ravenel, R.J. Hu, L.R. Lustig, G. Tomaselli, R.D. Berger, S.A. Brandenburg, T.J. 
Litzi, T.E. Bunton, C. Limb, H. Francis, M. Gorelikow, H. Gu, K. Washington, P. Argani, 
	  	    
131	  
J.R. Goldenring, R.J. Coffey, and A.P. Feinberg. 2000. Targeted disruption of the kvlqt1 
gene causes deafness and gastric hyperplasia in mice. 106:1447-1455. 
 
Lee, S.Y., A. Banerjee, and R. MacKinnon. 2009. Two separate interfaces between the voltage 
sensor and pore are required for the function of voltage-dependent K(+) channels. PLoS 
Biol. 7:e47. 
 
Lesage, F., B. Attali, J. Lakey, E. Honore, G. Romey, E. Faurobert, M. Lazdunski, and J. 
Barhanin. 1993. Are Xenopus oocytes unique in displaying functional IsK channel 
heterologous expression? Receptors Channels. 1:143-152. 
 
Liu, G., S.I. Zakharov, L. Yang, S.X. Deng, D.W. Landry, A. Karlin, and S.O. Marx. 2008a. 
Position and Role of the BK Channel {alpha} Subunit S0 Helix Inferred from Disulfide 
Crosslinking. J Gen Physiol. 131:537-548.  
 
Liu, G., S.I. Zakharov, L. Yang, R.S. Wu, S.X. Deng, D.W. Landry, A. Karlin, and S.O. Marx. 
2008b. Locations of the beta1 transmembrane helices in the BK potassium channel. Proc 
Natl Acad Sci U S A. 105:10727-10732.  
 
Long, S.B., E.B. Campbell, and R. Mackinnon. 2005a. Crystal structure of a mammalian 
voltage-dependent Shaker family K+ channel. Science. 309:897-903. 
 
Long, S.B., E.B. Campbell, and R. Mackinnon. 2005b. Voltage sensor of Kv1.2: structural basis 
of electromechanical coupling. Science. 309:903-908. 
 
Long, S.B., X. Tao, E.B. Campbell, and R. MacKinnon. 2007. Atomic structure of a voltage-
dependent K+ channel in a lipid membrane-like environment. Nature. 450:376-382.  
 
Lundby, A., L.S. Ravn, J.H. Svendsen, S.P. Olesen, and N. Schmitt. 2007. KCNQ1 mutation 
Q147R is associated with atrial fibrillation and prolonged QT interval. Heart Rhythm. 
4:1532-1541.  
 
Luo, X., J. Xiao, H. Lin, Y. Lu, B. Yang, and Z. Wang. 2008. Genomic structure, transcriptional 
control, and tissue distribution of HERG1 and KCNQ1 genes.  Am J Physiol Heart Circ 
Physiol.  294:1371-80.  
 
Lvov, A., S.D. Gage, V.M. Berrios, and W.R. Kobertz. 2010. Identification of a protein-protein 
interaction between KCNE1 and the activation gate machinery of KCNQ1. J Gen Physiol. 
135:607-618. 
 
MacKinnon, R. 1991. Determination of the subunit stoichiometry of a voltage-activated 
potassium channel. Nature. 350:232-235. 
 
MacKinnon, R. 1995. Pore loops: an emerging theme in ion channel structure. [Review]. Neuron. 
14:889-892. 
 
	  	    
132	  
MacKinnon, R., and C. Miller. 1988. Mechanism of charybdotoxin block of the high-
conductance, Ca2+- activated K+ channel. Journal of General Physiology. 91:335-349. 
 
MacKinnon, R., and G. Yellen. 1990. Mutations affecting TEA blockade and ion permeation in 
voltage- activated K+ channels. 250:276-279. 
 
Marx, S.O., J. Kurokawa, S. Reiken, H. Motoike, J. D'Armiento, A.R. Marks, and R.S. Kass. 
2002. Requirement of a macromolecular signaling complex for beta adrenergic receptor 
modulation of the KCNQ1-KCNE1 potassium channel. Science. 295:496-499. 
 
Melman, Y.F., A. Domenech, S. de la Luna, and T.V. McDonald. 2001. Structural determinants 
of KvLQT1 control by the KCNE family of proteins. J Biol Chem. 276:6439-6444. 
 
Melman, Y.F., A. Krumerman, and T.V. McDonald. 2002. A single transmembrane site in the 
KCNE-encoded proteins controls the specificity of KvLQT1 channel gating. J Biol Chem. 
277:25187-25194. 
 
Melman, Y.F., S.Y. Um, A. Krumerman, A. Kagan, and T.V. McDonald. 2004. KCNE1 binds to 
the KCNQ1 pore to regulate potassium channel activity. Neuron. 42:927-937. 
 
Miller, C., E. Moczydlowski, R. Latorre, and M. Phillips. 1985. Charybdotoxin, a protein 
inhibitor of single Ca2+-activated K+ channels from mammalian skeletal muscle. Nature. 
313:316-318. 
 
Morin, T.J., and W.R. Kobertz. 2007. A derivatized scorpion toxin reveals the functional output 
of heteromeric KCNQ1-KCNE K+ channel complexes. ACS Chem Biol. 2:469-473.  
 
Morin, T.J., and W.R. Kobertz. 2008. Counting membrane-embedded KCNE beta-subunits in 
functioning K+ channel complexes. Proc Natl Acad Sci U S A. 105:1478-1482.  
 
Murai, T., A. Kazikuza, T. Takumi, H. Ohkubo, and S. Nakanishi. 1989. Molecular cloning and 
sequence analysis of human genomic DNA encoding a novel membrane protein which 
exhibits a slowly activating potassium channel activity. Biochemical and biophysical 
research communications. 161:176-181. 
 
Mustapha, Z., L. Pang, and S. Nattel. 2007. Characterization of the cardiac KCNE1 gene 
promoter. Cardiovasc Res. 73:82-91.  
 
Nakajo, K., and Y. Kubo. 2007. KCNE1 and KCNE3 stabilize and/or slow voltage sensing S4 
segment of KCNQ1 channel. J Gen Physiol. 130:269-281.  
 
Nakajo, K., M.H. Ulbrich, Y. Kubo, and E.Y. Isacoff. 2010. Stoichiometry of the KCNQ1 - 
KCNE1 ion channel complex. Proc Natl Acad Sci U S A. 107:18862-18867. 
 
Nattel, S. 2002. New ideas about atrial fibrillation 50 years on. Nature. 415:219-226.  
 
	  	    
133	  
Neyroud, N., F. Tesson, I. Denjoy, M. Leibovici, C. Donger, J. Barhanin, S. Faure, F. Gary, P. 
Coumel, C. Petit, K. Schwartz, and P. Guicheney. 1997. A novel mutation in the 
potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory 
syndrome. 15:186-189. 
 
Noble, D., and R.W. Tsien. 1969. Outward membrane currents activated in the plateau range of 
potentials in cardiac Purkinje fibres. Journal of Physiology. 200:205-231. 
 
Osteen, J.D., C. Gonzalez, K.J. Sampson, V. Iyer, S. Rebolledo, H.P. Larsson, and R.S. Kass. 
2010. KCNE1 alters the voltage sensor movements necessary to open the KCNQ1 
channel gate. Proc Natl Acad Sci U S A.  
 
Panaghie, G., and G.W. Abbott. 2007. The Role of S4 Charges in Voltage-dependent and 
Voltage-independent KCNQ1 Potassium Channel Complexes. J Gen Physiol. 
 
Panaghie, G., K.K. Tai, and G.W. Abbott. 2006. Interaction of KCNE subunits with the KCNQ1 
K+ channel pore. The Journal of physiology. 570:455-467. 
 
Papazian, D.M. 1999. Potassium channels: some assembly required. Neuron. 23:7-10.  
 
Papazian, D.M., X.M. Shao, S.A. Seoh, A.F. Mock, Y. Huang, and D.H. Wainstock. 1995. 
Electrostatic interactions of S4 voltage sensor in Shaker K+ channel. Neuron. 14:1293-
1301. 
 
Pascual, J.M., C.C. Shieh, G.E. Kirsch, and A.M. Brown. 1995. Multiple residues specify 
external tetraethylammonium blockade in voltage-gated potassium channels. 69:428-434. 
 
Peretz, A., H. Schottelndreier, L.B. Aharon-Shamgar, and B. Attali. 2002. Modulation of 
homomeric and heteromeric KCNQ1 channels by external acidification. The Journal of 
physiology. 545:751-766. 
 
Piccini, M., F. Vitelli, M. Seri, L.J. Galietta, O. Moran, A. Bulfone, S. Banfi, B. Pober, and A. 
Renieri. 1999. KCNE1-like gene is deleted in AMME contiguous gene syndrome: 
identification and characterization of the human and mouse homologs. 60:251-257. 
 
Pusch, M., R. Magrassi, B. Wollnik, and F. Conti. 1998. Activation and inactivation of 
homomeric KvLQT1 potassium channels. 75:785-792. 
 
Restier, L., L. Cheng, and M.C. Sanguinetti. 2008. Mechanisms by which atrial fibrillation-
associated mutations in the S1 domain of KCNQ1 slow deactivation of IKs channels. The 
Journal of physiology. 586:4179-4191.  
 
Rhodes, T.E., R.L. Abraham, R.C. Welch, C.G. Vanoye, L. Crotti, M. Arnestad, R. Insolia, M. 
Pedrazzini, C. Ferrandi, A. Vege, T. Rognum, D.M. Roden, P.J. Schwartz, and A.L. 
George, Jr. 2008. Cardiac potassium channel dysfunction in sudden infant death 
syndrome. J Mol Cell Cardiol. 44:571-581.  
	  	    
134	  
 
Rocheleau, J.M., S.D. Gage, and W.R. Kobertz. 2006. Secondary structure of a KCNE 
cytoplasmic domain. J Gen Physiol. 128:721-729.  
 
Rocheleau, J.M., and W.R. Kobertz. 2008. KCNE peptides differently affect voltage sensor 
equilibrium and equilibration rates in KCNQ1 K+ channels. J Gen Physiol. 131:59-68.  
 
Roepke, T.K., K. Purtell, E.C. King, K.M. La Perle, D.J. Lerner, and G.W. Abbott. 2010. 
Targeted deletion of Kcne2 causes gastritis cystica profunda and gastric neoplasia. PLoS 
One.  
 
Romey, G., B. Attali, C. Chouabe, I. Abitbol, E. Guillemare, J. Barhanin, and M. Lazdunski. 
1997. Molecular mechanism and functional significance of the MinK control of the 
KvLQT1 channel activity. J Biol Chem. 272:16713-16716. 
 
Sanguinetti, M.C., M.E. Curran, A. Zou, J. Shen, P.S. Spector, D.L. Atkinson, and M.T. Keating. 
1996. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) 
potassium channel. Nature. 384:80-83. 
 
Sanguinetti, M.C., and N.K. Jurkiewicz. 1990. Two components of cardiac delayed rectifier K+ 
current. Differential sensitivity to block by class III antiarrhythmic agents. Journal of 
General Physiology. 96:195-215. 
 
Schroeder, B.C., S. Waldegger, S. Fehr, M. Bleich, R. Warth, R. Greger, and T.J. Jentsch. 2000. 
A constitutively open potassium channel formed by KCNQ1 and KCNE3. Nature. 
403:196-199. 
 
Schulze-Bahr, E., W. Haverkamp, H. Wedekind, C. Rubie, M. Hordt, M. Borggrefe, G. Assmann, 
G. Breithardt, and H. Funke. 1997. Autosomal recessive long-QT syndrome (Jervell 
Lange-Nielsen syndrome) is genetically heterogeneous. 100:573-576. 
 
Seebohm, G., N. Strutz-Seebohm, R. Birkin, G. Dell, C. Bucci, M.R. Spinosa, R. Baltaev, A.F. 
Mack, G. Korniychuk, A. Choudhury, D. Marks, R.E. Pagano, B. Attali, A. Pfeufer, R.S. 
Kass, M.C. Sanguinetti, J.M. Tavare, and F. Lang. 2007. Regulation of endocytic 
recycling of KCNQ1/KCNE1 potassium channels. Circ Res. 100:686-692. 
 
Sesti, F., K.K. Tai, and S.A. Goldstein. 2000. MinK endows the I(Ks) potassium channel pore 
with sensitivity to internal tetraethylammonium. Biophysical journal. 79:1369-1378. 
 
Shamgar, L., Y. Haitin, I. Yisharel, E. Malka, H. Schottelndreier, A. Peretz, Y. Paas, and B. 
Attali. 2008. KCNE1 constrains the voltage sensor of Kv7.1 K+ channels. PLoS ONE. 
3:e1943. doi:10.1371/journal.pone.0001943. 
 
Smith, J.A., C.G. Vanoye, A.L. George, Jr., J. Meiler, and C.R. Sanders. 2007. Structural models 
for the KCNQ1 voltage-gated potassium channel. Biochemistry. 46:14141-14152.  
 
	  	    
135	  
Soma, K., K. Nagaoka, M. Kuwahara, H. Tsubone, and K. Ito. 2010. Abundant expression of 
KCNE1 in the left ventricle of the miniature pig. Heart Vessels. 26:353-356.  
 
Tai, K.K., and S.A. Goldstein. 1998. The conduction pore of a cardiac potassium channel. 
Nature. 391:605-608. 
 
Takumi, T., K. Moriyoshi, I. Aramori, T. Ishii, S. Oiki, Y. Okada, OhkuboH., and S. Nakanishi. 
1991. Alteration of channel activities and gating by mutations of slow ISK potassium 
channel. J Biol Chem. 266:22192-22198. 
 
Takumi, T., H. Ohkubo, and S. Nakanishi. 1988. Cloning of a membrane protein that induces a 
slow voltage-gated potassium current. Science J1  - sci. 242:1042-1045. 
 
Tamargo, J., R. Caballero, R. Gomez, C. Valenzuela, and E. Delpon. 2004. Pharmacology of 
cardiac potassium channels. Cardiovasc Res. 62:9-33.  
 
Tapper, A.R., and A.L. George, Jr. 2000. MinK subdomains that mediate modulation of and 
association with KvLQT1. 116:379-390. 
 
Tapper, A.R., and A.L. George, Jr. 2001. Location and orientation of minK within the I(Ks) 
potassium channel complex. J Biol Chem. 276:38249-38254. 
 
Tian, C., C.G. Vanoye, C. Kang, R.C. Welch, H.J. Kim, A.L. George, Jr., and C.R. Sanders. 
2007a. Preparation, functional characterization, and NMR studies of human KCNE1, a 
voltage-gated potassium channel accessory subunit associated with deafness and long QT 
syndrome. Biochemistry. 46:11459-11472.  
 
Tian, X.L., Y. Cheng, T. Zhang, M.L. Liao, S.L. Yong, and Q.K. Wang. 2007b. Optical mapping 
of ventricular arrhythmias in LQTS mice with SCN5A mutation N1325S. Biochemical 
and biophysical research communications. 352:879-883. 
 
Tinel, N., S. Diochot, M. Borsotto, M. Lazdunski, and J. Barhanin. 2000. KCNE2 confers 
background current characteristics to the cardiac KCNQ1 potassium channel. 19:6326-
6330. 
 
Tiwari-Woodruff, S.K., M.A. Lin, C.T. Schulteis, and D.M. Papazian. 2000. Voltage-dependent 
structural interactions in the Shaker K(+) channel. J Gen Physiol. 115:123-138. 
 
Tristani-Firouzi, M., and M.C. Sanguinetti. 1998. Voltage-dependent inactivation of the human 
K+ channel KvLQT1 is eliminated by association with minimal K+ channel (minK) 
subunits. The Journal of physiology. 510 ( Pt 1):37-45. 
 
Tyson, J., L. Tranebjaerg, S. Bellman, C. Wren, J.F. Taylor, J. Bathen, B. Aslaksen, S.J. Sorland, 
O. Lund, S. Malcolm, M. Pembrey, S. Bhattacharya, and M. Bitner-Glindzicz. 1997. IsK 
and KvLQT1: mutation in either of the two subunits of the slow component of the 
	  	    
136	  
delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome. 
6:2179-2185. 
 
Tzounopoulos, T., H.R. Guy, S. Durell, J.P. Adelman, and J. Maylie. 1995. min K channels form 
by assembly of at least 14 subunits. Proc Natl Acad Sci U S A. 92:9593-9597. 
 
Van Horn, W.D., C.G. Vanoye, and C.R. Sanders. 2011. Working model for the structural basis 
for KCNE1 modulation of the KCNQ1 potassium channel. Curr Opin Struct Biol. 
21:283-291.  
 
Vemana, S., S. Pandey, and H.P. Larsson. 2004. S4 movement in a mammalian HCN channel. J 
Gen Physiol. 123:21-32.  
 
Wang, K.W., and S.A. Goldstein. 1995. Subunit composition of minK potassium channels.  
Neuron. 14:1303-1309.  
Wang, Q., J. Shen, I. Splawski, D. Atkinson, Z. Li, J.L. Robinson, A.J. Moss, J.A. Towbin, M.T.  
Keating. 1995. SCN5A mutations associated with an inherited cardiac arrhythmia, long 
QT syndrome. Cell. 80: 805-11.  
 
Wang, K.W., K.K. Tai, and S.A. Goldstein. 1996a. MinK residues line a potassium channel pore. 
Neuron. 16:571-577. 
 
Wang, Q., M.E. Curran, I. Splawski, T.C. Burn, J.M. Millholland, T.J. VanRaay, J. Shen, K.W. 
Timothy, G.M. Vincent, T. de Jager, P.J. Schwartz, J.A. Toubin, A.J. Moss, D.L. 
Atkinson, G.M. Landes, T.D. Connors, and M.T. Keating. 1996b. Positional cloning of a 
novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet. 
12:17-23. 
 
Wang, W., J. Xia, and R.S. Kass. 1998. MinK-KvLQT1 fusion proteins, evidence for multiple 
stoichiometries of the assembled IsK channel. J Biol Chem. 273:34069-34074. 
 
Wiener, R., Y. Haitin, L. Shamgar, M.C. Fernandez-Alonso, A. Martos, O. Chomsky-Hecht, G. 
Rivas, B. Attali, and J.A. Hirsch. 2008. The KCNQ1 (Kv7.1) COOH terminus, a 
multitiered scaffold for subunit assembly and protein interaction. J Biol Chem. 283:5815-
5830.  
 
Woycechowsky, K.J., and R.T. Raines. 2000. Native disulfide bond formation in proteins. Curr 
Opin Chem Biol. 4:533-539.  
 
Xu, X., M. Jiang, K.L. Hsu, M. Zhang, and G.N. Tseng. 2008. KCNQ1 and KCNE1 in the IKs 
channel complex make state-dependent contacts in their extracellular domains. J Gen 
Physiol. 131:589-603.  
 
Xu, X., V.A. Kanda, E. Choi, G. Panaghie, T.K. Roepke, S.A. Gaeta, D.J. Christini, D.J. Lerner, 
and G.W. Abbott. 2009. MinK-dependent internalization of the IKs potassium channel. 
	  	    
137	  
Cardiovasc Res. 82:430-438. Yang, N., A.L. George, Jr., and R. Horn. 1997a. Probing 
the outer vestibule of a sodium channel voltage sensor. Biophysical journal. 73:2260-
2268.  
 
Yang, W.P., P.C. Levesque, W.A. Little, M.L. Conder, F.Y. Shalaby, and M.A. Blanar. 1997b. 
KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias. 
Proc.Natl.Acad.Sci.U.S.A. 94:4017-4021. 
 
Yarov-Yarovoy, V., D. Baker, and W.A. Catterall. 2006. Voltage sensor conformations in the 
open and closed states in ROSETTA structural models of K(+) channels. Proc Natl Acad 
Sci U S A. 103:7292-7297.  
 
Yellen, G., M.E. Jurman, T. Abramson, and R. MacKinnon. 1991. Mutations affecting internal 
TEA blockade identify the probable pore- forming region of a K+ channel. 251:939-942. 
 
Zheng, R., K. Thompson, E. Obeng-Gyimah, D. Alessi, J. Chen, H. Cheng, and T.V. McDonald. 
2010. Analysis of the interactions between the C-terminal cytoplasmic domains of 
KCNQ1 and KCNE1 channel subunits. Biochem J. 428:75-84. 
 
 
